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Summary 
Mycobacterium abscessus is a multidrug resistant pathogen commonly isolated from 
patients with cystic fibrosis. Currently, there is no rapid diagnostic tool to detect the 
presence of M. abscessus. Rapid diagnosis followed by appropriate, prompt treatment 
remains the best curative approach to mitigate disease burden and halt transmission. A 
major bottle neck in developing a rapid diagnostic assay is DNA extraction. 
Mycobacterial cells are very difficult to lyse, the existing methods are time consuming 
resulting in long turnaround time to detect the pathogen. 
 
This study employed the use of microwave energy to rapidly release nucleic acids from 
microorganisms and test the ability to detect the released nucleic acids in a magnetic-
bead-based sandwich hybridisation assay using specific DNA probes. Based on published 
genome sequences, probes targeting the rpoB and erm-41 genes of M. abscessus and M. 
smegmatis were designed. In a magnetic-bead-based sandwich hybridisation assay using 
these specific probes, M. abscessus and M. smegmatis were distinguished from non-
specific isolates within 70 mins with a lower detection limit of 1 pg/µL.  
 
The disruptive effects of microwaves on biological structures has been attributed to the 
local generation of heat. The contribution, if any, of non-thermal factors is yet to be 
determined. To study the interaction of microwaves with cell membranes, the structure 
which represents the major barrier to DNA release, fluorescent microscopy was employed 
to examine the passage of different sized fluorescent dextran particles into bacterial and 
yeast cells following microwave exposure. The results show a transient membrane 
disruption, size dependent permeabilization of dextran particles into cells.  
 
In conclusion, a prototype hybridisation assay capable of detecting M. abscessus and M. 
smegmatis has been developed. The application of microwaves to cells induced membrane 
disruption allowing internalisation of varying sizes of fluorescent dextran particles and 
the release of intact DNA for detection in hybridisation assay.   
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1.0 Mycobacteria 
Mycobacteria species are a worrying problem consistently generating research interest 
due to their pathogenicity for humans and animals (Han et al. 2007). They are a diverse 
species reported to number over 100 members ranging from harmless saprophytes to 
pathogenic organisms (Ripoll et al. 2009). They are grouped as slow or rapid growing, 
pigmented or non-pigmented and tuberculous or nontuberculous (Adekambi and 
Drancourt 2004). They are characterised by the unique composition of their cell wall 
structure and high mycolic acid content comprising mainly of alkyl and long β-hydroxyl 
fatty acids (Hett and Rubin 2008). This enhances cell wall rigidity and enables the bacteria 
to survive in the presence of antibiotics which target cell wall structures common to other 
classes of bacteria. A typical mycobacteria specie is considered as Gram-positive, non-
motile, non-spore forming and rod-shaped bacilli with size ranging between 0.3 to 0.5 µm 
in diameter and length between 1.5 μm and 4.0 µm (Cook et al. 2009). The cell wall 
structure and membrane compositions of mycobacteria in comparison to other groups of 
bacteria e.g. Gram-negative, Gram-positive and yeast cells differ significantly, and these 
are discussed below.  
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1.1 Cell wall differences of mycobacteria and other cell types  
Structurally, Gram positives e.g. S. aureus and Gram-negatives e.g. E. coli are 
differentiated based on the composition of peptidoglycan in their cell wall. E. coli has a 
thin peptidoglycan (PG) layer that is a few nanometres thick, representing one to a few 
layers while in S. aureus, the PG is between 30–100 nm thick and contains many layers 
(Fig. 1.1) (Huanga et al. 2008). Peptidoglycan is not present in yeast cells (C. albicans) 
but the outer core consist of intricate network of polysaccharide fibrils composed of β-
(1,3)-glucan which is linked covalently to β-(1,6)-glucan and chitin- a β-(1,4)-linked 
polymer of N-acetylglucosamine (Ruiz-Herrera et al. 2006). This organised core structure 
acts as a scaffold for the external layer which consist of highly glycosylated 
mannoproteins (McKenzie et al. 2010). The cell wall characteristics of mycobacteria lie 
between that of Gram-positive and Gram-negative bacteria. Mycobacteria have a complex 
cell envelope consisting of a PG containing arabinogalactan that is covalently attached to 
mycolic acids (Fig 1.1). Mycolic acids are characterised by intricate long chain alkyl 
groups with a maximum length of about 90 carbons. This intricate network of alkyl chains 
give the bacteria a waxy appearance and become resistant to lyse and for exogenous 
substances to penetrate (Silhavy et al. 2010).  
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Figure 1.1. Comparison of cell wall composition between Mycobacteria  (A), 
Gram-positive (B), Gram-negative (C) and yeast cells (D). Picture adapted from 
(Brown et al. 2015) 
 
 
 
 
 
Tuberculous mycobacteria (slow growers) are those that cause tuberculosis and is 
comprised of six members known as the Mycobacterium tuberculosis complex (MTBC). 
These include; M. tuberculosis (M. tb), the causative agent for tuberculosis in man, 
Mycobacterium africanum, Mycobacterium bovis, Mycobacterium canettii, 
Mycobacterium pinnipedii and Mycobacterium microti. Although this group (MTBC) are 
genetically similar, they affect a diverse range of hosts. For instance, M. africanum and 
M. canettii are the closest relative to M. tb both causing tuberculosis (TB) but are 
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restricted to the equatorial regions of Africa. M. bovis, the causative agent of bovine 
tuberculosis is the only member of the complex capable of infecting a diverse range of 
animals including wild and domestic species (Mostowy et al. 2005). M. pinnipedii and M. 
microti infect seals and wolves respectively (Cousins et al. 2003; Mostowy et al. 2005). 
Although mycobacteria species are known primarily for their pathogenicity, some possess 
unique characteristics which are being exploited for industrial applications. For example, 
Mycobacterium austroafricanuum has the  unique ability  to degrade methyl tert-butyl 
ether and is being explored as a potential decontaminant of contaminated ground water 
(Maciel et al. 2008). Of species in the MTBC, M. tb and M. bovis are the most common 
and are described below.  
 
 
1.2 Bovine tuberculosis (B. Tb) 
Mycobacterium bovis (M. bovis) is the causative agent of B. tb, which mostly occurs in 
domestic and wild animals. M. bovis can be shared between humans and animals (zoonotic 
transmission) (Mostowy et al. 2004; Mostowy et al. 2005; Schiller et al. 2010). Zoonotic 
transmission occurs through the consumption of unpasteurised cow milk or meat infected 
with the bacilli (de la Rua-Domenech et al. 2006; Torres-Gonzalez et al. 2013). There is 
undisputable scientific evidence from badgers acting as reservoirs for M. bovis and are 
actively involved in transmission to cattle (Bhuachalla et al. 2015). Clinical evidence of 
human to human transmission has also been documented (Sunder et al. 2009). Infection 
with M. bovis is characterised by the formation of granuloma lesions with different 
degrees of calcification, necrosis and encapsulation in the lung tissues and other organs 
(Michel et al. 2010). B. tb remains a major public health concern in developing countries 
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and developed countries such as the UK. Identifying the presence of the pathogen in a 
single animal often results in the slaughter of the entire herd. Between 2008 and 2015, a 
total of 68, 630 cattle were slaughtered in the UK due to B. tb with 11.8% of these cases 
occurring in 2015 alone (fig 1.2) (Carl 2015). Such losses can have a huge financial impact 
on farm output and a subsequent decline in business. Between 2008 and 2009, Britain 
spent approximately £100 million on the management of B. tb (Schiller et al. 2010) and 
the Welsh government spends about £5 million a year on vaccination research. 
 
 
 
Figure 1.2 The scale of Bovine tuberculosis in UK. The total number of animals 
slaughtered in regions of Wales, Scotland and England. Picture adapted from 
https://www.thetimes.co.uk/article/shoot-the-badgers-ql67nxgjdf9. Date accessed 18/11/2018 
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On the global scale, an estimated US$3 billion is lost annually due to B. tb (Schiller et al. 
2010). These are huge expenditures which are very costly and presents a major problem. 
The above challenges can be attributed in part to the absence of effective diagnostic tools 
capable of delivering patients results within a short time frame. The most widely used 
screening tool is the tuberculin skin test (TST). This test is discussed in detail in section 
1.9.4.1. Unfortunately, TST is prone to false-positive results due to exposure of cattle to 
other environmental mycobacteria species (Katial et al. 2001; Buddle et al. 2009). Also, 
the test can generate a false-negative result due to immunosuppression, desensitization 
towards tuberculin and the use of less potent tuberculin (Wadhwa et al. 2012). Measuring 
humoral antibody following injection of a mycobacterial purified protein derivative (PPD) 
is as an alternative method to detect M. bovis infection. Unfortunately, this test lacks 
specificity due to cross reactivity with other pathogens (Lilenmaum et al. 1999; Molicotti 
et al. 2014). Accessing sensitive, specific point-of-care (POC) assay capable of 
determining whether an animal is infected will have a significant effect on disease control 
and prevent the needless slaughter of farm animals. 
 
 
1.3  Human tuberculosis (M. tb) 
TB is the number one cause of mycobacteriosis worldwide. It is transmitted through 
inhalation of respiratory droplet containing viable bacteria which can be produced by 
sneezing or coughing. Such respiratory droplets are usually 1-5 µm in diameter and 
contain between 1-10 bacilli (Lee 2016a). TB is reported in over 205 countries and 
territories which consists about 99% of the world’s population (WHO 2015). The reported 
disease burden is low in developed countries such as Canada, New Zealand and Australia 
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but considerably higher in countries such as Brazil, China, Namibia and some parts of the 
African continent (McNerney et al. 2012). This is mainly attributed to factors such as 
HIV/AIDS co-infection, the emergence of multidrug resistant isolates, the absence of 
rapid and efficient diagnostic tools and the deterioration of public health systems (Weyer 
et al. 2011; Forrellad et al. 2013; WHO 2015). For instance, HIV/AIDS patients suffer a 
weakening of the immune system and as a result become susceptible to M. tb (Kasprowicz 
et al. 2011; Venturini et al. 2014). Disturbingly, TB has become incessantly resistant to 
antibiotics. In 2014, the global estimate of new multidrug resistant TB (MDR-TB) was 
480, 000 with half of these cases occurring in China, India and the Russian federation 
(WHO 2015). TB drug resistance is difficult to treat (Kamphee et al. 2015).  
 
Currently, only a small number of drug resistant TB cases are detected and appropriately 
treated since the tools for providing accurate and rapid diagnosis at the time of the initial 
patient consultation are unavailable (Ormerod 2005). A reported 32% of HIV related 
deaths are associated with TB, with over 650,000 cases due to MDR-TB (Moreno-
Altamirano et al. 2012). Out of the total number of individuals infected with TB in 2014, 
12% (1.2 million) were living with HIV and 0.4 million subsequently died (WHO 2015) 
and in 2015, an estimated 10.4 million people were reported to have suffered from TB 
which resulted in a total of 1.8 million deaths (WHO 2015).  
 
TB transmission and its ability to establish lifelong infections depends on the bacterial 
load at the time of infection, the immune status of the individual, virulent state of the 
bacilli, environmental stress and biosocial factors (Lee 2016b). TB mainly presents in two 
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different states namely; active and latent forms. Latent TB is when an individual is 
infected with the TB bacilli but does not present with any clinical symptoms, with a 
negative chest X-ray and no microbiological evidence. Latent TB is not transmitted (Lee 
2016a) since the bacilli has reduced metabolic activity and remains dormant for decades 
unless the host immune response is compromised then the bacterium is reactivated (fig 
1.3a).  
 
Upon infection, TB bacilli are engulfed by antigen presenting cells (alveolar macrophages 
or dendritic cells) to form a solid granuloma. Inside the granuloma, the bacilli are 
contained so that they do not develop into active forms (Fig 1.3a) (Pai et al. 2016). Latent 
TB is reported in about 2 billion individuals (Kaufmann et al. 2017). Solid granulomas 
can lose their ability to contain the bacterium through cell death and necrosis releasing 
dormant bacteria which are subsequently activated and go on to cause clinical symptoms 
(active TB) (Fig 1.3b). Apart from the lungs which TB primarily infects (pulmonary TB), 
M. tb also infect the lymph nodes, pleura, skin, joints, central nervous system (CNS), 
gastrointestinal tract, abdomen (extrapulmonary TB). Miliary TB is a hematogenous form 
of TB which is characterised by tiny lesions on multiple organs involving the lungs, 
spleen, CNS and liver (Nachiappan et al. 2017).  
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Figure 1.3. Infection stages of (a) latent and (b) active TB . (a) Latent TB – M. tb 
bacilli enters the lungs and reaches the alveoli space where it is phagocytosed by the alveolar 
macrophages. When this defence mechanism fails, M. tb progresses to infect the interstitial tissues 
of the alveolar epithelium or the infected alveolar, macrophages migrating to the lung 
parenchyma. This event is followed by the action of dendritic cells or inflammatory cells 
transporting M. tb to the pulmonary lymph nodes for T cells to be primed. T and B cells are then 
recruited to the lung parenchyma to form granuloma. (b) Active TB - The active stage develops 
at the stage of granuloma formation. When the bacilli load is too large for the granuloma to 
contain, or necrosis of the granuloma occurs, it ruptures and leads to the active and symptomatic 
TB. Picture adapted from (Pai et al. 2016). 
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1.4 Virulence factors of M. tb 
Unlike other bacteria (e.g. Clostridium difficle) that produce toxins, mycobacteria lacks 
classical virulent factors (Forrellad et al. 2013). Complete sequencing of the M. tb genome 
reveals about 4,000 genes, of which 91 (2.3%) have been associated with virulence. Genes 
required for lipid metabolism, cell wall function and regulatory proteins synthesis 
accounts for approximately 5.7%, 13% and 4.7% respectively. These genes are needed 
for bacterial survival and thus could be considered as factors contributing to M. tb 
virulence (Smith 2003). Additionally, genes that are essential for signal transduction 
pathways and cell surface proteins have all been implicated as virulent factors (Smith 
2003). To this end, a classical definition of M. tb virulence factors is yet to be determined. 
According to Dubnau, M. tb virulent factors includes elements that are required for 
pathogenicity and bacterial survival inside a host while excluding those that are required 
for bacterial growth in culture medium (Dubnau 2002). Some of the key elements 
considered as M. tb virulent factors (i.e. controlling the interaction of the pathogen with 
host phagosomes and lysosomes) are discussed in more detail below. 
 
 
1.4.1 Interaction with phagosome and Lysosome 
As a well-known fact, TB infection begins with the inhalation of aerosols from the 
environment containing viable M. tb bacilli. Upon entering the lung, the bacillus is 
internalised by host activated macrophages and are taken up into the acidic compartment 
of the lysosomes. The mechanism is demonstrated with the use of nanoparticles (fig. 1.4) 
(Kaufmann 2001). Bacilli which are able to evade delivery to the lysosome and survive 
go onto cause an infection (Kaufmann 2001; Russell 2001). The bacterium possesses a 
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molecule called lipoarabinomannan (LAM) in its cell wall which prevents the formation 
of phosphatidylinositol 3-phosphate (PIP3) on the surface of endosomal and phagosomal 
membranes and regulates the transfer of phagocytosed M. tb bacilli to lysosomes. (Vergne 
et al. 2003). In addition, M. tb also produces a lipid phosphatase (SapM) and a protein 
phosphatase (PtpA and PtpB) which are released into the cytosol for specific functions 
upon entry into the host. SapM hydrolyses PIP3 on the phagosomal membrane while 
Protein tyrosine phosphatase (A/B) interferes with trafficking processes via 
dephosphorylation mechanisms (Saleh and Belisle 2000; Bach et al. 2008).  
 
Another mechanism by which M. tb outwits lysosomal degradation is by producing a 
signalling molecule that prevents fusion of the phagosome to the lysosome. Increased 
synthesis of protein kinase G (PknG) in the phagosome of infected macrophages has been 
reported in a study by Walburger and colleagues. It was discovered that PknG prevents 
fusion of phagosomes and lysosomes. To confirm this observation mutants  lacking the 
ability to synthesise PknG were unable to prevent phagosome / lysosome fusion resulting 
the death of the bacterium  (Walburger et al. 2004).  
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Figure 1.4. The process of macrophage mediated phagocytosis and lysosome 
degradation of bacteria in infected host. Nanoparticles enter the cell via four major 
pathways, namely; clathrin/caveolar-mediated, phagocytosis, micropinocytosis and pinocytosis. 
Upon entry into the cell, nanoparticles exit via lysozyme secretion, vesicle related secretion and 
non-vesicle related secretion. MVBs means multivesicular bodies. Picture adapted from Oh and 
Park 2014.  
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1.4.2 Cell envelope virulent factors 
The outer membrane of M. tb is of interest as it interacts with macrophages. The 
mycobacterial cell wall consists of glycolipids such as LAM - as mentioned above, 
trehalose 6, 6´- di-mycolate (TDM) also known as cord factor and phithiocerol 
dimycocerate (PDM). All these glycolipids have been implicated in M. tb virulence 
(Meena and Rajni 2010). LAM stimulates the release of tumour necrosis factor (TNF- α), 
a major cytokine released in response to M. tb infection. TNF- α is over produced in TB 
infected individuals which leads to the notable Tb-like symptoms such as weight loss, 
fever and cytokine-mediated necrosis (Rajini et al., 2011). LAM also acts as a virulent 
factor by inhibiting the activity of protein kinase C, an enzyme required for macrophage 
activation (Chan et al. 1991). While macrophages are required to engulf (phagocytose) 
M. tb bacilli, their reduced activation implies a deficiency in phagocytic process, allowing 
M. tb to be viable and become virulent (Rajini et al., 2011).  
 
When M. tb is phagocytosed, the bacilli contained in the phagosome fuses with the 
lysosome (acidic environment) to form the phagolysosome for intracellular destruction of 
the pathogen. PDM and TDM demonstrate similar virulence characteristics by preventing 
the formation of the phagolysosome. PDM which is present on the plasma membrane of 
M. tb participates in a receptor dependent phagocytosis of M. tb. This process involves 
modifying the plasma membrane of the host cells which eventually affects its biophysical 
property. One way the bacteria benefits from this is to regulate phagosomal pH, thereby 
creating a protective niche for the bacteria to survive (Astarie-Dequeker et al. 2009).   
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Similarly, TDM is required to inhibit fusion of phospholipid vesicles between phagosome 
and lysosome. This is achieved by increasing the stearic hindrance and increasing the 
force of hydration atb their surfaces to hinder their fusion (Rajini et al., 2011).  
 
1.4.3 Metabolic adaption of gene expression 
Metabolic adaptation is very important for any pathogen to survive in its host and results 
in the activation of specific genes are to enable the bacterium to employ an alternate 
biosynthetic pathway for nutrient metabolism. Studies have found that, M. tb switches 
from a preference for carbohydrate as main source of carbon to fatty acids after infecting 
its host (Segal and Hubert 1955). A key enzyme which the bacteria needs to continually 
metabolise fatty acids is isocitrate lyase produced by the isocitrate lyase (icl) gene. For 
M. tb to be able to thrive on fatty acids as the sole carbon source, the fatty acid is first 
converted into acetyl coA which can be channelled into the Kreb’s cycle via the 
glyoxylate cycle. In this   cycle, M. tb utilises isocitrate lyase to metabolise isocitrate to 
succinate. Mutant strains lacking icl cannot synthesis isocitrate lyase, hence are unable to 
metabolise fatty acids leading to reduced bacterial growth. This has been experimented in 
the lungs and extra-pulmonary organs of infected mice (McKinney et al. 2000; Shi et al. 
2003). Also, the igr operon in M. tb contains virulent genes such as cytochrome 125, 
fadE28/29 and lipid transfer protein (lpl2) that are required for cholesterol metabolism 
(Joshi et al. 2006). Mutant M. tb (i.e. lacking igr operon) replicate at a lesser rate in mouse 
models (Chang et al. 2009).  
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1.5 Treatment of M. tb and multi-drug resistant (MDR) burden 
Drug resistance is a major challenge in TB treatment. Drugs commonly used include 
rifampicin (RIF), ethambutol (ETMB), pyrazinamide (PZ) and isoniazid (INH). These are 
considered the first line of drugs for TB treatment. The nature of M. tb to demonstrate 
varying level of resistance to antibiotics i.e. intrinsic and passive mechanisms renders 
monotherapy noneffective. By applying multitherapy, other resistant mechanism which 
normally would have escaped single antibiotic treatment can be averted. Various forms 
of resistance have been encountered in TB therapy, namely; multi-drug resistance (MDR), 
extensive drug resistance (XDR) and total drug resistance (TDR). MDR refers to high 
level resistance to rifampicin and isoniazid (Ormerod 2005). An MDR strain that has 
additional resistance to any of the fluoroquinolone antibiotics (ofloxacin, levofloxacin and 
moxifloxacin) and to any of the second line injectable antibiotics (amikacin, kanamycin 
and capreomycin) is considered an XDR (Shah et al. 2007). XDR TB has been detected 
in 92 countries and 9.6% of MDR-TB cases progress to XDR-TB (Blaas et al. 2008; 
Velayati et al. 2009). TDR refers to M. tb that is insensitive to all forms of anti-TB drugs. 
TDR M. tb  have been identified in India, Italy and Iran (Migliori et al. 2007; Udwadia et 
al. 2012).  
 
To enable accurate reporting of TB and drug resistant cases, the WHO collaborates with 
and request data from the national tuberculosis control programme (NTP) or relevant 
public health authorities within the 203 countries and territories that are engaged in TB 
surveillance. These data are collated following standard procedures and further forms the 
basis of annual TB reports. In 2013, less than 25% of MDR cases were detected resulting 
in 170, 000 deaths (WHO 2013; Günther 2014). A careful examination of this problem 
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could be attributed to patient-clinician inadequacies. The administration of wrong 
antibiotics, inappropriate treatment regimens and non-adherence to treatment plan by the 
patient are all contributing factors. TB treatment can be improved by following and 
adhering to the treatment regimen lasting between 6-9 months. Patients unable to adhere 
to this treatment regimen create the opportunity for selecting resistant strains. Another 
major contributing factor is the lack of rapid diagnostic procedures. Diagnosis remains a 
corner stone in TB treatment and drug resistance monitoring. Studies to underpin the 
development of effective POC diagnosis is lacking and there is no doubt that these tools 
are much needed for TB management.  
 
1.6 Drug resistance mechanisms 
Resistance due to the acquisition of transferable DNA elements has yet to be reported in 
TB therapy. Gene mutations at drug binding targets, or a modification of specific enzyme 
required to convert a pro-drug into an active drug are the main factors contributing to 
resistance in M. tb. Four main drugs are considered as the first line of anti-TB drugs. Their 
mechanism of action and resistance are discussed below.  
1.6.1 Rifampicin (RIF) 
RIF is a lipophilic drug which targets and binds to the β-subunit of the RNA polymerase 
(rpoB). Upon binding, rifampicin inhibits the elongation of mRNA, a key transcriptional 
process required for bacterial growth (fig. 1.5). Resistance to RIF arises when its binding 
target (an 81 base pair region of the rpoB gene) is mutated (El-Hajj et al. 2001). This 
region is also referred to as RIF resistance determining region (RRDR) and approximately 
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95% of RIF resistant strains harbour this mutated gene (Zaczek et al. 2009). Almost all 
RIF resistant strains demonstrate isoniazid resistance, hence detection of RIF resistant 
isolate is usually classified as MDR (Qazi et al. 2014).  
1.6.2 Isoniazid (INH) 
INH is only active against actively replicating M. tb (Palomino and Martin 2014). The 
drug is designed as a pro-drug that requires activation by an enzyme produced by the 
bacterium called  catalase-peroxidase enzyme, katG,  which is encoded by katG gene 
(Konno et al. 1967; Scorpio and Zhang 1996). Activated INH in the form of isonicotinoyl 
acyl radical complexes with NAD+/NADH to form an INH-NADH adduct which  inhibits 
an enoyl-acyl carrier protein (ACP) reductase encoded by isonicotinic acid hydrazide A 
(inhA) which plays a critical role in mycolic acid synthesis a key component  for cell wall 
biosynthesis  (Cade et al. 2010).  
 
Resistance to INH is mainly attributed to mutations occurring in katG, inhA, kasA and ndh 
genes which reduce the binding affinity of the resulting proteins for INH. These genes 
also perform specific functions aiding M. tb survival. For instance, KasA encodes β-
ketoacyl-ACP involved in the synthesis of mycolic acid, KatG catabolises catalase and 
peroxidases generated within macrophages to aid bacterial survival (Ng et al. 2015), inhA 
encodes NADH-specific enoyl-ACP reductase required for mycolic acid biosynthesis 
(Vilcheze et al. 2000) and ndh is involved in ATP generation (Awasthy et al. 2014). 
Mutations in KasA has been detected in INH resistant and susceptible isolates, hence their 
role in INH resistance may be of less significance (Larsen et al. 2002; Almeida Da Silva 
and Palomino 2011). 
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1.6.3 Ethambutol (ETMB) 
ETMB is a bacteriostatic drug which interferes with the biosynthesis of arabinogalactan 
in the bacterial cell wall (fig 1.5). It targets the embB gene at position 306, although other 
studies have shown that mutation in this region does not necessarily lead to drug resistance 
but predisposes to other resistance mechanisms (Sreevatsan et al. 1997). As this gene is 
not a clear indicator of ETMB resistance, there is the need to identify other genes that can 
accurately predict ETMB resistance.  
 
1.6.4 Pyrazinamide (PZ) 
This is also another prodrug which is converted to its active form (pyrazinoic acid) by 
pyrazinamidase (PZase). The exact mechanism of PZ action is not fully known. One 
mechanism suggests that in acidic conditions, pyrazinoic acid disrupts bacterial 
membrane energetics via depletion of membrane potential and inhibits membrane 
transport (fig. 1.5) (Whitfield et al. 2015). A second mechanism suggests pyrazinoic acid 
inhibits fatty acid synthase type I in actively replicating M. tb bacilli (Ramaswamy and 
Musser 1998; Almeida Da Silva and Palomino 2011). Mutations occurring within pncA 
gene (encoding PZase) is the chief mechanism of PZ resistance. However, some 
pyrazinamide resistant isolates have been found not to harbour pncA mutations, 
suggesting resistance occurring through other genes such as panD. It is believed that panD 
is a target for pyrazinoic acid which inhibits panthoenate and co-enzyme A synthesis 
which are essential for energy production and fatty acid metabolism (Zhang et al. 2013). 
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Figure 1.5 Schematic representation of the mechanism of action of the first -
line anti-TB drugs . Picture adapted from (National Institute of Allergy and Infectious 
Diseases 2016). 
 
1.7 Policies and strategies to prevent TB infection 
The WHO has set itself the goal of a world free of TB by 2035. This can only be realised 
if there is a concerted effort from governments, non-governmental organisations and all 
other relevant bodies in countries where TB burden is high to support and implement 
policies developed by WHO. Two of the major policies implemented by the WHO will 
be discussed here i.e. The STOP TB strategy and the Directly Observed Treatment Short-
Course (DOTS) program. The former was built on the success of the latter to address 
unmet needs. The DOTS control program was established in 1994 when the WHO 
declared TB a disease of public health concern. This policy has 5 main components which 
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requires; (1) Government bodies to be committed to and to sustain TB control activities, 
(2) Identification of TB by sputum smear microscopy in symptomatic patients, (3) A 
supervised treatment regimen in patients between 6 to 8 months of therapy, (4) A constant 
and uninterrupted supply of all essential TB drugs and (5) A detailed recording and 
reporting system that easily allows assessment to treatment (Enarsona and Billo 2007).  
 
After 10 years of successful DOTS implementation, 20 million people have been treated 
and more than 16 million have been cured (Otu 2013). The implementation of DOTS also 
ensured that patients who do not adhere to rigorous requirement of TB medication were 
monitored. Also, the right drug dosage was given to patient to swallow under direct 
supervision from a health worker (Otu 2013). To address the unmet needs in the DOTS 
program, the STOP TB strategy was implemented which further focuses on addressing 
TB/HIV, MDR-TB, promoting research with the aim to developing vaccines, produce 
new drugs and diagnostic tools (The Stop TB Strategy 2018) 
 
1.8 TB Prevention Challenges 
The goal of the WHO to reduce TB mortality to 95% by 2035 can be realised by 
intensifying research into the development of new drugs, vaccines and rapid diagnostic 
tools. Vaccination is an effective method for the control of most infectious disease. Bacilli 
Calmette-Guerin (BCG), an attenuated strain of M. bovis is the first TB vaccine to be 
introduced in 1921 and  while this vaccine shows efficacy against TB in children, it offers 
little or no protection in adults with pulmonary TB (Kaufmann et al. 2017). The inability 
of this vaccine in preventing pulmonary TB in adults could be due to immunogenetic 
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differences in adults and children. Exposure to environmental mycobacteria which is 
likely to be high in adults could explain the observed differences. Due to these challenges, 
a more efficacious form of the vaccine capable of being used to protect against all forms 
of TB must be developed. Having TB vaccine is also of great importance to reduce the 
increasing cases of MDR-TB. Currently, there are approximately 13 vaccines in clinical 
development. These vaccines fall under 3 categories namely; viral vectored subunit, 
adjuvanted protein subunit and whole cell-derived vaccines (Fletcher and Schrager 2016). 
These are discussed below. 
 
1.8.1 Subunit vaccine 
Subunit vaccines contain one or more antigens in the form of protein, peptides or DNA 
(Franco-Paredes et al. 2006). Out of the 13 vaccines currently being studied 8 are subunit 
vaccines. Six contain or express either Ag85A or Ag85B. Ag85A is an enzyme required 
for mycolic acid biosynthesis during M. tb dormancy. Ag85A is required for lipid 
accumulation and lipid storage in M. tb. To boost the protectivity of this vaccine type, 
antigens can be formulated with an adjuvant or expressed by a recombinant viral vector 
(Kaufmann et al. 2017).  
 
1.8.2 Viral vectored vaccines 
The immune markers produced in TB patients are very diverse. For a vaccine to be 
effective, it needs to identify all the immune markers produced by an individual. Subunit 
vaccines can only elicit an immune response in a specific subpopulation of CD4+ T- cells 
which may not provide complete protection against TB in humans. To increase the 
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efficacy and protectivity of TB vaccines, antigens can be expressed from a recombinant 
viral vector e.g. adenovirus or vaccinia vectors. The choice of these vectors for vaccine 
development stems from a number of advantages, namely (1) they are  respiratory viruses 
and can be targeted to the lungs where M. tb resides, (2) they can express multiple antigens 
at the same time, (3) they possess  intrinsic adjuvant property and (4) have  an acceptable 
safety profile (da Costa et al. 2015). Unfortunately problems have also been encountered 
with an adenovirus type 5 HIV-1 vaccine trial being  discontinued due to  the occurrence 
of HIV infection in vaccine recipients (da Costa et al. 2015).   
 
1.8.3 Whole Cell-derived vaccines 
The challenge of identifying a single universal antigen suitable to be incorporated into a 
TB vaccine remains a challenge and an area of increased research. In contrast whole cells 
are polyantigenic and thus have the potential to stimulate a more comprehensive spectrum 
of protection than subunit vaccines. VaccaeTM is a whole cell heat-inactivated vaccine 
generated from a non-tuberculous mycobacterium (M. vaccae) and is currently the only 
vaccine candidate that has reached the most advanced stage of clinical trials.  In China it 
is currently being administered as an adjunctive treatment to M. tb (Frick 2015; Kaufmann 
et al. 2017).  
 
1.9 Methods of TB diagnostics 
Diagnosis is a key and fundamental component in the fight against TB (WHO 2015). In 
the absence of effective preventative methods, it is estimated that 200 million individuals 
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will develop active TB of which 35 million will die between 2000 and 2020 (Meena and 
Rajni 2010). The current control strategy for TB management requires effective diagnosis, 
followed by treatment at an early stage and extensive patient follow-up (Battaglioli1 et al. 
2013). Diagnosis is estimated to have saved about 43 million lives between 2000 and 2014 
(WHO 2015). Unfortunately, these requirements are not easily met especially in low 
resource settings such as Asia and Africa where rapid and simple diagnostic tools are not 
widely available. The diagnostic methods which are currently available lack specificity, 
sensitivity, are time consuming, requires access to sophisticated equipment and the need 
for highly trained technical staff (Maiga et al. 2012). Diagnostic tools capable of detecting 
the presence of M. tb in a clinical sample and at the same time determining its antibiotic 
sensitivity would be helpful in the effective management and control of TB.  The methods 
that have been developed for TB diagnosis are discussed below. 
 
1.9.1 Microscopy 
Microscopy is the cheapest and fastest means of detecting pulmonary TB (WHO 2013). 
The characteristic cell wall composition of these species enables easy detection using the 
Ziehl-Neelsen (ZN) staining method which is a common staining method for 
mycobacteria species. After staining, bacilli appear as pink or red rods under light 
microscope (Perkins et al. 2006). This method suffers from sensitivity and is unreliable. 
Sensitivity ranges between 22-43% with a lower limit of detection between 103-104 bacilli 
per ml (Singh and Kashyap 2012; Singhal and Myneedu 2015). Sensitivity can be 
improved using fluorescent microscopy. While this approach makes it easier to visualise 
the bacterium, it is unable to determine antibiotic susceptibility and identify resistant 
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isolates (Ryu 2015). It is also unable to distinguish between virulent and non- virulent 
mycobacteria species. 
 
Also, the cost of operation, the frequent need to replace the expensive mercury vapour 
lamps, the need for a continuous power supply and the need for a dark room restricts its 
use in less resourced communities. Light emitting diode (LED)-based fluorescent 
microscope have been developed and while they deliver readings three times faster than 
ZN, they currently lack sensitivity and specificity (Bhalla et al. 2013). 
 
1.9.2 Chest X-ray 
Chest X-ray has been used for more than 100 years for TB diagnosis. In a typical Tb 
patient, chest X-rays depict miliary nodules, lymphadenopathy, pleural effusion, 
cavitation and consolidation (fig. 1.6) (Nachiappan et al. 2017). An abnormal X- ray data 
is not an absolute confirmation of TB infection as other diseases such as sarcoidosis and 
neoplasma present with similar radiologic evidence (Mortaz et al. 2013) and requires 
further  clinical testing to ascertain the diagnostic status of the patient. Chest X-ray also 
suffers interobserver variability and specificity. A sensitivity range between 73-79% and 
a specificity of 60-63% has been reported (Piccazzo et al. 2014). To improve on the 
specificity of TB radiology, more powerful and sensitive imaging tools such as magnetic 
resonance imaging (MRI) and computer tomography (CT) scan are currently being used 
(Skoura et al. 2015). A CT scan is twice as sensitive in the detection of  TB lung cavities 
compared to chest X-ray (Nachiappan et al. 2017). Clearly given the reported level of 
sensitivities and specificities, chest X-ray results need to be confirmed with an additional 
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confirmatory test. The cost of operating such equipment, the need to train radiologists and 
the health hazards associated with exposures to radiations require much simpler and less 
expensive methods.  
 
 
Figure 1.6 Conventional X-ray of a TB patient . The right upper lope indicates a large 
cavity in the lung surrounded by consolidation and infiltrates. Picture adapted from (Pai et al. 
2016).  
 
 
1.9.3 Mycobacterial culture 
Sputum culture remains the gold standard for TB diagnosis (Ryu 2015). Before culturing 
on specialised medium (Lowenstein-Jensen), sputum samples must first be 
decontaminated to reduce the number of other bacteria present. Although an important 
procedure, decontamination reduces the number of viable bacilli in the sputum samples 
thus compromises sensitivity (Grandjean et al. 2008). The specificity and sensitivity of 
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this method is reported to be 98% and between 26-42% respectively (Wadhwa et al. 
2012). Traditional M. tb culture require 4-6 weeks of incubation on solid media (fig. 1.7), 
but this can be reduced to 10 days using a highly enriched liquid culture (Murray et al. 
2003; Ryu 2015). This method has some limiting factors, such as the need for biosafety 
level 3 (BSL 3) containment and time for pathogen detection as M. tb grows slowly 
(Grandjean et al. 2008). A tool capable of the real-time detection of the pathogen would 
have a significant impact on TB control. 
 
 
Figure 1.7. Growth of M. tb on Lowenstein-Jensen (LJ) agar. Yellow colonies of M. 
tb are seen growing on LJ agar after 6-8 weeks post culture. Picture adapted from (Castellana et 
al. 2016). 
 
 
1.9.4 Immunological methods 
Direct detection of M. tb bacilli from sputum samples can be challenging especially in 
children below the age of 12 and in severely compromised individuals such as those 
infected with HIV and in those who are unable to produce quality sputum samples 
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(Shingadia and Novelli 2003). Serological based methods come in handy when blood and 
urine are sample targets, as any patient would be able to provide these specimens without 
any difficulty. Immunological assays can be categorised into (1) direct assays which target 
the bacterium and (2) indirect assays which detect the body’s immune response to the 
pathogen. 
 
1.9.4.1 Indirect assay - Tuberculin skin test (TST) 
In TST, a cocktail of mycobacterial proteins containing purified peptide protein (PPD) 
prepared from heat killed cultures of M. tb is injected intradermally (Trajman et al. 2013). 
This induces a delayed-type hypersensitivity reaction due to the release of interferon 
gamma (INF-γ) at the site of injection (Huebner et al. 1993) and causes skin induration. 
The size (diameter) of induration measured on the skin is compared to a cut-off to 
determine whether a person is infected with TB. Although TST has been used extensively 
to diagnose active and latent TB (Trajman et al. 2013), the test lacks specificity. The 
components of PPD are found in other species of mycobacteria such as M. bovis and non-
tuberculous mycobacteria. Secondly, individuals vaccinated with Bacillus Calmette-
Guérin (BCG)- an attenuated strain of M. bovis, also respond positively to TST. The assay 
takes between 2-3 days for an induration to form on the skin (Pouchot et al. 1997). The 
protracted waiting period to determine ones TB status may lead to loss of active TB as 
patients at remote testing centres as they may fail to return to the health facility.  
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1.9.4.2 Direct assay - Antigen based test 
The low specificity of PPD necessitates the use of more specific pathogen derived 
antigens.  ESAT-6 and culture filtrate protein (CFP-10) are major antigenic proteins 
associated with M. tb and can trigger the release of INF-γ in TB infected patients (Xu et 
al. 2012). The genes encoding these antigens are located in the region of difference 1 
(RD1) in the mycobacteria genome. RD1 is not present in M. bovis and other non-
tuberculous mycobacteria species hence, it is expected to be more specific in TB 
diagnostic assays than TST (Trajman et al. 2013). The combined use of these antigens 
specifically selects for M. tb hence a potential to be an effective diagnostic marker (Ravn 
et al. 2000). Two commercially available test kits; QuantiFERON-TB Gold-In-Tube 
(QFT-GIT) assay and T-SPOT.TB have been developed to measure the amount of INF-γ 
released in response to ESAT-6 and CFP-10 in sputum samples (Ahmad 2010).  
 
Unfortunately, the cost of these tests (QFT-GIT and T-SPOT.TB) limits their use in low 
resource settings (Lalvani and Pareek 2010; WHO 2010). Secondly, the production of 
antibodies in TB patients are not homogenous as they vary from patient to patient. Thus, 
designing a diagnostic tool based on these two antigenic proteins is likely to suffer 
sensitivity towards M. tb detection in a larger population set.  
 
The nature of antigen and antigen stability in clinical specimen are very important factors 
to be considered in the design of an antigen based detection kit (Cho 2007). LAM, a 
17KDa lipopolysaccharide is another M. tb antigen released into the urine of active TB 
patients (Achkar and Ziegenbalg 2012; Gomez et al. 2012). The sensitivity and specificity 
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of diagnostic assays based on this antigen ranges from 59-67% and 80-94% respectively 
(Peter et al. 2012). 
 
1.9.5 DNA based methods 
DNA diagnostic tests have proven  in identifying bacteria and determining their antibiotic 
sensitivity within a short time frame as compared to sputum culture (Craw and 
Balachandran 2012). Several DNA based methods for M. tb detection have been 
developed and are currently in use, these are discussed below.  
1.9.5.1 Xpert MTB/RIF assay 
Xpert MTB/RIF is an automated real time nucleic acid assay developed for the 
identification of both M. tb and rifampicin resistance (Theron et al. 2014). This is the only 
rapid test approved by the WHO for the detection of TB and rifampicin resistance in 
symptomatic TB patients (Horne et al., 2019). This assay requires an extensive DNA 
preparation step for DNA release and to remove PCR inhibitors. This is followed by DNA 
amplification which takes approximately 120 minutes. In smear positive TB specimens, 
this assay has a sensitivity of approximately 98% while in smear negative but culture-
positive specimens, the sensitivity of the assay is reduced to between 60-80% (Boehme et 
al. 2010). Although the Xpert MTB/RIF assay is an improvement over immunological 
tests, its low sensitivity in smear negative but culture positive samples makes it unreliable 
for TB diagnosis especially in patients with very low bacilli levels.  
 
Currently, the assay is designed to detect rifampicin resistance only, which limits its 
application for other resistance detection. The cost in obtaining a single cartridge ($10) is 
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also a limitation (Engstrom et al. 2012). Performing this assay requires a computer, a 
constant supply of electrical power and requires routine maintenance to operate 
efficiently. All these contribute to financial burdens and makes it unattractive to use 
especially in resource deprived areas (Kamphee et al. 2015). Other assays such as 
MTBDRplus and MTBDRsl are approved by the WHO. MTBDRplus is developed for 
the detection of RIF and INH resistance. RIF resistance is associated with mutations in 
the rpoB gene while INH resistance involves multiple genes such as the katG, inhA, 
and kasA genes and the intergenic region of the oxyR-ahpC complex (Lacoma et al., 
2008). MTBDRsl targets mutations in the gyrA and rrs genes and are associated with 
XDR-TB (Viveiros et al. 2005; Barnard et al. 2008; Jacobson et al. 2013; Kipiani et al. 
2014; Theron et al. 2014). Similarly, these tests are limited by factors akin to the Xpert 
MTB/RIF assay (Yadav et al. 2013). 
 
1.9.5.2 Isothermal nucleic acid amplification tests 
PCR based diagnosis of M. tb involves long and repetitive cycles of template denaturation, 
annealing and strand extension of specific target region using a thermocycler. The 
amplicons generated can only be visualised with a specialised equipment via 
electrophoresis. Isothermal amplification tests rely on the generation of DNA amplicons 
by autocycling and strand displacement process under a constant temperature (Iwamoto 
et al. 2003). The process is mediated by a specialised polymerase (Bst) and is faster (60 
minutes) than traditional PCR (2-3 hours). Also, the amplicons can be visual observed by 
a colour change in the reaction assay. Some examples of isothermal detection include 
Loop mediated isothermal amplification (LAMP) (Iwamoto et al. 2003; Ou et al. 2014) 
and transcription mediated amplification (TMA) (Shenai et al. 2001). LAMP and TMA 
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have been developed to detect TB, mainly targeting the rrs, gyrB gene and the insertion 
sequence (IS 6110). The performance of LAMP assays targeting these gene sequences 
have been evaluated. 
 
TB-LAMP targeting the rrs gene has sensitivity and specificity of 100% and 94.2% 
respectively (Pandey et al. 2008) while targeting gyrB gene yielded about 97% sensitivity 
in smear-positive, culture positive specimens and 48.8% in smear negative but culture 
positive specimens respectively (Boehme et al. 2007). TB-LAMP targeting the IS6110 
also has the highest sensitivity (100%) but was less specific in detecting other members 
of the MTB complex (Aryan et al. 2010). While these test shorten the time to detection in 
comparison to traditional PCR, they still require purified DNA from clinical samples 
(Shah et al. 2007). These assays also need costly and cold storage to guarantee assay 
reproducibility.  
 
1.9.6 High performance liquid chromatography (HPLC) 
HPLC is mainly used for the analysis of different compounds in samples at microliter 
volumes. Samples are injected into a stream of liquid (mobile phase) which passes through 
a column (stationary phase). The efficiency of separation is dependent on the degree of 
sample retention in the column (Butler et al. 1991). HPLC is further equipped with 
detectors that can identify different components present in a sample. The difference in 
sample composition generates a distinct chromatograph which is unique to the sample (fig 
1.8) (Floyd et al. 1992). With the aid of an appropriate standard, the chromatograph 
generated can be identified. In mycobacteria species, the distributions of mycolic acids 
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(2-alkyl, 3-hydroxy fatty acids) are unique and has been the basis of bacteria identification 
via HPLC technique (Duffey et al. 1996). To determine this, mycolic acid is first extracted 
from pure cultures of mycobacteria and then analysed. This method has 100% sensitivity 
(Thibert and Lapierre 1993) and takes about 2 hours with the exception of the added time 
required to culture the pathogen (7-21 days) and extract mycolic acid from the bacteria 
(Duffey et al. 1996). HPLC is sophisticated and requires trained personnel which comes 
at a cost. Studies show that, growing the bacteria on solid media as compared to liquid 
media boosts the specificity of the assay since liquid media are likely to contain chemicals 
acting as contaminants (Duffey et al. 1996).  
 
 
Figure 1. 8 Superimposed chromatographs of M. tuberculosis and M. bovis 
(BCG) determined using HPLC . The unique chromatographs from BCG and M. tb are 
clearly separated based on their mycolic acid composition. Picture adapted from (Floyd et al. 
1992). 
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1.10 Surrogate model for TB diagnosis 
Owing to the challenges associated with working with M. tb, i.e. its slow growth requiring 
6-8 weeks and the need to handle the bacterium in biosafety level 3 facilities, many 
researchers employ faster growing and less virulent member of the mycobacterial group. 
These group of mycobacteria shares with M. tb the ability to develop broad spectrum 
antibiotic resistance, to undertake preliminary research to develop new diagnostics for M. 
tb. Commonly used bacteria as models for M. tb studies include M. smegmatis and M. 
abscessus (Cortes et al. 2010). These two species fall under the umbrella of 
nontuberculous mycobacteria (NTM) and are described below.  
 
1.11 Non-tuberculous mycobacteria (NTM) 
Non-tuberculous mycobacteria (NTM) refers to all other mycobacteria except those 
belonging to MTBC and Mycobacterium leprae (the causative agents for leprosy) (Lee et 
al. 2014). NTM are common environmental pathogens causing significant morbidity and 
mortality in both immunocompetent and immunosuppressed individuals (Döffinger et al. 
2000; Nessar et al. 2012). Currently, species of NTM are estimated at more than 150 
(Johnson and Odell 2014) with major infections occurring in HIV/AIDS patients (fig 1.9). 
There is a correlation between NTM infections and HIV/AIDS patients, claiming the lives 
of millions every year. This could be attributed to the weakening of the immune system 
in HIV patients. Treatment is also a major challenge due to the complex pharmacological 
interactions between antiretroviral and anti-mycobacterial drugs (Abston and Farber 
2018; AIDSinfo. 2018). 
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Figure 1.9 Global distribution of NTM isolated from various parts of the 
continent. The picture above depicts NTM surveillance among HIV/TB patients across the 
continent. Picture adapted from (Nishiuchi et al. 2017).  
 
 
 
Other diseases that predisposes an individual to NTM infections include cystic fibrosis 
(CF), hematopoietic stem cell transplant, hematologic malignancies and hairy cell 
leukaemia (Henkle and Winthrop 2014). Based on their growth rate NTMs can be divided 
into two groups, namely; rapid growing (e.g. M. abscessus, M. smegmatis, M. chelonae) 
and slow growing (e.g. M. kansasii, M. avium). The rapid growers require 2-3 days to 
grow on artificial media while the slow growers take more than 7 days (Esteban and Ortiz-
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Pe´rez 2009). The phylogeny of mycobacterial species showing the fast growing and slow 
growing NTM are indicated in figure 1.10. The most common and frequent in clinical 
infections (M. abscessus) is described below. 
 
 
 
Figure 1.10. Phylogenetic tree of Mycobacteria . Mycobacterial species categorised as 
rapid or slow growers and are represented with thin or thick lines respectively. Picture adapted 
from https://ars.els-cdn.com/content/image/1-s2.0-S1567134817303519-gr1_lrg.jpg. Date 
accessed: 28/09/2019. 
 
37 
 
1.12 Mycobacterium smegmatis (M. smegmatis) 
M. smegmatis is an aerobic fast-growing bacterium, commonly used as a surrogate model 
in TB research (Chaturvedi et al. 2007). M. smegmatis was first isolated from the human 
smegma in 1885. Smegma is a natural liquid produced under the foreskin of the human 
penis (Bohsali et al. 2010). This bacterium is considered non-pathogenic and uncapable 
of eliciting immune response even in immunocompromised individuals. A study by Best 
and Best contradicts the above claim, where M. smegmatis was implicated in the 
formation of granuloma on the hand of a 67-year old Caucasian (Best and Best 2009). 
Treatment of this condition required the combination of antibiotic (doxycycline) and 
surgical therapy. The gene sequence of this pathogen was not provided by the authors to 
ascertain whether a mutation or acquisition of a foreign gene has occurred, as is the 
predominant modes of resistance with bacteria. M. smegmatis has a generation time of 
between 3-4 hours as compared to M. tb 24 hours. The short generation time and safe 
working with a biosafety level 2 cabinet makes it a good choice as a surrogate bacterium.  
 
 
1.13 Mycobacterium abscessus (M. abscessus) 
M. abscessus were previously considered as an environmental pathogen inhabiting soil, 
biofilms and tap water systems (Honda et al. 2016), it is now known as the most 
pathogenic and multi-drug resistant opportunistic pathogen currently infecting patients 
with CF (Nessar et al. 2012). Infection with M. abscessus leads to TB-like symptoms in 
the lungs of CF patients causing lung dysfunction (Floto et al. 2016). The nomenclature 
of M. abscessus has undergone frequent revisions, hence the classification in the literature 
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is not uniform (Brown-Elliott and Wallace 2002; Adekambi and Drancourt 2004; 
Adekambi et al. 2006; Leão et al. 2010 ; Leao et al. 2011).  
 
To enhance clarity and to facilitate reference to recent publications, the following three 
subspecies names is adopted in this work, i.e. M. abscessus subspecie abscessus, M. 
abscessus subspecie bolletii and M. abscessus subspecie massiliense, all three referred to 
as the M. abscessus complex (Lee et al. 2015). Of these three species, M. bolletii is very 
rare while M. abscessus and M. massiliense occur in similar numbers (Koh et al. 2010). 
Global estimate of M. abscessus infection may be under reported as guidelines for the 
reporting and diagnosing of M. abscessus and NTM do not exist (Johnson and Odell 
2014). Countries such as United States (Esther et al. 2010), Brazil (Duarte et al. 2009), 
Korea (Kwon et al. 2009), China (Nie et al. 2014) and countries in Western Europe (Roux 
et al. 2009) have documented numerous cases of M. abscessus infections (Tettelin et al. 
2014). 
 
 
1.14 Pathogenicity 
As the name suggest, M. abscessus is responsible for causing an abscess in soft tissues 
and on the skin, characterised by a red-pink swelling filled with pus (fig. 1.11) (Kwon et 
al. 2009). M. abscessus infections can also occur in causing acute and chronic meningitis, 
neutrophilic pleocytosis and meningoencephalitis (Talati et al. 2008; Medjahed et al. 
2010). M. abscessus contributes to about 65-80% of pulmonary disease caused by rapidly 
growing mycobacterium (Lee et al. 2014). It is the most frequent mycobacteria pathogen 
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isolated from patients with cystic fibrosis (Fletcher et al. 2016). Approximately, 3-10% 
of cystic fibrosis patients living in the UK and the USA are infected with M. abscessus 
(Bryant et al. 2013).  
 
The lung microbiome of CF patients is very complex. While M. abscesssus represent the 
dominant mycobacterial pathogen, Pseudomonas aeruginosa followed by Burkholderia 
cepacia complex are the most common opportunistic bacterial pathogen isolated in these 
patients (Birmes et al. 2017). Recent studies suggest that, M. abscessus can inhibit quorum 
sensing thus preventing the growth of Pseudomonas aeruginosa (Birmes et al. 2017). This 
finding could suggest other multifaceted interaction occurring within the microbiome of 
CF patients which are yet to be investigated. 
 
 
Figure 1.11 M. abscessus  infection on the left forearm of a patient 
characterised by red-pink nodules filled with pus . Picture adapted from (Kwon et al. 
2009). 
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1.15 M. abscessus virulence factors 
Similar to other pathogens, M. abscessus is able to evade the host immune response. This 
suggests that the organism possesses certain virulent factors that enhances its ability to 
outwit host immune mechanisms and promote survival. Based on the growth morphology 
of M. abscessus on solid agar plates, two major forms (rough and smooth) have been 
identified (fig. 1.12). The rough (R) form lacking glycopeptidolipid (GPL) are more 
pathogenic, can persist and multiply in the host macrophages upon infection. The smooth 
(S) forms are characterised by the presence of GPL, present in their cell membrane and 
they tend to succumb easily to the host immune machinery (Ruger et al. 2014).  
 
 
Figure 1.12 Morphology of rough (left) and smooth (right) forms of M. abscessus  
cultured on 7H11 agar . Picture adapted from (Ruger et al. 2014). 
 
 
The chemical structure of GPL is depicted in Fig 1.13 below. Upon entry into the host 
cells, M. abscessus (R form, wild type) become tightly attached to the phagosomal 
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membrane while the S forms are unable to attach but resides loosely in the phagosome 
(Byrd and Lyons 1999). M. abscessus attachment to the phagosome is dependent on the 
absence of GPL in R (Howard et al. 2006). The S morphotype exhibit sliding motility and 
have the capacity to form biofilms (Schorey and Sweet 2008). 
 
 
Figure 1.13. Schematic diagram of mycobacterium cell envelope. The magnified 
cell membrane envelope shows the different layers biomolecule arrangement and lipids present. 
The membrane also depicts the presence of GPL responsible for producing smooth colonies of M. 
abscessus. Picture adapted from Gutiérrez et al., 2018.  
 
 
GPL mutants (R morphotype) are non-motile, lack the ability to form biofilms and are 
cord forming. Cord formation is the ability of bacteria to align end to end and side to side 
as compared to forming clumps (aggregates of bacteria in random orientation). Cord 
formation is a property of bacterial virulence associated with M. tb and NTM (Sa´nchez-
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Chardi et al. 2011). Cord formation is enhanced by the production of trehalose 6, 6 ̍- 
dimycolate (TDM) - a known virulent factor in M. tb (Behling et al. 1993). The 
mechanism of R morphotype virulence has been demonstrated using a zebrafish model. It 
was found that, the R morphotype inhibits macrophage and neutrophil mediated 
phagocytosis, partly aided by their ability to attach (Bernut et al. 2014). Further studies 
have also shown that, spontaneous conversion of the S to R form does occur after several 
passages (Howard et al. 2006). This is believed to occur due to the insertion or deletion 
of nucleotide bases in the mps1 gene required for GPL synthesis or the mmpL4b gene 
which is responsible for the translocation of GPL into the cell surface (Fig. 1.14) (Pawlik 
et al. 2013; Ridell 2015). 
 
 
 
Figure 1.14 Schematic representation of the M. abscessus  GPL genes 
associated with the synthesis and transport of GPL . Picture adapted from (Pawlik et 
al. 2013) 
 
 
M. abscessus also harbours other genes that are linked to virulence. For instance, 
MAB_O55 which encodes phospholipase C (PLC), an enzyme which is absent in most 
rapidly growing mycobacteria. PLC mediates hydrolysis of  host phospholipids to  
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produces diacylglycerol (DAG) which activates protein kinase C, resulting in the 
unregulated activation of neutrophils and macrophages which results in the  inflammation 
observed in the lungs of CF patients (N’Goma et al. 2015). 
 
1.16 Transmission of M. abscessus  
The primary environment of M. abscessus includes fresh water and soil (Honda et al., 
2016). Transmission from the environment to an individual could occur when there is 
close contact. Some healthy fish farmers have been reported to be infected with M. 
abscessus through contact with fish possibly contaminated with the bacterium. This is 
possible to the extent that, M. abscessus shares the same ecological niche with the fish 
pathogen M. marinum. It has been reported that M. abscessus harbours a mercury resistant 
plasmid with about 99% of its nucleotide sequence identical to an episome of M. marinum 
(Bernut et al. 2014).  
 
Nosocomial transmission of NTM is also very common in haemodialysis, dental and 
surgery departments. Portable and treated water from hospital taps have been found to be 
contaminated with NTM (Phillipsa and von Reyn 2001). Recent studies have also 
suggested that person-to-person through the generation of aerosols particularly among CF 
patients is possible (Bryant et al. 2013; Birmes et al. 2017), although this observation 
contradicts other studies (Harris and Kenna 2014). Aerosols generated by CF patients 
contain significant concentrations of viable bacteria of a respirable size range which could 
be responsible  for air borne transmission (Birmes et al. 2017). Additionally, the ability 
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of M. abscessus to withstand desiccation in arid environment could also suggest 
transmission via air (Wallace et al. 1997; Bryant et al. 2013).  
 
Transmission via fomite formation is also another possibility, owing to M. abscessus 
resistance to disinfectants and chlorination (Koh et al. 2010). To prevent this form of 
transmission, surgical wounds, intravenous catheters and injection sites should be 
shielded from environmental contamination. Also, surgical apparatus (e.g. endoscope, 
catheters) must be well sterilised after use.  
1.17 M. abscessus treatment and resistance mechanisms  
Clarithromycin, a macrolide antibiotic is the current drug of choice for the treatment of 
M. abscessus infections (Petrini 2006). The mechanism of action of action is similar to 
other macrolide antibiotics in that it  binds to 23S rRNA and subsequently inhibit protein 
synthesis (Stout and Floto 2012). Resistance to clarithromycin is a major concern and 
occurs in two forms, acquired and inducible. The former results from a mutation in the 
drug binding pocket at position 2057 or 2058 of the rrl gene which encodes  23S rRNA 
(Bastian et al. 2011), while the latter is associated with the presence of a complete, 
functional and active erm-41 gene. In the presence of clarithromycin, the erm-41 gene is 
activated and encodes a methylase enzyme (erythromycin methylase). This enzyme adds 
a methyl group to adenine at position 2057 or 2058 in the 23S rRNA, thereby inhibiting 
clarithromycin binding (Mougaria et al. 2017). 
 
All three subspecies of M. abscessus have varying treatment responses to clarithromycin. 
M. abscessus and M. bolletii have full length copies of the erm-41 gene and hence are 
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resistant to clarithromycin. M. massiliense have a 274 bp deletion in the erm-41 gene, 
making it non-functional and rendering it susceptible to clarithromycin (Kim et al. 2010; 
Yoshida et al. 2014). Other features also contribute to the functionality of the erm-41 
gene. The presence of thymine (T) or cytosine (C) at position 28 of erm-41 gene confers 
either resistance or susceptibility  to clarithromycin respectively (Mougaria et al. 2017). 
 
Amikacin, an aminoglycoside antibiotic is another drug frequently used for the treatment 
of M. abscessus (Nessar et al. 2012). Amikacin like other aminoglycosides (kanamycin, 
tobramycin) inhibits protein synthesis by binding to the rrs gene of the 16S rRNA. Since 
M. abscessus possess a single copy of the rRNA operon which is a target for binding, a 
single point mutation occurring within this operon  can result  in resistance (Cortes et al. 
2010).  A point mutation is a single base change from A to G at position 1408 and is a 
well-known mutation site in the M. abscessus rrs gene (Nessar et al. 2012). 
 
Azithromycin an anti-inflammatory drug has also been used to treat M. abscessus 
infections. However, its use has been reported to increase patient’s susceptibility to M. 
abscessus and NTM in general (Renna et al. 2011). In a study by Renna and colleagues, 
azithromycin terminates autophagosome process and lysosomal acidification and 
degradation of pathogens in macrophages. As a result, engulfed bacteria continue to 
proliferate increasing pathogen survival (Renna et al. 2011).  
 
M. abscessus is resistant to several anti-TB drugs including rifampicin and ethambutol 
making it a good surrogate bacterium for M. tb (Nessar et al. 2012). The antibiotic 
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resistance could be due to the uniqueness and diversity that exist within its genome. 
Among the species of mycobacteria, certain virulent genes have been identified to exist 
only in M. abscessus (Nunes-Costa et al. 2016). Furthermore, it has also been shown that, 
M. abscessus has undergone frequent evolutionary changes, progressing from an 
environmental organism to a successful human virulent lung pathogen (Birmes et al. 
2017), during which it is likely to have acquired unique genes which encode antibiotic 
resistance. One of the unique enzymes produced by M. abscesssus i.e. 2-N-
acytyltransferase and aminoglycoside phosphotransferase have been found to degrade 
aminoglycoside antibiotics and promote resistance (Ripoll et al. 2009).  
 
The nature of M. abscessus resistance demands urgent therapeutic procedures i.e. multi 
therapy as opposed to monotherapy. The latter is no longer recommended for M. 
abscessus treatment. The American Thoracic Society (ATS) recommends a combinatorial 
approach based on an oral macrolide and intravenous administration of either amikacin, 
cefoxitin or imipenem (Griffith et al. 2007). In extremely difficult to manage cases 
removal of affected body parts by surgery is required to enhance treatment success and 
this has been applied in many conditions (Jarand et al. 2011).  
 
1.18 Diagnosis of M. abscessus 
Many of the traditional approaches for M. tb diagnosis can also be applied to the detection 
of M. abscessus. Microscopy and culturing on 7H10, 7H11 agar and in 7H9 broth or 
Luria-Bertani broth or on agar are commonly applied (Ryu 2015). Growth appears as 
yellow or cream colonies after 3 days of culture (Cortes et al. 2010). Previously, M. 
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abscessus and M. chelonae were considered as same species. Biochemical tests such as 
sodium chloride tolerance and citrate uptake can be used to distinguish between M. 
abscessus and M. chelonae (Conville and Witebsky 1998). Also, growth on MacConkey 
agar without crystal violet, aryl sulphatase and nitrate reductase tests are used for 
identification (Silcox et al. 1981). These biochemical tests are not always reliable, giving 
overlapping phenotypic patterns and are time consuming and labour intensive (Conville 
and Witebsky 1998; Kulandai et al. 2014). Other innovative methods (e.g. HPLC) for M. 
abscessus detection have also been developed. HPLC is limited in the sense that it is not 
able to discriminate between M. chelonae and M. abscessus (Jeong et al. 2011). Also, in 
terms of simplicity, cost and portability, HPLC cannot match the requirements of a rapid 
diagnostic tool.  
 
The optimal treatment regimen for M. abscessus is specie specific, necessitating accurate 
speciation followed by treatment. Thus, the diagnostic tool must be developed to be very 
specific and sensitive. The INNO-LiPA is an example of a molecular based commercial 
kit developed for the identification of M. tb complex and 8 other NTM species including 
M. abscessus (Miller et al. 2000; Padilla et al. 2004). This kit requires DNA extraction 
followed by DNA amplification with probes targeting the 16S-23S rRNA internal 
transcribed spacer region (ITS). The ITS region is selected because it is predicted to have 
more discriminatory power in distinguishing closely related mycobacteria species. 
Evaluation of the INNO-LiPA kit shows that it has specificity (87%) as compared to 
culture (96.3%) (García-Agudo et al. 2011). The reduced level of specificity could be 
attributed to  cross reactivity with other mycobacteria species (Tortoli et al. 2010). 
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Performing this assay takes about 3 hours in addition to a DNA extraction and 
amplification step, defeating the purpose of POC developments.  
 
PCR, targeting multiple gene sequences (rpoB, 16s rRNA, erm-41, gyrB) has also been 
developed for detection of M. abscessus (Matsumoto et al. 2011). The performance of 
PCR based assays are comparable to culture in terms of specificity and sensitivity (Kim 
et al. 2015). The disadvantage to using PCR over culture is the time to detection and the 
need for costly reagents and equipment. While PCR may take about 2-3 hours, culture 
may require about 48-72 hours. Regarding the challenges with the current detection 
methods as described above, they do not present as attractive tools for rapid detection of 
M. abscessus, hence the need for rapid detection tools to meet POC needs. 
 
1.19 Point-of-care (POC) diagnostics 
POC testing refers to the use of diagnostic tools to generate patient results at the point 
where patient consultation and presentation takes place or within the perimeter of the 
health care facility (Dheda et al. 2013). Failure to produce diagnostic results on same day 
has been a major challenge for disease control (Rossato Silva et al. 2012). By generating 
timely results, treatment can begin immediately and prevent adverse case of the disease 
(Dheda et al. 2013). A POC diagnostic tool must be designed to meet the ASSURED 
guidelines. ASSURED is an acronym meaning the diagnostic tool should be Affordable, 
Sensitive, Specific, User-friendly, Rapid, Equipment-free and Deliverable (Urdea et al. 
2006). In addition, the PC tool must be portable for easy transport (fig 1.15). An ideal 
POC test should be able to identify the biological marker in a clinical specimen that is 
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predictive of a disease state. In addition, the biomarker should be specific to the pathogen 
causing the disease and not cross react with other pathogens. This is a challenge 
encountered using serological based assays.  
 
DNA based detection methods offer superior advantage over serological tests and could 
be a promising option for the development of a POC testing. Identifying the specific 
nucleic acid sequence in M. tb as well as M. abscessus could serve as an important 
biological marker for specific and sensitive detection and monitoring of treatments. The 
development of a rapid assay with the potential of miniaturisation into a portable device 
to be used at the POC will alleviate the burden of mycobacteria related disease and other 
diseases of public health importance.  
 
 
Fig 1.15 Innovative technologies for the development of miniaturised 
biosensors. Complex and large laboratory equipment for diagnostic purposes translated into 
miniaturised format biosensors. Picture adapted from (Ahmed et al. 2014) 
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1.20 Techniques for bacteria cell wall lysis 
The sensitivity of any DNA based detection assay is dependent on the ability to access 
the target (DNA) from the specimen. This requires the release of the target DNA from the 
organism in sufficient quantities to allow their detection. In the case of bacteria, the DNA 
is locked within the bacterium necessitating the use of some form of lysis method. Also, 
the nature of the clinical sample in which the bacterium is present may require the use of 
complex purification procedures to remove inhibitory factors such (e.g. proteins) which 
could inhibit detection of targets. Thus, the initial processing of the clinical sample is an 
important consideration when attempting to develop a rapid POC. Mycobacteria species 
have a rigid cell wall composed of mycolic acid which make it more resistant to disruption 
than other types of bacteria. Currently, there lacks an efficient and rapid method for lysing 
mycobacterial cells and it is a bottleneck in the development of rapid DNA based 
detection tools.  
1.20.1 Boiling and sonication 
 Boiling is one of the simplest methods to break open bacterial cells. This usually involves 
heating the bacterial suspension at boiling temperature (100˚C) in Tris acetate EDTA 
(TAE) buffered solution (Odumeru et al. 2001). Typically for mycobacterial cells that 
have rigid cell walls, this temperature is necessitated to permeabilise cell wall and to 
release intracellular DNA. Although simple to perform the purity of the DNA yield is 
usually low due to the presence of contaminants such as proteins and carbohydrates. Lysis 
protocols have been developed that employ mechanical methods such as sonication and 
bead beating. In sonication, a bacterial suspension is exposed to sound waves generated 
by an oscillating transducer which causes the bacterial cells to agitate and subsequently 
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leads to cell lysis. This method involves high frequency oscillation of bacterial cells in an 
enclosed tube containing beads (Vandeventer et al. 2011). These procedures also cause 
DNA shearing which compromise the integrity of the DNA. Rapid testing of nucleic acids 
in resource deprived areas require novel tools that are less sophisticated and can perform 
cell lysis in microliter quantities. The use of microwave energy is one such approach 
currently being considered (Vaid and Bishop 1998). 
 
1.20.2 Microwave (MW) mediated cell lysis 
Microwave (MW) is the second component of the electromagnetic spectrum after radio 
waves having a low frequency but longer wavelengths. Bacterial cells exposed to MWs 
results in cell lysis and the release of DNA (Jankovic et al. 2014). Joshi et al. demonstrated 
the use of microwave energy as a means of disrupting the vegetative and sporulating C. 
difficile. Additionally, the MW induced cell lysis, resulting in the release of sufficient 
single stranded DNA to enable detection of C. difficle toxin genes using specific DNA 
probes. A similar approach has also been used to recover DNA from Bacillus anthracis 
spores (Aslan et al. 2008) and Chlamydia trachomatis (Zhang et al. 2010). In this 
research, the optimum microwave condition for the release of ssDNA and dsDNA from 
M. abscessus will be determined. The released nucleic acid will then be detected in an 
enzyme linked oligonucleotide sandwich hybridisation assay (ELOSHA).  
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1.21 Factors modulating MWs effect in biological membranes 
As MWs will be considered as a fast DNA release tool from cells, it is worth noting that 
cells have significant differences in their cell wall and membrane composition (discussed 
in section 1.1).  The type and composition of membrane phospholipids and fatty acids in 
cell membranes are reported to influence cells susceptibility to MWs (Unsay et al. 2013a; 
Oncul et al. 2016). Fatty acids and phospholipids components in their membranes are 
present in diverse proportions, the reason being that the environmental conditions to 
which cells are cultivated or exposed in the natural are different (Sohlenkamp and Geiger 
2016). The membranes of E. coli are composed of three major phospholipids: 
phosphatidyl ethanolamine (PE), phosphatidyl glycerol (PG) and cardiolipin (Raetz and 
Dowhan 1990; Raetz and Whitfield 2002). S aureus is also mainly composed of 
phosphatidyl glycerol, lysyl phosphatidyl glycerol and wall teichoic acids (Haest et al. 
1972; Atilano et al. 2011; Piggot et al. 2011). Teichoic acids play a key role in concealing 
PG at the bacterial surface, and could contribute to membrane rigidity (Brown et al. 2013). 
Phosphatidyl choline, phosphatidyl inositol and phosphatidyl ethanolamine are the major 
phospholipids in C. albicans (Haest et al. 1969; Georgopapadakou et al. 1987). 
Cardiolipin (1,3-diphosphatidyl-sn-glycerol) is present in all the four types of cell 
membranes and has four acyl chains (Crellin et al. 2013). It plays a key role in maintaining 
membrane integrity in response to stress. Its presence of cardiolipin induces bilayer 
structure remodelling, deformation of the membrane and enhancing permeabilization 
(Unsay et al. 2013b).   
 
Generally, saturated fatty acids tend to increase membrane fluidity unlike unsaturated 
fatty acids (Marrink et al. 2009). The composition of saturated FA in E. coli and C. 
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albicans are below 50% (Haest et al. 1969; Georgopapadakou et al. 1987) suggesting a 
less compact membrane. In the case of M. smegmatis, mycolic acid is the major fatty acid 
constituting about 30-60% and are predominantly saturated (Taneja et al. 1979). 
Cardiolipin is composed of about 95% unsaturated fatty acids (Unsay et al. 2013b). The 
presence of cholesterol and membrane proteins (constituting about 50% of weight in cell 
membrane) reduces membrane fluidity, increases stability and could also pose resistance 
to an external MW E fields (Israelachvili and Mitchell 1975; Cullis and De Kruijff 1979; 
Smaby et al. 1994; Veatch and Keller 2005; van Uitert et al. 2010a; van Uitert et al. 
2010b).  
1.22 Thesis Aim 
The principal aim of this study is to develop a colorimetric oligonucleotide hybridisation 
assay (COHA) capable of detecting the presence of M. abscessus within a short time 
frame. The rapidity and sensitivity of the COHA would be aided using microwaves for 
fast DNA release and magnetite particles to trap and enrich target molecules. The 
development of this assay will serve as a proof-of-concept that can be used for the 
detection of M. tb and other pathogenic bacteria of clinical importance.  
1.23 Thesis Objectives 
The specific objectives of this thesis were; 
1. To develop an optimised method for the extraction of DNA from M. abscessus 
2. To design DNA probes using bioinformatic approach for the detection of M. 
abscessus and M. smegmatis 
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3. To characterise the biological effect of microwaves on micro-organisms of 
structural diversity 
4. To identify the optimum microwave conditions for the release of DNA from M. 
abscessus  
5. To develop a sandwich hybridisation assay on a magnetite bead support for the 
detection of M. abscessus  
6. To develop M. smegmatis-macrophage infection model and detect the presence 
of intracellular M. smegmatis using the hybridisation assay. 
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Chapter 2 
General materials and methodology 
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2.0 General Materials 
The following methods were general throughout the study. Specific methods are described 
in their respective chapters (3,4,5 and 6). 
2.1 Materials 
The following bacterial culture media were purchased and used in the study: Luria-Bertani 
(LB) broth and LB agar were purchased from Thermo Fisher Scientific Ltd, UK. Yeast 
extract, Low-Dusting (LD) was purchased from Becton Dickinson (BD, Difco). 
Biological media was prepared according to manufacturer’s protocol and sterilised for 15 
minutes at 121°C and 100 kPa using a bench top autoclave (CertoClav EL sterilizer, 
Austria). Deionised water was obtained from an ELGA pure lab option BP15 dispenser 
(ELGA lab water, UK).  
2.2 General Instruments 
Nanodrop (ND 1000 spectrophotometer, LabTech), Qubit 3.0 Fluorometer (Life 
Technologies), Orbital incubator shaker (MaxQTM 440, Thermo Scientific), Eppendorf 
AG Centrifuge 5417R (Hamburg, Germany), Heat Block (DRI-Block® DB.3D, Techne), 
UV/Vis spectrophotometer (Ultrospec 2100 pro, Biochrom, USA), T100 Thermo cycler 
(Bio-Rad, UK). 
2.3 General Methods 
2.3.1 Revival of isolates and culture from MicrobankTM cryo-protective beads 
Cryo-protective beads containing bacteria were stored in vials at freezing conditions (-80 
ºC). Beads were thawed and kept in ice. A single bead was inoculated in 20 ml LB broth 
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using a 10 µl sterile loop. Broth containing bead was incubated at 37°C for 72 hours under 
constant shaking at 200 rpm.  
 
2.3.2 Culture of bacterial and yeast cells 
The following micro-organisms were used in this study: Escherichia coli (NCTC 1093) 
and Staphylococcus aureus (NCTC 13373) were purchased from the HPA culture 
collections service (Public Health England, Porton Down, UK). Mycobacterium 
abscessus (ATCC 19977T) was purchased from American Type Culture Collection 
(ATCC), UK. Candida albicans (NCPF 3179) was purchased from the National collection 
of pathogenic fungi (NCPF), England, UK. Mycobacterium smegmatis (NCTC 8159) is 
an archived clinical isolate used in a previous study and was included in this study. All 
micro-organisms were cultured in their respective media. M. abscessus, M. kansasii, E. 
coli and S. aureus were cultured in 20 ml of LB broth and incubated at 37°C. 
Mycobacteria cells were cultured between 48 - 72 hours, whiles E. coli and S. aureus were 
cultured overnight under constant shaking in an orbital incubator shaker at 200 rpm. C. 
albicans were cultured in yeast extract broth at 30 °C overnight with constant shaking in 
an orbital incubator shaker at 200 rpm. Cells were harvested (centrifugation at 4, 000 rpm 
for 10 min) and resuspended in phosphate buffered saline (PBS).  
 
2.3.3 Determining the purity of cell cultures 
The following methods were performed to determine whether all bacterial and yeast cells 
were pure and not contaminated with other bacteria.  
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2.3.3.1 Streak plate method 
Cell suspensions were streaked on their respective agar plate to identify single colonies 
(pure bacterial cultures) or mixed colonies suggesting the presence of other bacterial 
contaminants. With the aid of a sterile inoculating loop, 10 µL of cells suspension were 
transferred onto either LB agar (to identify M. abscessus, M. kansasii, M. smegmatis, E. 
coli and S. aureus) or yeast extract agar (to identify C. albicans) and incubated at 37°C 
for 48 - 72 hours in the case of M. abscessus and overnight for the remaining cells. Single 
colonies were observed for uniformity. The colonies were also stained using Ziehl 
Neelson and Gram staining procedures. Ziehl Neelson stain was performed to identify 
acid-fast bacilli (mycobacteria) and Gram staining to identify Gram-negative (E. coli) and 
Gram-positive (S. aureus) isolates. The methods for staining are described below. 
 
2.3.3.2 Bacterial staining methods to determine bacterial purity 
2.3.3.2.1 Acid fast staining [Ziehl Neelsen stain (ZN)] 
Acid fast staining also known as ZN stain was developed specifically to identify 
mycobacteria species. A single colony of bacteria growing on agar and suspension 
prepared in PBS. Ten microliters of the stock suspension was diluted (1/100) and 10 µL 
spotted and smeared on microscope slide, dried in a biosafety cabinet and heat fixed for 
staining. The staining procedures are as follows; bacterial smear on slides were flooded 
with carbol fuchsin, warmed over a flame of fire and allowed to stand for 5 minutes. This 
is to allow carbol fuchsin to penetrate the thick cell wall of mycobacteria. Bacteria were 
then washed under a gentle flowing water to remove excess carbol fuchsin, decolourized 
with 95% ethanol containing 5% HCl for 5 minutes and washed again under tap water to 
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remove excess decolorizing solution. Finally, bacteria were counter stained with 
methylene blue for 1 minute and washed with gentle flowing tap water. The procedure for 
the ZN stain is depicted in Fig 2.1 below. The slide was then dried under room temperature 
and observed with light microscope under oil immersion using X100 objective lens.  
 
 
Fig 2.1. Ziehl-Neelsen Stain (ZN-Stain): principle, procedure, reporting and 
modifications  (Laboratory Info 2018). Adapted from https://laboratoryinfo.com/zn-stain/. Date 
accessed 02.10.2018 
 
 
2.3.2.2 Gram staining 
This method was developed by Hans Christian Gram for the differentiation of bacteria 
based on their cell wall composition. This method can distinguish bacteria with (Gram-
positive) or without (Gram-negative) peptidoglycan in their cell wall. Prior to staining, 10 
µL of diluted bacteria (section 2.3.3.2.1) was spotted on microscope slides and heat fixed. 
Heat fixed slides were flooded with 2% crystal violet solution for 1 minute and washed 
using gentle flowing tap water. Slides were flooded with iodine solution for 1 minute and 
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rinsed with water to remove excess iodine. Slide was decolorized by dropwise addition of 
95% HCl for 5 seconds while washing gently with tap water. Finally, bacteria were stained 
with safranin for 1 minute and the excess safranin washed with water, dried under room 
temperature and observed with light microscope under oil immersion using X100 
objective lens.  
2.3.4 Standardization of cells concentration 
Suspension of M. avium at optical density of 1.0 corresponds to approximately 2 x 108 
CFU/mL (Radomski et al. 2013). Cell density indirectly measures the turbidity of the cells 
solution. This parameter is largely dependent on the cells number, size and the nutritional 
requirement (Stevenson et al. 2016). Since all cells differ in relation to these parameters, 
the cells used in this study were standardised to determine their concentration to be used 
in subsequent assays. A calibration curve was generated to determine cells concentration 
at varying optical density (OD). Prior to standardisation, cells were cultured as described 
above (section 2.3.2), pelleted (centrifugation at 4,000 g for 10 min) and washed twice 
with sterile 1X PBS solution. This referred to as the stock bacterial concentration). Stock 
concentration of cells (M. abscessus, E. coli, S. aureus and C. albicans) were serially 
diluted ((1/10) in PBS solution to bacterial suspensions at varying OD (measured at 600 
nm) ranging from 1.3 to 0.05.  
 
The concentration of cells in CFU/mL were determined in each dilution using the method 
described by Miles and Misra (Miles and Misra, 1938) and is described below. Cell 
suspensions at their respective optical densities were further diluted (1/10), 8 times. 
Twenty microliters of each dilution was plated on either LB agar (M. abscessus, E. coli, 
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S. aureus) or Yeast extract agar (C. albicans) in triplicate and incubated at 37°C overnight, 
except for M. abscessus which was incubated for 72 hours. The dilution resulting in 
countable cell colonies between 30-100 was used to determine cell concentration and 
expressed as CFU/mL. The experiment was repeated twice and the mean colony forming 
unit was determined using the formula below.  
 
Colony forming unit per millilitre (CFU/mL) = Mean colony count x dilution factor 
               Volume inoculated (mL)  
 
 
The mean number of colonies forming unit per millilitre (y-axis) was plotted against the 
optical densities on the x-axis. The line of best fit and the equation of the line was 
generated. The estimated concentration of cells was calculated from the equation of the 
graph with known optical density values (Appendix 1). 
 
2.4 Statistical Analysis 
All experiments were performed at least two times under independent conditions. 
Statistical analysis of data was performed using the Statistical Package for the Social 
Sciences (SPSS) version 25 or Microsoft excel 2013 analysis tool pack. Independent 
sample t-Test was performed to determine statistical significance between two groups. 
Data was considered significant when the p-value < 0.05. Analysis of Variance (ANOVA) 
was performed to determine the difference among group means. To determine the 
difference within groups, post-hoc analysis was performed using Bonferroni and Tukey 
tests. p-values less than 0.05 were considered as significant.  
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Chapter 3 
Molecular and antibiotic based characterization of Mycobacterium abscessus 
isolates 
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3.0 Introduction 
3.1 Identification and typing methods for bacteria  
Bacterial typing/characterisation systems are important scientific tools frequently used to 
study and understand disease epidemiology, clinical outbreaks and disease relapse 
(Iakhiaeva et al. 2012; Wong et al. 2012). Non-tuberculous mycobacteria (NTM) are 
oligotrophs, commonly inhabits the environments e.g. soil and water distribution systems 
and are likely to be frequently associated with humans through inhalation and soil 
bioaerosols (Honda et al. 2016). The transmission of M. abscessus has been hypothesised 
to occur via aerosol generation (Bryant et al. 2013; Trovato et al. 2017). For this reason, 
it is possible for frequent outbreaks of and this would require bacterial typing tools to 
identify and characterise them. Various techniques for typing micro-organisms have been 
developed and these vary widely with respect to cost, specificity, sensitivity, simplicity 
and the time required to perform the assay. Commonly used typing methods can be 
broadly divided into phenotypic and molecular approaches and are discussed in more 
detail below.  
 
3.2 Phenotypic typing of M. abscessus 
Phenotypic methods represent the traditional approach for the identification of bacteria 
for which other identification strategies are based on. The approach generally consists of 
(1) collection of a sample which is representative of the site of bacterial infection, (2) the 
application of various staining methods and an examination of colonial morphology and 
(3) response to biochemical and serological tests, susceptibility to phages and 
antimicrobial agents such as bacteriocins (Castro-Escarpulli et al. 2015). Examples of 
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clinical samples which are routinely screened for the presence of the pathogen include 
urine, semen, blood, faeces, vaginal fluid and cerebrospinal fluid. These methods albeit 
being cheap and simple to perform have several limitations. For instance, the presence of 
bacteria which are not the target organism can result in misinterpretation of clinical 
results.  They also suffer from a lack of specificity in that they are unable to discriminate 
between closely related species (Suffys et al. 2001). To improve on specificity, it is 
recommended that the sample is obtained directly from the site of bacterial infection and 
kept under proper storage conditions (Suffys et al. 2001).  
 
Clarithromycin is the drug of choice for treatment of M. abscessus, but treatment success 
is severely hampered due to inducible resistance. This mode of resistance is expressed in 
M. abscessus when full length of erm-41 gene is present (Ruger et al. 2014). While the 
erm-41 gene has phenotypic consequence, it is not definitive in M. abscessus 
characterisation. Its polymorphic nature was genotypically explored for precise detection 
of M. abscessus (discussed in chapter 4).  
 
The full length of this gene is present in M. abscessus subsp abscessus and M. bolletii but 
truncated in M. massiliense. Variants of this gene are present in M. tb (erm-37), M. 
fortuitum (erm-39) and M. smegmatis (erm-38). The erm gene is believed to have 
originated from Streptomyces, a specie which synthesises macrolides (Nash et al. 2005) 
and also demonstrate inducible resistant to macrolides but they carry subtle differences in 
their individual nucleotide sequences which can serve as a basis for genotypic 
characterisation. 
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 3.3 Molecular typing techniques 
Molecular typing offers a number of advantages over phenotypic methods with regards to  
precision and  accuracy as well as the ability to distinguish between closely related species 
and to detect antibiotic susceptible strains (Harris and Kenna 2014). Some of the methods 
currently used include DNA hybridisation, plasmid profiling, PCR, ribotyping, 
spoligotyping and mycobacterial interspersed repetitive unit variable number tandem 
repeat (MIRUS-VNTR) (Castro-Escarpulli et al. 2015). The massive expansion in the use 
of these techniques has been made possible by the proliferation of low-cost whole genome 
sequencing systems and the availability of open source bioinformatic tools. 
3.4 Techniques for the isolation of DNA from M. abscessus 
DNA based molecular typing methods are dependent on the ability to access high quality 
DNA locked inside the cell. Mycobacteria species possess a thick, waxy cell wall, which 
makes them difficult to lyse compared to Gram-negative and Gram-positive bacteria. 
Commercial DNA extraction kits are designed to lyse Gram-positive and negative 
bacteria and thus are relatively inefficient when applied to a mycobacteria (Kaser et al. 
2009). In addition to affecting the overall DNA yield, the purity can also be compromised 
by the presence of bacterial contaminants such as carbohydrates, lipids and proteins 
(Timms et al. 2015). To increase DNA yields additional approaches such as mechanical  
disruption (the use of glass beads), sonication (subjecting cells to high frequency 
vibration) and enzymatic cell disruption have been employed (Granger et al. 2004; 
Radomski et al. 2013; Park et al. 2014). Mechanical cell disruption of mycobacteria cells 
has been reported to cause a 10-fold increase in DNA concentration (Granger et al. 2004; 
Radomski et al. 2013; Park et al. 2014). In-house DNA extraction methods developed by 
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Timms and colleagues improves yield but do not produce better DNA purity than 
commercial kits (Timms et al. 2015). This challenge needs to be addressed as any 
molecular based detection assay (e.g. VNTR), which would be used in this study would 
require purified and high yield DNA. 
3.5 Molecular typing of M. abscessus 
In the context of the molecular typing of M. abscessus isolates, the following methods 
have been employed; pulsed field gel electrophoresis (PFGE), repetitive sequence-based 
(Rep)-PCR, multilocus sequence typing (MLST), multispacer sequence typing (MST), 
variable number of tandem repeat (VNTR) and whole-genome sequencing (Harris and 
Kenna 2014). The usefulness and advantages of these methods over other methods are 
described below. 
 
3.5.1 Pulsed field gel electrophoresis (PFGE) 
PFGE is considered the gold standard for bacterial typing and is performed when a 
bacteria-specific typing method is not available (Machado et al. 2014). This technique 
requires careful isolation of genomic DNA, followed by restriction enzyme digest before 
pulsed electrophoresis. PFGE can be used to separate large size DNA (10 Mb) on an 
agarose gel using pulsed or alternating voltage gradients to produce high resolution DNA 
patterns (Jagielski et al. 2014). PFGE has been developed for the differentiation of the M. 
abscessus complex (Wallace et al. 1993; Matsumoto et al. 2011). Although it is 
considered reproducible, it requires careful isolation of DNA to avoid shearing and 
damage due to the rigidity of the mycobacteria cell wall as this has been observed in M. 
abscessus isolates (Machado et al. 2014). The procedure is also expensive to perform, 
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requiring high level expertise and thus is confined to highly resourced laboratories. While 
no standard protocol for PFGE has been approved, the existing protocols require about 
one week to complete (Jagielski et al. 2014). PFGE can only discriminate bacteria to the 
strain level (Quainoo et al. 2017). 
 
3.5.2 Repetitive sequence-based PCR 
Rep-PCR amplifies repetitive elements within the bacterial genome. The amplified 
fragments once separated on a gel produce a band pattern corresponding to the length and 
the size of the amplified region. While commercial Rep-PCR systems (e.g. DiversiLab 
System, bioMerieux, France) has been develop for the identification of M. abscessus, 
concerns have been expressed as to the specificity of this approach (Zelazny et al. 2009; 
Harris et al. 2012). It remains unclear whether the DNA profile generated represent same 
strain or related strains of a genotype (Harris and Kenna 2014).  
 
3.5.3 Multilocus sequence typing (MLST) and multispacer sequence typing 
(MST) 
MLST amplifies nucleotide sequences that are conserved in housekeeping genes 
(Eisenberg and Levanon 2013). Usually, about 8 housekeeping genes are targeted 
(Macheras et al. 2011). In other instances, MLST can be performed by sequencing a single 
copy of a gene in combination with different gene alleles to generate an allelic profile. 
This allele profile serves as a fingerprint to differentiate other isolate and develop an 
evolutionary relationship (Macheras et al. 2011). MLST compared to PFGE is less 
discriminative in identifying M. abscessus (Machado et al. 2014). It does not provide 
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discrimination between variants of a single clone (Machado et al., 2014). In organisms 
that have undergone high levels of recombination, MLST may not provide detail 
biological diversity, hence results may be misleading (Quainoo et al. 2017). While MLST 
targets housekeeping genes, MST amplifies sequences in the spacer region located 
between the 16S rRNA and 23S rRNA genes. These regions are less exposed to 
evolutionary pressures and are well conserved, hence can be informative of M. abscessus 
identity (Sassi et al. 2013).   
 
3.5.4 Variable number of tandem Repeats (VNTR) 
Short repeated DNA sequences adjacent to each other (tandem repeat) are useful bacterial 
fingerprints. The frequency with which these DNA repeats occur within the genome can 
vary between isolates of the same species and is referred to as VNTR. Using bioinformatic 
tools, VNTRs can be identified and amplified by PCR using specific DNA primers. The 
approach is relatively simple, rapid to perform and comparable in sensitivity to PFGE 
(Harris and Kenna 2014; Chen et al. 2017a). Several studies have reported the usefulness, 
efficiency and reliability of VNTR in typing M. abscessus isolates (Choi et al. 2011; 
Harris et al. 2012; Wong et al. 2012; Davidson et al. 2013; Trovato et al. 2017). A duplex, 
low cost PCR assay based on targeting a VNTR region of M. abscessus has been 
developed and proves to be efficient in differentiating M. abscessus group (Choi et al. 
2011). This method is also simple, reliable and accurate. The accuracy of this method was 
confirmed by subjecting same bacterial isolates to multiple sequence analysis (Choi et al. 
2011). 
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3.5.5 Whole Genome Sequencing (WGS) 
Whole-genome sequencing is a popular and easy tool for genotyping. With the use of the 
tool the entire genome of a bacterial pathogen can be determined at high resolution and 
distinguish highly related lineages. The genomic data obtained can also detect 
antimicrobial resistant genes which can improve treatment outcome. Additionally, WGS 
can identify single nucleotide polymorphisms (SNPs), which are impossible to detect with 
PFGE. SNPs refer to nucleotide differences that occur at a specific location within the 
genome. Usually, such nucleotide differences have phenotypic outcomes and are 
additional source of information for differentiating closely related bacterial species. 
Recently, WGS has been used to predict possible person-to-person transmission of M. 
abscessus among CF patients confined in a particular hospital (Bryant et al. 2013). The 
ability of this tool to identify individual nucleotide base differences makes it valuable to 
support transmission dynamics and epidemiological studies. Despite carrying lots of 
advantages, it presents with high costs. The interpretation of genomic data also requires 
specific algorithms which will demand expertise.  
 
Based on the advantages of VNTR typing (as discussed above), this tool was used for the 
characterisation of suspected clinical isolates of M. abscessus that were received from the 
University Hospital of Wales (UHW). VNTR typing was further supported with 
phenotypic testing (antibiotic susceptibility to clarithromycin).   
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3.6 Aims and objectives 
The aim of this chapter is to characterise and confirm the identity of a collection of clinical 
isolates of M. abscessus provided by Public Health Wales  
 
The objectives are to;  
1. determine their antibiotic susceptibility to clarithromycin.  
2. develop an efficient cell lysis method which maximise the release of DNA from 
M. abscessus to support VNTR based characterisation. 
3. employ a VNTR assay to determine the genetic identify of each clinical isolate   
 
3.7 Materials 
3.7.1 Chemicals 
Clarithromycin (Cat. No.: C9742), Tween 20, Triton X-100, acid washed diatomaceous 
earth, ethylenediaminetetraacetic acid (EDTA) and GenElute bacterial genomic DNA 
isolation kit were all purchased from Sigma Aldrich, UK. Sodium dodecyl sulphate 
(SDS), urea, lysozyme and Tris base were purchased from Fisher Scientific, UK. Taq PCR 
core kit (250U) and DNeasy blood & tissue kit were purchased from Qiagen, UK. Zirconia 
beads (0.1 mm) was also purchased from (BioSpec, USA). 96-well microtiter plate (Life 
Science, USA). All reagents were purchased as molecular grade.  
3.7.2 Preparation of diatomaceous earth solution 
Diatomaceous earth powder (10 g) was mixed with 50 ml of sterile milli-Q water and 500 
uL of 37% HCl. The mixture was mixed and stored at 4 °C for further use. 
 
71 
 
3.7.3 Instruments 
Nanodrop (ND 1000 spectrophotometer, LabTech), spectrophotometer (Ultrospec 2100 
pro, USA), UV transilluminator (ChemiDoc, Bio-Rad laboratories, UK), Thermal cycler 
(T100, Bio-Rad). 
 
3.7.4 Bacterial isolates 
3.7.4.1 M. abscessus (ATCC 19977T) 
The type strain of M. abscessus (ATCC 19977T) is a biosafety level 2 pathogen and was 
purchased from the American type culture collections (ATCC), UK. This isolate 
demonstrates intrinsic resistance to clarithromycin due to the presence of a complete and 
functional erm-41 gene  (Bryant et al. 2013).  
 
3.7.4.2 M. kansasii (ATCC 12478) 
The type strain of M. kansasii (ATCC 12478T) is a biosafety level 2 pathogen which was 
first isolated from human pulmonary secretions and lesions. This bacterium was included 
as a negative control in the MIC assay as it lacks the erm-41 gene making it susceptible 
to clarithromycin (Biehle and Cavalieri 1992).  
 
3.7.4.3 E. coli (NCTC 1093) 
E. coli (NCTC 1093) is a biosafety level 2 pathogen was originally isolated from human 
faeces. This bacterium being Gram-negative and having a less rigid cell wall as compared 
to mycobacteria was used as a negative control in the DNA extraction. 
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3.7.4.4 M. abscessus clinical isolates 
Eight suspected clinical isolates of M. abscessus were obtained from the UHW with 
unique identity numbers (9723, 11490, 10006, 10332, 11365, 8899, 9568, 9495) assigned 
by the hospital. The isolates were collected from patients in July 2012 and their 
corresponding antibiotic resistance profiles shown in Table 3.1 
 
Table 3.1 The clinical isolates of suspected M. abscessus used in this study  
Unique strain 
Number 
Antibiotic resistance (MIC > 128 µg/mL) 
determined by UHW 
Collection date 
8899 Imipenem, Rifampicin 11/07/2012 
10006 Rifampicin, ciprofloxacin, Imipenem 12/07/2012 
10332 Rifampicin 22/07/2012 
11365 Rifampicin, ciprofloxacin, Imipenem 23/07/2012 
9495 Rifampicin, Imipenem 11/07/2012 
9723 Rifampicin, ciprofloxacin 12/07/2012 
11490 Rifampicin 24/07/2012 
9568 Rifampicin 12/07/2012 
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3.8.1 Lysis buffers for DNA extraction 
Genomic DNA from M. abscessus (ATCC 19977T) was performed using three different 
lysis buffers (A, B and C) (Boom et al. 1990; Kotlowski et al. 2004; Kaser et al. 2009; 
Omar et al. 2014). The composition of the lysis buffers is shown in Table 3.2 below. E. 
coli (NCTC 1093) a common Gram-negative bacterium having a less rigid cell wall was 
included as a control. 
 
 
Table 3.2 Lysis buffers developed to enhance mycobacteria cell wall lysis and the 
subsequent recovery of DNA 
Lysis Buffer Buffer Composition 
Buffer A 8M urea, 60 mM Tris-HCl, 1% Triton X-100, 10% Tween-20, 3mg/mL 
proteinase K 
Buffer B 2 mM EDTA, 10 mM Tris-HCl, 0.6% SDS, 400 mM NaCl, 3mg/mL 
proteinase K 
Buffer C 60 mM Tris-HCl, lysozyme (50 mg/mL), 3% SDS 
 
 
3.8.2 Sample processing 
Stationary phase cultures of M. abscessus and E. coli grown in their respective media 
(described in section 2.3.2) were pelleted (centrifugation at 4, 000g for 10 min at 4 °C). 
Bacterial pellets were resuspended in 500 µL of PBS to a final concentration of 1 x 108 
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CFU/mL. Bacterial concentration was determined by comparing the optical density 
against that of a previously constructed calibration curve (Appendix 1). One hundred 
microliter of this bacterial suspension was used for DNA extraction using either a 
commercial kit or an in-house method as described below.  
 
3.8.3 In-house method 
To isolate DNA from highly rigid mycobacterial cell walls and support molecular 
characterisation of isolates by VNTR, an in-house DNA extraction protocol was 
developed. The in-house method was evaluated alongside commercial DNA extraction 
methods (section 3.8.4) with cells of E. coli and M. abscessus. One hundred microliters 
of bacterial suspension (E. coli or M. abscessus) were lysed with 250 µL of one of the 
following lysis buffers (A, B or C) (Table 3.2) and 500 µL zirconia beads. Cells were 
lysed overnight at 60⁰C with constant shaking at 200 rpm. To capture the released DNA, 
40 µL of diatomaceous earth solution was added to the lysed sample and incubated at 
37⁰C for 60 mins. DNA bound to diatomaceous earth was pelleted by centrifugation at 
10,000 rpm for 60 seconds and the supernatant discarded. Bound DNA was washed twice 
with 900 µL of ice cold 70% alcohol and 900 µL of absolute acetone. After the wash step, 
DNA bound to diatomaceous earth was dried at 50⁰C for 20 min using a heat block to 
evaporate any excess acetone that might be present. To elute DNA from the diatomaceous 
earth, 100 µL of 1x TE buffer was added and incubated at 55⁰C for 20 min with 
intermittent vortexing. The mixture was then centrifuged (10, 000 rpm for 2 min) and the 
supernatant containing DNA extract was aliquoted into a new microcentrifuge tube and 
quantified using a Nanodrop. DNA purity was determined by measuring the 260/280 nm 
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absorbance ratio. The lysis buffer which resulted in the highest DNA yield was used to 
extract DNA from the remaining M. abscessus isolates (Table 3.1).  
 
3.8.4 DNA extraction using commercial DNA extraction kits 
Using the same bacterial suspension as stated in section 3.6.3, DNA was extracted using 
two commercial DNA kits namely (1) GenElute bacterial genomic DNA kit (Sigma 
Aldrich) and (2) DNeasy Blood & Tissue Kit (Qiagen) following the respective 
manufacture’s protocol. The purity and yield of the extracted DNA obtained from both 
methods were quantified using a Nanodrop. 
 
3.8.5 Characterization of M. abscessus isolates 
The identity of the 8 clinical isolates (Table 3.1) were determined using a VNTR assay 
and by determining their susceptibility to clarithromycin. 
 
3.8.5.1 VNTR assay 
All M. abscessus DNA extracts obtained were subject to VNTR analysis. The VNTR 
assay is a duplex PCR based on the amplification of two VNTR targets (11 and 23). PCR 
was performed in 20 µL reaction containing 1 µL each of 20 nmoL of VNTR primers 
(Appendix 2.1), 4 µL of 5X Q-solution, 2 µL of 10X PCR buffer, 0.4 µL of 25mM MgCl2, 
0.4 µL of 10mM dNTP mix, 1µM each of primer, 0.2 µL of Taq DNA polymerase and 1 
µL of extracted DNA. PCR was performed in a 200 µL PCR tube in a thermal cycler with 
the following thermocycling profile; denaturation at 95⁰C for 10 min, followed by 35 
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cycles of 95⁰C for 30s, 63⁰C for 30s, 72⁰C for 45s and a final extension at 72⁰C for 10 
min. PCR products were electrophoresed on a 2% agarose gel stained with 4 µL of 
SafeviewTM. Electrophoresis was performed in 1X TAE buffer at 100V for 30 min and 
visualised in UV transilluminator.  
 
3.8.5.2 Detection of non-M. abscessus isolates by PCR 
A conventional PCR using specific probes was performed to determine the identity of 
isolates which were not M. abscessus using primers targeting the 50 bp region of the erm-
38 gene of M. smegmatis. Extracted DNA (5 µL) from isolates were amplified in a total 
reaction volume of 20 µL containing 0.2 µM of forward, 0.2 µM of reverse primers 
(Appendix 2.2), 4 µL of 5X Q-solution, 2 µL of 10X PCR buffer, 0.4 µL of 25mM MgCl2, 
0.4 µL of 10mM dNTP mix, 0.2 µL of Taq DNA polymerase and 1 µL of extracted DNA. 
DNA was first denatured at 95⁰C for 10 min, followed by 35 cycles of 95⁰C for 30s, 56⁰C 
for 30s, 72⁰C for 30s and a final extension at 72⁰C for 10 min. PCR products were viewed 
as described above (Section 3.6.5.1). 
 
3.8.6 Preparation of clarithromycin stock 
Clarithromycin (30,000 ug/mL) was prepared in acetone and then diluted in LB broth to 
a stock concentration of 1000 µg/mL. The antibiotic solution was sterilised using a 0.2 
µm millipore filter (Minisart syringe filter, Germany). Two-fold serial dilution of the 
working concentrations of the antibiotic (10, 20, 40, 80, 160, 320 and 640) µg/mL was 
prepared in fresh LB broth. The final antibiotic concentrations tested in each assay was 
reduced by 10-fold to give a final concentration range of 0, 1, 2, 4, 8, 16, 32 and 64 µg/mL. 
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3.8.7 Determining MIC using broth microdilution method 
Bacterial suspensions to be tested (1 x 106 CFU/mL) as determined in section 2.2.4 were 
tested in the MIC assay. MIC of the bacterial isolates (Table 3.1) were determined using 
the broth microdilution method in a 96-well plate (CLSI 2012). In a typical experiment, 
the MIC assay consisted of the following; bacterial suspension (25 µL), LB broth (200 
µL) and varying concentrations of clarithromycin solution (25 µL) incubated in a 96-well 
plate. Two standard mycobacteria strains; M. kansasii ATCC 12478 (clarithromycin 
sensitive < 1 ug/ml) and M. abscessus ATCC 19977T (clarithromycin resistant > 64 ug/ml) 
were included in the assay. Broth solutions without clarithromycin were included to 
determine whether acetone had an inhibitory effect on the growth of bacterial cultures. In 
addition, broth alone was also included as a control to ensure that there was no bacterial 
contamination. The plates were incubated at 37°C and observed visually for growth on 
days 3, 5, 7, 9, 11, 13 and 14. Each assay was performed in triplicates and repeated twice. 
3.9 Statistics 
Statistical analysis of data was performed using Microsoft excel 2013 analysis tool pack. 
A two-tailed independent sample t-test was performed to determine statistical significance 
between the extraction methods.  
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3.10 Results 
3.10.1 Determination of the clarithromycin sensitivity of M. abscessus isolates   
The MIC of M. abscessus isolates was determined against clarithromycin at varying 
concentrations of 1, 2, 4, 8, 16, 32 and 64 µg/mL. M. abscessus demonstrates inducible 
resistance after 3 days when cultured with clarithromycin. To determine this, the MIC of 
each isolate was monitored on days 3, 5, 7, 9, 11, 13 and 14. The following antibiotic 
susceptibility breakpoints were applied based on CLSI guidelines (CLSI 2012). Isolates 
were determined to be susceptible, intermediate and resistant if the MIC < 2 µg/mL, MIC 
= 4 µg/mL and MIC ≥ 8 µg/mL respectively (Brown-Elliott et al. 2012). Following 14 
days of incubation, isolates 10332 and 11365 were found to be sensitive and intermediate 
sensitive respectively. The remaining 6 isolates (9495, 8899, 10006, 9723, 11490 and 
9568) were sensitive on day 3 (MIC <2 µg/mL) but had MIC values ≥ 8 µg/mL on day 14 
indicating inducible resistance (fig 3.1A, B). As expected, the control isolates ATCC 
19977T and ATCC 12478 remained resistant and sensitive respectively 14 days post 
culture. There was no growth in the broth only samples or in the broth with antibiotic 
controls after 14 days of incubation (fig 3.1A, B).
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Figure 3.1A MIC of bacterial isolates against clarithromycin. M. abscessus isolates (9568, 11365, 11490, and 10006) at 1 x 
106 CFU/mL were tested against varying concentrations of clarithromycin (1, 2, 4, 8, 16, 32 and 64 µg/mL) and incubated for 14 days. The 
MIC of each isolate was determined on days 3, 5, 7, 9, 11 and 14. Each experiment included a positive (M. abscessus ATCC 19977; blue 
line) and a negative control (M. Kansasii ATCC 12478; black line) isolate. Data represents MIC of triplicate experiments.  
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Figure 3.1B MIC of bacterial isolates against clarithromycin. M. abscessus isolates (9495, 10332, 8899 and 9723) at 1 x 106 
CFU/mL were tested against varying concentrations of clarithromycin (1, 2, 4, 8, 16, 32 and 64 µg/mL) and incubated for 14 days. The 
MIC of each isolate was determined on days 3, 5, 7, 9, 11 and 14. Each experiment included a positive (M. abscessus ATCC 19977; blue 
line) and a negative control (M. Kansasii ATCC; black line) isolate. Data represents MIC of triplicate experiments. 
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3.10.2 Developing DNA extraction for mycobacterial cells 
Three different buffer formulations (buffer A, B and C) (Table 3.1) were investigated for 
their ability to efficiently lyse mycobacterial cells to release DNA. Two commercial DNA 
extraction kits [GenElute bacterial genomic DNA kit (Sigma Aldrich) and DNeasy Blood 
& Tissue Kit (Qiagen)] were also included for comparison. Also, E. coli was included in 
the extraction protocol to investigate the effect of the different cell lysis compositions on 
different cell wall structures. The concentrations of the DNA extracts and purity obtained 
by the commercial kits and in-house methods were compared (fig. 3.2). The two 
commercial kits were effective in recovering DNA from E. coli but not from M. abscessus 
as the DNA yields   were significantly lower than that obtained for E. coli (p<0.05). All 
buffer formulations investigated resulted in a significant recovery of DNA from M. 
abscessus and E. coli as compared to the commercial kits (p <0.05). Comparing the three 
lysis buffer formulations, buffer A was the most efficient as it resulted in a significant 
release of DNA (p<0.05) from M. abscessus and E. coli (fig. 3.2). There was no significant 
difference in DNA purity as determined by the 260/280 ratio when both methods i.e. 
commercial and in-house methods were compared (p > 0.05).  
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Figure 3.2 Comparison of DNA yield and purity using different extraction 
methods. Pairwise DNA extraction was performed on suspensions of E. coli and M. abscessus 
(1.0 x 108 CFU/mL) using two commercial kits (Qiagen and Sigma Aldrich) and an in-house 
method. DNA yield (bar) and purity (dotted lines) were compared from all methods. Data 
represents mean of 2 replicates ± standard error (SE).  
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Following the optimisation of the lysis buffer, DNA extraction was performed using 
buffer A on all of the bacterial isolates (Table 3.1). The DNA yield and purity were 
quantified, and the result displayed in fig 3.3. The concentration of DNA recovered varied 
markedly with the highest yield being obtained from isolate 8899 which was significantly 
higher than that obtained for isolate 11490 (p < 0.05).  
 
 
 
Figure 3.3. Mean concentration (bar) and purity (line) of M. abscessus  DNA 
extracts. DNA was extracted from all clinical isolates using lysis buffer A. DNA concentration 
(bar) and purity (dotted lines) were measured using the Nanodrop. Neg ctrl represents a DNA 
extraction mixture where bacteria were not added. Data represents mean of 2 replicates ± standard 
Error (SE).  
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3.10.3 VNTR characterization of M. abscessus isolates 
To confirm the identity of the clinical isolates provided by the UHW, a VNTR assay was 
performed targeting loci 11 and 23 of the M. abscessus genome. A typical M. abscessus 
with both loci present will generate two distinct bands with estimated band sizes of 
between 393-492 bp and 196-238 bp. Bands of the expected sizes were observed for 
isolates (11365, 10332, 9568, 10006, 11490, 8899 and 9495) and the positive control 
isolate ATCC 19977T. No bands were seen for isolate 9723 (lane 8), suggesting the 
absence of the VNTR targets that characterise M. abscessus (fig 3.4). Subsequent PCR 
analysis using primers designed to identify the rpoB gene of M. smegmatis revealed the 
presence of a band of the expected size (200 bp) for the M. smegmatis control and sample 
9723 but was absent from M. abscessus the ATCC 19977T (fig. 3.5). These results suggest 
that 9723 is an isolate of M. smegmatis. The results for the VNTR and antibiotic 
susceptibility testing for each isolate are summarised in Table 3.3 
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Figure 3.4. VNTR characterization of M. abscessus  isolate. Two VNTR loci (11 and 
23) were amplified in a duplex PCR. PCR amplicons (5 µL) were electrophoresed on 2% agarose 
gel stained with SafeviewTM in a 1X TAE buffer. Lane L= 50 bp molecular weight marker; lane 
1= 11365, lane 2= 10332, lane 3= 9568, lane 4= 10006, lane 5= 11490, lane 6= 8899, lane 7= 
9495, lane 8= 9723 (M. smegmatis) and lane 9= ATCC 19977T (M. abscessus).  
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Figure 3.5 PCR identification of isolate 9723. M. smegmatis specific primer targeting 
rpoB gene was synthesised and the identity of isolate 9723 determined in a conventional PCR 
assay. PCR amplicons (5 µL) were electrophoresed on 1.5% agarose gel stained with SafeviewTM 
in a 1X TBE electrophoresis buffer. Lane L= 100 bp molecular weight marker; lane 1= no template 
control, lane 2= ATCC 19977T (M. abscessus), lane 3= 9723 (M. smegmatis), lane 4= M. 
smegmatis (NCTC 8159). 
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Table 3. 3 Summary of antibiotic and VNTR characterizations of UHW test isolates  
Bacterial isolate MIC VNTR (loci 11 and 
23) 
Bacterial isolate 
9568 Ind. Resistant Present  M. abscessus 
11365 Mod Resistant  Present  M. abscessus 
11490 Ind. Resistant Present  M. abscessus 
10006 Ind. Resistant Present  M. abscessus 
9495 Ind. Resistant Present  M. abscessus 
10332 Sensitive Present  M. abscessus 
8899 Ind. Resistant Present  M. abscessus 
9723 Ind. Resistant Absent  M. smegmatis 
ATCC 19977 Resistant Present  M. abscessus 
ATCC 12478 Sensitive  ND - 
 
Key 
Ind. Resistant = inducible resistant; Mod. Sensitivity = Moderate sensitivity; ND = Not detected. 
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3.11 Discussion 
Identification of bacteria using phenotypic methods is not always accurate and reliable 
(Harris and Kenna 2014). For this reason, VNTR typing was performed in addition to 
clarithromycin susceptibility testing to comprehensively characterise the bacterial isolates 
used in this study. Based on the VNTR data, all the isolates with the exception of 9723 
produced a VNTR profile indicative of M. abscessus. Further analysis of isolate 9723 
using a PCR assay targeting the erm-38 gene confirmed and identified this isolate as M. 
smegmatis.  
 
Subsequently, the susceptibility profile of the isolates to clarithromycin, which is the drug 
of choice for M. abscessus treatment was determined. Their susceptibility to 
clarithromycin is dependent on the presence and functionality of the erm-41 gene which 
is present in all isolates of M. abscessus. Of the eight isolates tested, 10332 and 11365 
were susceptible and moderately susceptible respectively to clarithromycin after 14 days 
of incubation. Since this test is not decisive, it is not possible to assign these isolates as 
M. abscessus as these could be susceptible M. abscessus isolates, M. massiliense or any 
of the rapid growing NTM species harbouring the inducible erm gene.  
 
While a strain may have an MIC value below 2 (susceptible) on day 3 of incubation, it 
could become resistant to clarithromycin with MIC greater than 8 on day 14 of incubation 
(Bastian et al. 2011). This mode of resistance which is described as inducible requires the 
presence of a complete and functional erm-41 gene. Full length erm-41 gene is present in 
M. abscessus and M. bolletii and confers resistance to clarithromycin but when 
truncated/incomplete it renders the isolate sensitive and this is usually seen in M. 
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massiliense (Sapriel et al. 2016). Inducible resistance was observed in 9495, 8899, 10006, 
11490, 9568 and 9723 having MIC lower than 2 on day 3 but greater than 8 after 14 days 
post culture.  
 
Although isolate 9723 was identified as M. smegmatis by PCR, it demonstrated inducible 
resistance to clarithromycin similar to the M. abscessus isolates. Inducible resistance to 
macrolides does not only occur in M. abscessus but in all mycobacteria species harbouring 
the erm gene (Nash 2003; El Helou et al. 2013). Variants of the erm gene have been 
identified in M. smegmatis, M. tb complex, M. fortuitum and M. mageritense and harbours 
the erm-38, erm-37, erm-39 and erm-40 genes respectively (Nash et al. 2009).  
 
While the antibiotic testing of the isolates informs of inducible resistance instigated by 
the erm gene, the VNTR is more decisive in characterising M. abscessus isolates. This 
further highlight the advantage of using VNTR over clarithromycin susceptibility testing 
as without the former, isolate 9723 would have been characterised as M. abscessus. The 
uniqueness of the erm-41 gene as it is only present in M. abscessus serves as a useful 
molecular target to be used in molecular based detection assays, and this will be discussed 
in the next chapter.  
 
Isolation of DNA from mycobacterium species is complicated by the presence of mycolic 
acids (MA) which contribute to the creation of thick and rigid cell walls which are difficult 
to lyse. MA is not a component of Gram-negative bacterial cell walls, and this partly 
explains why bacterial cells belonging to this group are easier to disrupt using 
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commercially available methods (Mitchell et al. 2012). DNA extraction from 
mycobacterial cells have been a major bottleneck to PCR and other DNA dependent 
typing and identification methods. It becomes a research priority to develop an effective 
cell lysis procedure to augment DNA yield and purity. To achieve this, we compared the 
efficiency of three different lysis buffers in combination with zirconia beads to that of two 
commercially available methods.  
 
It was evident from the study that the in-house method was effective in releasing DNA 
from mycobacterial cells and E. coli compared to the two commercial DNA extraction 
methods. The latter was only effective against E. coli. DNA release from bacterial cells is 
enhanced in the presence of chaotropic agents, detergents, enzymes and mechanical 
disruption (Belisle and Sonnenberg 1998). 
 
Urea is a chaotropic agent and detergents such as  Triton X-100, SDS and Tween-20 are 
able to denature proteins and disrupt membrane integrity (Belisle and Sonnenberg 1998; 
Danilevich et al. 2008). These chemicals in combination with zirconia beads (mechanical 
lysis) maximised the recovery of DNA from the bacteria used in this study. The highest 
yield of DNA was achieved using buffer formulation A compared to the commercial kits. 
The significant release of DNA is an indicator of severe membrane damage (Zhen et al. 
2013).   
 
It was observed that, the three lysis buffer formulations resulted in varying DNA yield. 
As shown in Table 3.1, buffer A contained two main detergents (Tween 20 and Triton X-
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100) and proteinase K while buffers B and C contained SDS and lysozyme. Lysozymes 
are known to have a disruptive and lytic activity against mycobacterial cell walls (Salton 
1958) but appeared to have been inhibited in this study. Lysozyme degrades cell wall by 
disrupting N-acetyl-glucosamine and N-acetylmuramic acid bonds in murein. This 
enzyme is stabilized by four disulphide bonds which keeps it stable and active (Chamani 
et al. 2010). Lysozyme are inactivated in the presence of surfactants and detergents such 
as SDS (Chamani et al. 2010). It is likely that the lytic activity of lysozyme may have 
been inhibited in buffers B and C due to the presence of SDS, and resulting in the lesser 
DNA yield than that of buffer A (Koga and Kramer 1983). The optimal lysis buffer (A), 
was applied for DNA extraction from the remaining M. abscessus isolates. The lysis 
buffer components of the commercial kits were not disclosed for commercial reason and 
thus it was impossible to draw any conclusion as to the relative contribution of the any of 
the individual elements to the differences in DNA yield which was observed. 
 
Differences in the incubation periods employed in the various lysis approaches may have 
also contributed to the observed differences in DNA yield (Lever et al. 2015). The in-
house methods included an overnight (18 hours) lysis step compared to the commercial 
kits where the incubation period was 2 hours. Thus, the markedly longer incubation time 
for the in-house methods may have been a contributing factor for DNA release.  
 
The yield of DNA recovered from the 7 M. abscessus isolates using lysis buffer A method 
differed significantly and this could be influenced by a number of factors. Mechanical and 
chemical cell lysis could interact with and cause degradation of nucleic acids (Islam et al. 
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2017). Another factor worthy of consideration is the technicalities of the DNA extraction 
procedure i.e. binding of the DNA and subsequent elution form the diatomaceous earth as 
this was key to maximise DNA recovery. Diatomaceous earth consists of positively 
charged silica matrix that attract and selectively binding to negatively charged DNA. The 
challenge with this technique is the inability to recover small fragments of DNA as these 
types of DNA bind tightly to the silica matrix (Koo et al., 1998) and could affect the 
overall DNA recovery.  
 
On the basis of a comparison of the 260/280 ratio of the isolated DNA, the in-house 
method had the same level of DNA purity as that of the commercial DNA extracts, 
suggesting an efficient removal of DNA contaminants such as proteins and carbohydrates. 
The commercial kits required spin columns containing silica for DNA purification. The 
use of diatomaceous earth in this study proved to be efficient as that of spin columns, 
yielding comparable DNA purity. 
 
Overall, the in-house method was time consuming, but economically more viable (£0.34 
per sample) than the commercial kits (£3.32 per sample) and allows for the control of 
other parameters i.e. buffer concentrations to applied on other sample types. The method 
developed in this study demonstrates the ability to produce relatively high DNA yields 
without compromising on purity and can serve as an excellent alternative to the 
commercial kits. A major selling point of commercial kits is the fact that they are less 
time consuming. The reason we did this was to optimise DNA release from these bacteria 
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so that can support our subsequent probe detector work and to have a base line method 
against which we could compare our microwave-based lysis method. 
 
In conclusion, the identity of the bacterial isolates obtained from the UHW have been 
confirmed using a combination of genetic and phenotypic methods. An efficient DNA 
extraction method has been developed for M. abscessus which would be employed in this 
study to isolate high quality DNA. The challenge in isolating purified DNA from 
mycobacterial cells that has been a frequent challenge and a bottleneck in major studies 
can be surmounted by employing the bacterial cell lysis procedure developed in this study.  
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Chapter 4 
The design of DNA probes for the detection of Mycobacterium abscessus and 
Mycobacterium smegmatis  
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4.0 Introduction 
The success of any molecular based identification method relies on the identification of specific 
nucleotide sequences which are only found in a bacterial genome. This is particularly important 
in the case of the non-tuberculous mycobacteria (NTM) as the taxonomy of M. abscessus group 
remains complex and debatable due to the lack of individual gene targets with sufficient specificity 
to support species level discrimination (Wertz et al. 2003; Zeigler 2003; Johnson and Odell 2014; 
Rubio et al. 2015). In chapter 3, VNTR typing was used as a tool to distinguish individual M. 
abscessus isolates. VNTR relies on the amplification of repeats of short nucleotide sequence at 
different loci across the genome. Thus, while an effective typing tool, it is not suitable for the 
development of a rapid detection system. Individual gene targets such as the rpoB gene have  been 
proposed as a diagnostic marker for the identification of rapid growing mycobacteria (de Zwaan 
et al. 2014; Nasiri et al. 2017), but others have questioned its sensitivity reporting that it is unable 
to distinguish M. abscessus from M. avium (Adekambi and Drancourt 2004).  
 
In some clinical laboratory, M. abscessus isolates are not routinely distinguished from M. 
chelonae and are report as M. abscessus-M. chelonae complex (Griffith et al. 2015). The 
distinction between these two isolates is relevant for their effective treatment. The absence of erm-
41 gene in M. chelonae could be used as the basis for distinction between these two bacterial 
species. As discussed in section 3.2, the erm gene (erm-41) represents a potentially unique target 
for M. abscessus identification (Brown-Elliott et al. 2015) and the rpoB gene being polymorphic 
in nature could be exploited for specific bacterial identification (ref).  
In this study we employed a bioinformatic based approach to identify unique target sequences 
within the erm-41 and rpoB gene sequences of M. abscessus and M. smegmatis (rpoB only). This 
approach is discussed below. 
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4.1 Bioinformatic probe design  
When designing probes for bacterial identification, it is important to target conserved regions of 
the bacterial genome, as these regions are unlikely to be affected by evolution and/or 
environmental cues (Guerrero et al. 2010). An efficient method of achieving this is to employ a 
bioinformatic based approach (Luo et al. 2015). Bioinformatics refers to the application of 
computational algorithms to study biological information e.g. protein or DNA sequences for 
evidences relating to their function, identifying homologs, sequence patterns and evolutionary 
relatedness (Xiong 2006). The potential of this approach is based on the ability to access 
sequencing data from open source databases such as the National Centre for Bioinformatics 
Information (NCBI). In addition to providing access to genomic data, the NCBI database provides 
researchers with the ability to identify unknown nucleotide or protein sequences by comparing 
their homology to known sequences stored in its database. This homolog search is performed 
using a software tool called Basic Local Alignment Search Tool (BLAST) (Altschul et al. 1990; 
Pearson and Lipman 1998). BLAST can also be used to determine the specificity of short stretches 
of DNA probes.  
4.2 Basic Local Alignment Search Tool (BLAST) 
Various BLAST formats have been developed, and these include MegaBLAST, BLAST URL 
API, BLAST standalone applications, BLAST+ remote service, C++ Application programming 
interface (API) and NCBI BLAST. All except NCBI BLAST require much stricter settings 
(Madden 2013). The NCBI BLAST algorithm is the easiest to access and is much simpler, quick 
to use, requires only a web browser and  set-up requires no registration (Madden 2013). In addition 
to its diverse formats, BLAST is designed to support more detailed data analysis. For instance, 
MegaBLAST performs nucleotide search by considering the first 28 nucleotides of the query 
sequence and then proceeds to align the remaining nucleotides. This approach is different to that 
of BLASTN which considers more than 28 nucleotides of the query sequence (Madden 2013). 
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BLASTP (searches for protein sequences and compares to other protein sequences), BLASTX 
(searches for nucleotide sequences and compares to protein database), TBLASTN (searches for 
protein sequences and compares to nucleotide database) (Morgulis et al. 2008; Pearson 2013). In 
this study, BLASTN was used to retrieve nucleotide sequences from the NCBI database.  
4.3 Statistical analysis of BLAST output  
To perform a similarity search, the  query sequence (DNA or protein) is compared against the 
NCBI database of sequences (subject sequences), to generate a number of sequence output called 
‘matched sequence’ (Pearson and Lipman 1998). While a database search will always turn out 
with a ‘match sequence’, this will require further analysis using specific statistical scoring 
matrices to ascertain the significance of the ‘matched sequence’ (Karlin et al. 1991). Scoring 
matrices such as the E- value, maximum score, total score, query coverage and maximum identity 
are mostly used. The E-value is the traditional statistic test used to score ‘matched sequences.’ 
The E-value is the probability of the match and the query sequence being identical. The lower the 
E-value, or the closer it is to zero, the more significant is the alignment between the query and the 
matched sequence. Shorter query sequences will produce high E-value and vice versa. This is 
because, the probability of finding another short sequence in the database is very high (Pearson 
2013). An E-value of 10-3 and below is indicative of statistical significance, however, it is not 
uncommon for a BLAST search to produce a match with an E-value of 10-50 (Nagar and Hahsler 
2013), indicating a very strong relationship between the query and the ‘matched sequence’. The 
maximum score generates similar output to that of the E-value. It determines the highest scoring 
between a set of aligned segments from the same subject sequence. It also considers the sum of 
the matches, mismatches, gap openings for each segment. Gap openings usually occur because of 
genetic mutations from nucleotide deletions or insertions (Krane and Raymer 2002). The 
maximum identity is the highest percentage similarity between the query and the subject sequence 
over the length of the coverage area. The query coverage refers to the percentage of the length of 
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query sequence covered and included in the aligned sequence. The total score is also determined 
by the sum of the alignment scores of all segments from the same subject sequence (Madden 
2013).  
4.4 Multiple Sequence Alignment (MSA) 
MSA is an important technique in probe design. After the BLAST search, several matched 
sequences are identified and the homology between these matched sequences can be retrieved and 
if there is any region of homology, this can be determined by performing a sequence alignment. 
Two types of alignment can be performed i.e. pairwise and multiple sequence alignment. The 
former is the alignment between two sequences and the latter is more than two nucleotide 
sequences using bioinformatics tools such as CLUSTAL W and T-coffee (Thompson et al. 1994; 
Notredame et al. 2000 ; Larkin et al. 2007). The regions showing homology after sequence 
alignment is usually chosen for the probe/ primer design. Also, when homology is identified 
between multiple sequences, there is the likelihood that, this region of comparison has similar 
function and could be structurally related and have biochemical functions (Karlin and Altschul 
1990; Altschul et al. 1997). This can be confirmed by determined using specific tools to predict 
the presence of any protein secondary structures (discussed in section 4.5 below).  The design of 
probes using bioinformatic tools are discussed in this chapter using two genes of M. abscessus 
(erm-41 and rpoB) were selected to be tested as for specific identification.  
4.5 Predicting protein structure  
One approach to confirm whether the nucleotide region against which our  probes were designed 
are conserved is to determine  in the gene sequence encodes for  secondary structures, which 
serves as a starting point for determining tertiary and quaternary structures of the protein (Deng 
and Cheng 2011). In that case, the corresponding amino acid sequence would be the required 
template for secondary structure prediction. Predicting the secondary structure provides clues for 
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functional sites, conserved regions and protein stability (Zhou and Zhou 2005; Godzik et al. 2007; 
Deng and Cheng 2011). Additionally, the secondary structure also determines how the proteins 
fold (Hol et al. 1981).  
 
Proteins are polymers of amino acids linked by a polypeptide bond. Four types of protein 
structures are formed in living tissues, namely; primary, secondary, tertiary and quaternary 
structures. Primary structures are the simplest, made of linear chains of amino acids. Secondary 
structures are composed of the α-helix and β sheet. The α-helix resembles spiral staircases while 
β sheets are formed when β strands self-assemble and both are stabilized by hydrogen bonding 
(Deng and Cheng 2011).  
 
The initial steps in predicting secondary structure follows the same principle as determining 
conserved nucleotide regions. First, the query protein sequence is used to identify similar protein 
sequences using BLASTP, followed by sequence alignment with CLUSTAL Omega to identify 
domains and predict their secondary structures using a specific bioinformatic tools. A myriad of 
such tools is available e.g. JPRED, PHD, 3D-PSSM, GenThreader, Meta Server CBS and Phyre2 
(Edwards and Cottage 2003).  
 
4.6 Aims and objectives 
The aim of this chapter is to design DNA probes capable of distinguishing M. abscessus from 
other mycobacteria. 
The objectives are to;  
1. employ a bioinformatic approach to identify unique nucleotide regions within the rpoB 
and the erm-41 genes of M. abscessus  
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2. predict the secondary structures of the conserved regions from their corresponding protein 
sequences 
3. design DNA specific probes capable of binding to these unique regions 
4. determine the ability of the candidate probes to differentiate M. abscessus from other 
mycobacteria 
 
 
4.7 Materials 
4.7.1 Chemicals 
Qiagen PCR core kit (Qiagen, UK), 100 bp Hyper ladder (Bioline, UK) 
4.7.2 Bioinformatic tools 
The following bioinformatic tools were used in this study;  
1. National Center for Bioinformatic Information (NCBI). Accessed from  
https://www.ncbi.nlm.nih.gov/. Date accessed: November 2015. 
2. NCBI-BLAST. 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearc
h&LINK_LOC=blasthome). (Date accessed: December 2015) 
3. CLUSTAL W (http://www.ebi.ac.uk/Tools/msa/clustalw/) 
(Accessed on November 2015).  
4. Oligo integrated DNA technologies (IDT) analyser 
(https://www.idtdna.com/calc/analyzer) (Accessed on December 2015). 
5. Reverse complement. https://www.bioinformatics.org/sms/rev_comp.html (Date 
accessed: December 2015) 
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6. Probe check. http://131.130.66.200/cgi-bin/probecheck/probecheck.pl (Date accessed: 
December 2015) 
7. Phyre2. Accessed from  
http://www.sbg.bio.ic.ac.uk/phyre2/phyre2_output/4dfba067a02da9d8/summary.html. 
(Date accessed: 29.01.2019) 
8. Thermo scientific Tm calculator. Accessed from   
(https://www.thermofisher.com/uk/en/home/brands/thermo-scientific/molecular-
biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-
scientific-web-tools/tm-calculator.html) (Date accessed January 2016) 
 
4.8 Methodology 
4.8.1 Bioinformatic identification of target gene and multiple sequence alignment 
The full and complete nucleotide sequences of the erm-41 and rpoB genes of M. abscessus (M. 
abscessus; ATCC 19977T) and the rpoB gene sequence of M. smegmatis (MC2 155) were 
downloaded in FASTA format from NCBI. Using the BLAST tool, a similarity search was 
performed against the NCBI nucleotide database to obtain sequences that matched the query 
sequence. A major challenge encountered in post BLAST analysis was the availability of the full 
and complete coding sequences of the erm-41 and rpoB genes that matched the query sequence. 
For this reason, the number of the matched sequences that were complete were used. A total of 
ten, eight and three complete matched sequences out of the possible 100 for the erm-41 (M. 
abscessus; ATCC 19977T), rpoB (M. abscessus; ATCC 19977T) and rpoB (M. smegmatis; MC2 
155) genes respectively were retrieved from NCBI, as these sequences showed 100% homology 
to the query sequence. A multiple sequence alignment was then performed using CLUSTAL W 
to identify conserved regions showing 100% nucleotide alignment and numbering more than 50 
nucleotides in length. This region was considered suitable for probe design. Phylogenetic trees 
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based on each target gene (erm-41 and rpoB) were constructed with CLUSTAL W using 
the neighbour-joining methods. The default setting of CLUSTAL W for constructing the 
phylogenetic tree was applied.  
4.8.2 Predicting secondary structure of conserved regions 
The amino acid sequence of the erm-41 and rpoB gene (M. abscessus; ATCC 19977T) and the 
rpoB of M. smegmatis (MC2 155) was retrieved from NCBI and imported to Phyre2 software to 
determine if the conserved regions from which the probes were designed bears any secondary 
structures. The Phyre2 data output were then compared to the erm-41 nucleotide sequence to 
determine regions of secondary structure formation.  
4.8.3 In silico analysis of designed probes 
In silico analysis of potential probes (anchor and detector) were performed to determine if they 
were capable of forming hairpin, self- and hetero dimerization using the oligo IDT analyser tool. 
This tool predicts hairpin oligo secondary structure using a multiple fold (mfold) algorithm (Zuker 
2003). Probes capable of forming secondary structures were discarded based on their Gibbs free 
energy (∆G) values. Self-dimerization and hetero dimerization were also computed using the same 
software. The percentage of G-C in the probe was also determined and if more than 70%, those 
probes were excluded. The specificity of the probes was also determined using BLAST. Probes 
that were found to have nucleotide similarity with non-M. abscessus species were rejected. An 
overview of the bioinformatic probe design and analysis is shown if figure 4.1 below.   
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Figure 4.1. Overview of the workflow for bioinformatic probe design and in 
silico analysis. The first step is to load the query sequences to NCBI then the tool searches for 
similar sequences. Conserved regions are then located from the similarity search and the probes 
designed form the conserved regions.  
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4.8.4 Probe synthesis and modification 
A pair of probes (anchor and detector) were synthesized for each conserved region that showed 
100% homology. The anchor and detector probe were designed to have 17 and 22 nucleotides 
respectively with 5’-biotin and 3’-HRP modifications. To allow flexibility between the anchor 
probe and the magnetite beads, 5 thymine residues were inserted to the anchor probe sequence 
between the biotin and the 17-nucleotide sequence. These probes were designed to facilitate the 
development of the hybridization assay which will be discussed in Chapter 6. The same probes 
without biotin or HRP modifications at 5’ (anchor probe) or 3’ (detector probe) ends were 
synthesized so that they could be used in a PCR assay with the anchor probe serving as the forward 
primer and the reverse complement of the detector probe functioning as the reverse primer (Fig 
4.2).  
 
 
Figure 4.2 Schematic representation of probe design . The anchor (17 nucleotide) and 
detector probe (22 nucleotide) were designed to target same strand of bacterial gene. The reverse 
complement of the detector probe was obtained using Oligo IDT analyser. Between the anchor 
and the detector probe is a 5-nucleotide gap. 
 
4.8.5 Determination of probe specificity via PCR assay 
Following probe design and in silico analysis, probes were synthesized and subjected to specificity 
testing in a PCR assay using DNA extracts obtained from M. abscessus isolates (Chapter 3, Table 
3.3) and non-M. abscessus isolates (E. coli, S. aureus, M. smegmatis and M. kansasii). DNA were 
amplified using the Taq PCR core kit (Qiagen, UK). The synthesized probes (forward and reverse 
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primer without biotin and HRP modification) were used for the PCR assay. In a typical 
experiment, PCR was performed in a total reaction volume of 20 µl reaction containing 10.7 µl of 
nuclease free water, 0.1 µM of anchor and detector probe, 4 µl of 5X Q-solution, 2 µl of 10X PCR 
buffer, 0.6 µl of 25mM MgCl2, 0.4 µl of 10mM dNTP mix, 0.2 µl of Taq DNA polymerase and 2 
µl of DNA extract. Amplification was performed in a 200 µl PCR tube using a thermal cycler 
(T100, Bio-Rad) with the following thermocycling profile; initial denaturation at 95⁰C for 5 min, 
followed by 35 cycles of denaturation at 95⁰C for 30s, annealing at the probe respective 
temperature as determined by thermo scientific Tm calculator (Table 4.5) for 60 s, 72⁰C for 20s 
and a final extension at 72⁰C for 10 min. PCR products were electrophoresed on 2% agarose gel 
stained with 4 µl of SafeviewTM. Electrophoresis was performed in 1X TBE buffer at 100 Volts 
for 30 min and visualized in UV transilluminator (ChemiDoc, Bio-Rad laboratories, UK). 
 
4.8.6 Determining the sensitivity of the probes by PCR 
M. abscessus (ATCC 19977T) DNA was serially diluted in nuclease free water to the following 
concentrations; 10 ng/µL, 2 ng/µL, 0.4 ng/µL, 80 pg/µL, 16 pg/ µL and 3.2 pg/ µL. Serially diluted 
DNA was then used in a PCR reaction using each candidate probe and the amplified DNA if any, 
was electrophoresed and visualized as described in section 4.7.4 above.  
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4.9 Results 
4.9.1 Multiple sequence alignment (MSA) of M. abscessus genes  
The nucleotide sequences of the erm-41 of M. abscessus were retrieved from NCBI and imported 
into CLUSTAL W for alignment to identify conserved regions. Probes (E1, E2 and E3) were 
designed to target the conserved regions of the erm-41 gene. These regions are highlighted in red 
as shown in fig. 4.3A-C. The probe targeting the rpoB gene of M. abscessus and M. smegmatis 
are displayed in fig 4.3 D and E respectively. Similarly, the probe binding regions are highlighted 
in red. The probe for M. smegmatis was also designed and used for the identification of M. 
smegmatis and isolate 9723 (discussed in chapter 3). The anchor and detector probes numbered 
17 and 22 nucleotides respectively. The erm sequences of S. aureus (ermA, ermB and ermC), and 
E. coli and the rpoB sequences of S. aureus and E. coli were added to determine the specificity of 
the selected region. The aligned sequence showed that the region selected for probe binding did 
not have any similarity with the erm sequences of E. coli or S. aureus. Similarly, the selected 
region for the rpoB probe did not have any similarity with the rpoB sequences of E. coli or S. 
aureus. The phylogenetic analysis of the 17 sequences of erm-41 did not show any similarity with 
the erm genes of E. coli and S. aureus (fig. 4.4). Similarly, that of the rpoB gene sequences of M. 
abscessus and M. smegmatis did not show any similarity with those of E. coli or S. aureus as 
shown in figures 4.5 and 4.6 respectively. 
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Figure 4.3A-C.  Sequence alignment of conserved regions of the erm-41 probe. 
Probe binding regions for E1, E2 and E3 are shown in A, B and C respectively. 
DNA sequences with their respective accession numbers were retrieved from NCBI database in 
FASTA format. Seventeen sequences for the M. abscessus targeting the erm-41 gene were 
downloaded in FASTA format and aligned using CLUSTAL W to identify conserved regions 
(highlighted in red). The erm genes of S. aureus and E. coli were also included.   
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Figure 4.3D-E.  Sequence alignment of conserved regions of the  rpoB probe for 
M. abscessus  (D) and M. smegmatis  (E). DNA sequences with their respective accession 
numbers were retrieved from NCBI database in FASTA format. Ten and three sequences of rpoB 
for M. abscessus and M. smegmatis were downloaded in FASTA format and aligned using 
CLUSTAL W to identify conserved regions. The probe sequences are highlighted in red in the 
aligned sequence. The rpoB sequence for E. coli and S. aureus were also retrieved from NCBI 
and imputed into CLUSTLAL W.  
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Figure 4.4. Phylogenetic tree based on the complete gene sequence of the erm-
41 gene of M. abscessus . The erm genes of E. coli (WP_110459157.1) and S. aureus  
(CP000258.1_7865-8599-0.00115, JF968510.1, AF299292.1, X03216.1) were included to 
identify sequence similarity. The phylogenetic tree was constructed using the 
neighbour joining model in the CLUSTALW program .  
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Figure 4.5. Phylogenetic tree based on the partial gene sequence of the rpoB 
gene of M. abscessus . The rpoB  genes of E. coli (NC_000913.3:4181245-4185273) and 
S. aureus  (NC_007795.1:522160-525711) were included to identify sequence 
similarity. The phylogenetic tree was constructed using the neighbour joining model 
in the CLUSTALW program .  
 
 
 
Figure 4.6. Phylogenetic tree based on the partial gene sequence of the rpoB 
gene of M. smegmatis . The rpoB genes of E. coli (NC_000913.3:4181245-4185273) and 
S. aureus  (YP_499096.2) were included to identify sequence similarity. The 
phylogenetic tree was constructed using the neighbour joining model in the 
CLUSTALW2 program .   
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4.9.2 Determining the secondary structures of the conserved regions 
To determine if the unique nucleotide regions from which the probes were designed were 
conserved due to an essential biological role their corresponding amino acid sequences were 
obtained from NCBI and modelled with Phyre2 to determine the presence of any secondary 
structures i.e. α-helix and β-strand. Analysis of the erm-41 gene, constituting 173 amino acids 
showed regions of α-helix (31%) and β-strand (28%), and 98% of the total amino acid sequence 
were modelled with 100% confidence. Positions 57-86 and 147-162 of the amino acid sequences, 
the regions from which the probes were designed, contained a three α-helix and β-strands (fig 
4.7).  
 
Similarly, for the rpoB gene of M. abscessus gene, 91% of the total amino acid residues (1128) 
were modelled with 100% confidence. The total percentage of α-helix and β-strand formed were 
28% and 26% respectively. The amino acid region where the probe was designed i.e. between 
positions 910 and 957 (indicated in a box in fig 4.8) had 3 α-helix and 1 β-sheet strand. Finally, 
the rpoB gene of M. smegmatis was modelled with a total of 1138 amino acid residues. Again, 
92% of the amino acids were modelled with 100% confidence which resulted in α-helix (28%) 
and β-strand (26%). The probe position was identified between amino acid positions 20 to 34, 
which shows α-helix formation and the appeared of disordered amino acids (fig. 4.9).  
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Figure 4.7 Secondary structure prediction of M abscessus erm-41 gene. The 
corresponding amino acid sequence of the erm-41 gene of M. abscessus was retrieved from NCBI 
and modelled in Phyre2 to reveal any α-helix and β-strand. The regions where probes were 
designed (in rectangle) showed the presence of α-helix (violet) and β strands (light blue arrow).  
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Figure 4.8 Secondary structure prediction of M abscessus rpoB gene. The 
corresponding amino acid sequence of the nucleotide sequence of the rpoB gene of M. abscessus 
was retrieved from NCBI and modelled in Phyre2 to reveal any α-helix and β-strands. The regions 
where the probe was designed (in rectangle shape) showed α-helix and β strand formation. Amino 
acid positions 1 to 900 have been truncated from the figure and only shows regions of interest.    
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Figure 4.9 Secondary structure prediction of M smegmatis  rpoB gene. The 
corresponding amino acid sequence of the nucleotide sequence of the rpoB gene of M. smegmatis 
was retrieved from NCBI and modelled in Phyre2 to reveal any α-helix and β-strands. The regions 
where the probe was designed (in rectangle shape) showed α-helix and β strand formation. 
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4.9.3 In silico analysis of candidate probes 
In silico analysis of candidate probes in terms of their potential to self and hetero-dimerize was 
determined. The thermodynamic stabilities of the probes, expressed as ∆G was computed by 
taking into consideration the probe length and concentration of Mg2+, Na+ and dNTP used in the 
PCR assay. The ∆G values for probe-target was approximately four times higher than in probe-
probe hybrid (Table 4.1), suggesting that hybrid formation between the probe and target is 
thermodynamically favourable. The specificity of the candidate probes was subjected to similarity 
check using BLAST. Probes that had similarity with any non-mycobacteria and any gut bacteria 
were rejected and considered non-specific (Appendix 3). Candidate probes with G-C content 
exceeding 70% were rejected as this will increase the annealing temperature substantially. The 
final probes for synthesis and to be used in the PCR and hybridization assays are shown in Table 
4.2 and 4.3 respectively.  
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Table 4.1 Thermodynamic stabilities (∆G) of probes as determine using the Oligo IDT 
Analyzer 
The thermodynamic stability (∆G) of the probes (anchor and detector) for each gene target 
forming self- or hetero dimers were determined using the Oligo IDT.  
Hybrid complex Duplex formation (∆G) 
kcal/mole 
Probe type 
anchor-anchor -9.75 E1 
detector-detector -9.89 E1 
anchor-detector -6.68  E1 
anchor-target -36.29   E1 
detector-target -48.17   E1 
anchor-anchor -9.75  E2 
detector-detector -4.95  E2 
anchor-detector -6.68  E2 
anchor-target -40.65  E2 
detector-target -43.17  E2 
anchor-anchor -3.61  E3 
detector-detector -4.74  E3 
anchor-detector -6.68  E3 
anchor-target -34.48  E3 
detector-target --47.58  E3 
anchor-anchor -5.02  rpoB-M. abscessus 
detector-detector -6.76  rpoB-M. abscessus 
anchor-detector -6.78  rpoB-M. abscessus 
anchor-target -36.34  rpoB-M. abscessus 
detector-target -45.23  rpoB-M. abscessus 
anchor-anchor -7.58 rpoB-M. smegmatis 
detector-detector -4.41 rpoB-M. smegmatis 
anchor-detector -7.58 rpoB-M. smegmatis 
anchor-target -32.21 rpoB-M. smegmatis 
detector-target -37.58 rpoB-M. smegmatis 
*ND = Not determined. 
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4.9.4 Probes used in the PCR and hybridization assay 
Probes targeting different conserved regions of the erm-41 gene (E1, E2 and E3), and rpoB of M. 
abscessus and M. smegmatis are presented in the Table 4.2 below. Their G-C content were also 
determined and those that exceed 70% were excluded. The anchor and detector probes were 
modified with biotin and HRP at their 5’ and 3’ ends respectively for the hybridization assay 
(Table 4.3).  
 
Table 4.2 Probes sequences synthesized for PCR assay 
Probe type Anchor probe (5’-3’) /  
G-C content (%) 
Detection probe (5’-3’) 
(Reverse complement) / G-C content 
(%) 
E1 GCCGGAATCACATTGCC 
58.8 % 
TGCGGTGGATGATGGAAAGCGC 
59.1 % 
E2 GAGCTGCATCCGGGGCG 
62.5 ºC 
AAACCGTGAACGAAGGTGTCGA 
50 % 
E3 GGTTTGCCGAGGAAGAT 
52.9 % 
GAGCAGGTCCGCTTCCGCTACC 
68.2 % 
rpoB (M. 
smegmatis) 
GTCCTAGCCTGAGTAGTTT 
47.4 % 
AACGACACAGGACCAGGTAC  
52.4 % 
rpoB (M. 
abscessus) 
CTCGGGTGGATTGCCAA 
58.8 % 
GGCTCACCCTCGATGTTCCAGC 
63.6 % 
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Table 4.3 Probes sequences synthesized for DNA hybridization studies 
Probe type Anchor probe (5’-3’) Detector probe (5’-3’) 
E1 tttttGCCGGAATCACATTGCC GCGCTTTCCATCATCCACCGCA-
HRP 
rpoB (M. 
smegmatis) 
tttttGTCCTAGCCTGAGTAGTTT AGTACCTGGTCCTGTGTCGTT-
HRP 
rpoB (M. 
smegmatis) 
GTCCTAGCCTGAGTAGTTT GTACCTGGTCCTGTGTCGTT-
HRP 
rpoB (M. 
abscessus) 
tttttCTCGGGTGGATTGCCAA GCTGGAACATCGAGGGTGAGCC-
HRP 
 
 
4.9.5 Determination of the specificity of candidate probes using PCR 
Prior to the PCR assay, the annealing temperatures for the candidate probes were determined using 
the Tm calculator algorithm (Thermos fisher Scientific), based on the primer pair sequence, primer 
concentration and DNA polymerase used in the PCR assay. The results are shown in Table 4.4. 
The specificity of the probes was tested against 7 M. abscessus isolates (as identified in Chapter 
3) and a collection of non-M. abscessus isolates (E. coli, S. aureus and M. kansasii) in a PCR 
assay. The anchor and detector probe pairs were designed to amplify a 50 bp region, hence an 
amplicon of the same size was expected. DNA amplicons estimated at 50 bp were identified for 
M. abscessus isolates 11365, 10332, 9568, 10006, 11490, 8899, 9495 (lane 1-7) and the positive 
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control isolate, ATCC19977T (lane P) (fig 4.10). A PCR master mix control (lane M) was also 
included to monitor PCR contamination. The non-M. abscessus isolates (lane 8-12) did not 
generate a 50 bp amplicon indicating that the specificity of the candidate probes except for the E2 
probe which produced DNA amplicons greater than 50 bp was non-specific (fig. 4.10B). 
 
Table 4.4 The annealing temperature of the candidate probes 
Bacterial target Probe type Annealing temperature (ºC) 
M. abscessus E 1 54.2 
M. abscessus E 2 52.4 
M. abscessus E 3 52.4 
M. abscessus rpoB 55.0 
M. smegmatis rpoB 56.0 
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Figure 4.10 Determining the specificity of the designed probe . PCR was performed using the designed probes (A) E1 (B) E2 (C) E3 
and (D) rpoB and amplified at their respective annealing temperatures (Table 3.2). The anchor and detector probes (reverse complement) were used 
as forward and reverse primer respectively against a panel of M. abscessus and non-M. abscessus DNA extracts. PCR amplicons (5 µl) was 
electrophoresed in 1% agarose gel stained with SafeviewTM in a 1X TBE electrophoresis buffer. Lane L= 50bp molecular weight marker; lane 1= 
11365, lane 2= 10332, lane 3= 9568, lane 4= 10006, lane 5= 11490, lane 6= 8899, lane 7= 9495, lane 8= 9723 (M. smegmatis), lane 9= S. aureus, 
lane 10=E. coli, lane 11=M. smegmatis, lane 12=M. kansasii, lane M= PCR master mix control and lane P= M. abscessus type strain (ATCC 19977T).
121 
 
4.9.6 Determination of probe sensitivity to M. abscessus  
Serial dilutions of M. abscessus DNA (ATCC 19977T) were performed and amplified with primers specific 
for E1, E2, E3, and rpoB. Lanes 1, 2, 3, 4, 5 and 6 represent DNA concentrations 10 ng/µL, 2 ng/µL, 0.4 
ng/µL, 80 pg/µL, 16 pg/ µL and 3.2 pg/ µL respectively. The limit of detection for primers E1 (A) and rpoB 
(D) was 80 pg/µL while that for E2 (B) and E3 (C) was 0.4 ng/µL and 2 ng/µL respectively (fig.4.11). E1 
and rpoB probes were selected as the most sensitive and specific probes for detection of M. abscessus DNA 
in the hybridization studies. 
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Figure 4.11 Determining the sensitivity of candidate probes (E1, E2, E3 and rpoB). Serially diluted M. abscessus DNA (10 ng/µL, 
2 ng/µL, 0.4 ng/µL, 80 pg/µL, 16 pg/ µL and 3.2 pg/ µL was amplified in a PCR reaction and electrophoresed in 2% agarose gel stained with 
SafeviewTM in a 1X TAE electrophoresis buffer. Gel electrogram results with the E1, E2, E3 and rpoB probes are shown in A, B, C and D respectively. 
Lane L= 50bp molecular weight marker; lane 1= 10 ng/µL, lane 2= 2 ng/µL, lane 3= 0.4 ng/µL, lane 4= 80 pg/µL, lane 5= 16 pg/ µL and lane 6= 
3.2 pg/ µL. Arrows indicate the least concentration of DNA detected with respective primers. PCR was repeated twice ensure consistency of the 
amplified region. 
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4.10 Discussion 
Conserved regions within bacterial genome are vital for the normal function of the organism and 
thus they represent useful identification targets (Luo et al. 2015). Indeed, this might be the case 
for the erm-41 gene as its maintenance is required for M. abscessus survival in presence of 
clarithromycin and other macrolide antibiotics. Also, the rpoB gene encode the β subunit of RNA 
polymerase where transcription events occur (Macheras et al. 2011). Additionally, this is a single 
copy gene (Adékambi et al. 2003), hence a highly important gene for bacterial survival and is not 
likely to undergo frequent mutation. Genomic regions conserved between related species are 
commonly detected by performing sequence alignment studies and as such represents the key first 
step in probe design (Hysom et al. 2012; Sobhy and Colson 2012; Nagar and Hahsler 2013).  
 
In this study, CLUSTAL W was employed to identify conserved regions of the erm-41 and rpoB 
genes of M. abscessus and M. smegmatis. The accuracy and speed of this tool makes it most 
preferred means of performing a MSA (Daugelaite et al. 2013). The number of sequences aligned 
was determined by their availability in the database and only complete coding sequences of each 
gene was included in the analysis. As a result, 10 separate sequences for the E1 and E2, 8 for E3, 
8 for rpoB gene of M. abscessus and 3 for rpoB gene of M. smegmatis were assessed.  
 
The presence of any secondary structures confirms that the regions are conserved and required for 
biological function. Analysis of the amino acid sequences encoded by these nucleotide regions 
indicated they were involved in the formation of α-helix and β-strands structures. These secondary 
structures are often essential to biological activity and as a consequence tend to be conserved 
(Yang et al. 2016) making the nucleotide regions good targets for detection probes. 
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The efficiency and specificity of any probe based molecular assay is strongly connected to the 
accuracy, efficiency and the physicochemical characteristics of the probes. In silico analysis of 
the candidate probes against the DNA sequences currently deposited in the NCBI database found 
not matches to any known mycobacteria or gut related bacteria, indicating that the probes may be 
well matched to their respective genes.  
 
The thermodynamics of the probe-target hybrid must be favourable for a successful hybridization 
assay. While the following thermodynamic properties; Gibbs free energy (∆G) and Enthalpy (∆H) 
can be determined the former is considered a more reliable indicator (Lomzov et al. 2015). Based 
on the algorithm of this tool, the ∆G value of a probe pair must not be more negative than -9 
kcal/mol (IDT 2011). Certainly, this was realized in the probe-probe hybrid complex, while that 
of the probe-target was approximately four times more negative. Furthermore, mycobacteria DNA 
have a high G-C content (Kumar and Kaur 2014). G-C formation in duplex oligonucleotides are 
energetically more favourable and gives maximum thermodynamic stability in DNA duplexes 
than A-T hybrids (Lomzov et al. 2015).  
 
Although published nucleotide sequences are very informative, they do not represent a holistic 
collection of diversity found in nature and thus require experimental testing to confirm the 
predicted results. Post PCR analysis of the candidate probes against the M. abscessus and non-M. 
abscessus isolates used in this study found the erm-41 (E1) and rpoB probes to be the most specific 
and sensitive for M. abscessus detection. The E2 and E3 probes generated amplification products 
in the presence of DNA from E. coli, M. smegmatis and M. kansasii indicating that they lacked 
specificity. An explanation for this lack of specificity could be due to the fact that bioinformatic 
tools such as BLAST and CLUSTAL W employ heuristic approaches which provide an estimate 
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of the actual binding and discriminatory performances of the probe (Kalendar et al. 2017). Also, 
BLAST performs local rather than a global alignment which could limit the coverage area between 
the query and subject sequences. These limitations highlight the need for experimental testing 
using target and non-target DNA (Loy et al. 2008).  
 
In conclusion, by using a bioinformatic based approach, probes which bind to the conserved 
regions of the erm-41 and rpoB genes of M. abscessus have been identified. Probes E1 and rpoB 
performed similarly in the PCR assays and were modified with biotin and HRP for use in the 
hybridization assays. These probes were designed based on the most recent nucleotides sequences 
of M. abscessus available in the database. The ability of these probes to correctly identify all 7 M. 
abscessus isolates suggest that these probes have the potential to be employed in the hybridization 
assay (discussed in chapter 6).  
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CHAPTER 5 
A study of the interaction between low power 2.45 GHz microwaves and the cell 
walls of structurally diverse microorganisms  
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5.0 Introduction 
5.1 Electromagnetic (EM) spectrum  
The electromagnetic spectrum is composed of seven waves, namely; Gamma (γ) rays, X-
rays, ultraviolet, visible light, infrared, microwaves (MW’s) and radio waves. These 
waves are defined by the wavelengths (λ), frequency (f) and photon energy (E), and are 
related by Planck’s equation as shown in Eqn. 1 below, 
 
Energy (E) = h f  = h c  ……………………. (5.1) 
                            λ 
 
where c is the speed of light in meters/second (m/s) and h is the Plank’s constant in 
electron volts (eV). In Eqn. 5.1, it can be deduced that, the energy of an EM wave is 
inversely related to the wavelength. The EM energy increases from radio waves to γ-rays 
and the wavelength increases from γ-rays to radio waves. The energy transmitted by γ-
rays are ionising while that of MW’s and radio waves are non-ionising. Ionising radiations 
have the capacity to break the chemical or molecular bond present in a molecule while 
non-ionising radiations do not have such sufficient enough energy (Beavers 2001). The 
frequencies of EM waves range from 1 Hz to 1025 Hz, with a corresponding wavelength 
from thousands of kilometres to the size of the nucleus of an atom (Fig 5.1) (Beavers 
2001).  
 
The EM field is a combination of both the electric (E) and magnetic (H) fields, and both 
are measured in volts per meter and Tesla respectively (Vorst et al. 2006). MWs are a 
component of the EM spectrum and their applications have been studied extensively and 
will be discussed in this chapter.   
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Fig 5.1 The Electromagnetic (EM) spectrum . Adapted from (Mini Physics 2018) 
 
5.2 Microwaves (MW’s) and applications 
MWs originate from two sources, namely artificially and from cosmic regions. Artificial 
MWs are generated from the electronic oscillations of humanly crafted devices whose 
frequencies ranges between 300 MHz to 300 GHz with wavelengths corresponding to 1 
m and 1 mm respectively (Banik et al. 2003; Geddes et al. 2017). Natural MWs are mainly 
those from the cosmic MW background which peaks at around 160 GHz. Other cosmic 
forms come from electronic transitions in hydrogen, the most common element in the 
universe, which emits at 1.4 GHz and correspond to a wavelength of about 21 cm (Hill et 
al. 2018). These two types of MWs differ in the sense that, natural MW’s (also non-
ionising) are not polarised and not biologically active while those generated artificially 
are polarised and have the capacity to cause biological effects (Panagopoulos et al. 2015). 
Polarisation refers to the ability of MWs to travel in a transverse manner such that the two 
main components i.e. the E and H fields are perpendicular to the direction of their travels 
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(Sun et al., 2016). The applications of polarised MW are numerous encompassing health, 
telecommunications, food industry and other industrial applications (Celandroni et al. 
2004; Shahin et al. 2013). In the food industry, MWs are employed to sterilise food items 
to prolong their storage times (Woo et al. 2000). They are also used in the medical field 
to treat various malignant diseases such as cancer in a procedure called diathermy. This 
is a surgical technique which uses high frequency EM waves to generate heat directly in 
cancer cells to induce killing, and thereby accelerate treatment (Yang and Wang 1979). 
Surgical tools are also sterilised with MWs to halt transmission of nosocomial and other 
pathogenic diseases (Celandroni et al. 2004). A growing field of MW application is the 
isolation of DNA from microbial cells for downstream application such as PCR and 
hybridisation assays (Vaid and Bishop 1998; Melendez et al. 2016). The ability of our 
prototype MW device to release nucleic acids from microbial cells is explored in this 
chapter while the subsequent detection of the liberated nucleic acids is discussed in 
chapter 6.  
 
Mobile phones, computers and several wireless devices have been built to operate at the 
MW frequency range. Other ISM frequency bands at 2.4 GHz, 5.7 GHz and 900 MHz 
also support Bluetooth applicators, RF heating and microwave heating respectively 
(Kumbhar 2017). The increase in demand for communication and wireless devices 
operating at such frequencies suggest that mankind is likely to be frequently exposed to 
MW radiations. This has been an area of concern and has obtained research attention. The 
next generation (5G) of mobile communication devices demands a high frequency to 
operate. The physiological effect of electromagnetic radiation changes with frequency and 
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as the frequency increases, the depth of penetration into biological tissues deepens. 
Biological organs such as eyes and skin could potential be at risk (Nature Research, 2019).  
 
The relationship between MW frequency and their penetration depth into materials is 
inversely correlated. MW frequency greater than 10 GHz have low penetration depth and 
only induce skin surface heating while those with frequency less than 150 MHz penetrate 
deep into the body without loss of energy (McRee 1974; Wu et al. 2015). Materials (e.g. 
biological tissues) with high moisture content efficiently absorb MWs and the effect is 
pronounced, while those materials without moisture content have diminished MW effect 
or rather require longer exposure times (Dawkins et al. 1979a). Although this is an 
increasing area of study, the exact mechanism MW action remains elusive and has been 
debated between thermal and non-thermal mechanisms. 
5.3 MW thermal and nonthermal bioeffect 
MW induced thermal effects have been widely reported and the mechanism of action is 
well explained compared to its nonthermal counterpart (Rougier et al. 2014). Heat 
generation is an inevitable process during MW excitation especially in materials with high 
moisture content and absorb MWs effectively. These water molecules interact with the 
high frequency alternating electric (E) fields, rotating at about 2.4 x 109 times per 
oscillation. The rapid motion of water molecules induces friction, leading to the loss of 
energy which is dissipated in the form of heat (Kim et al. 2014). MW heating is different 
from that of conventional heating in that, the former produces a rapid intense heating 
while the latter is  relatively slow (de la Hoz et al. 2007). 
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Nonthermal MW effect is believed to occur via direct interaction of MWs (E and or H 
field) with a biological material without the concomitant increase in temperature. Its 
existence is doubted mainly because the mechanism of action remains speculative and not 
well understood. Also, experiments reporting nonthermal effect are sometimes not 
reproducible (Pall 2013). Albeit these hindrances, several studies have reported the 
existence of nonthermal MW effect at a range of frequencies in biological membranes, 
mammalian organs (e.g. kidney, heart, brain), and their disruptive effect on purified DNA 
(Pall 2014; Nguyen et al. 2015; Pall 2015; Nguyen et al. 2016; Geddes et al. 2017).  
 
Several mechanisms have been proposed to support the nonthermal effect and these vary 
with regards to the material under study. For instance, it is believed that MWs produce 
reactive oxygen species (ROS) that are responsible for dsDNA and ssDNA breaks 
(Scholes et al. 1960; Buxton et al. 1988; von sonntag 2007), Although this has been 
reported, the mechanism for ROS production still remain elusive (Wang and Zhang, 
2017). ROS are normally generated from the mitochondria in the electron transport chain 
and damage to this cell machinery could lead to unregulated ROS production, hence it 
could be that MW induced damage to the mitochondria is responsible for the increased 
levels of ROS. Pore formation in biological membranes have also been reported in a 
phenomenon akin to electroporation (Nguyen et al. 2015). In electroporation, an external 
E field just above the membrane potential of the cell causes membrane distortion and 
induces pores within the membrane (Nguyen et al., 2016). Although such pores have been 
reported, they are yet to be visualised under any experimental setting.  
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MW parameters are key factors that determine their effect on biological cells. Also, the 
complexity/ composition of cells also impacts on their susceptibility to MWs, and both 
are discussed below specifically in their application towards biological membrane 
disruption 
 
5.4 Factors modulating membrane disruption  
Pulse MW are about twice more effective than continuous waves (CW) applied at same 
power levels (Watchtel et al., 1989). The former is believed to generate energetic 
electrons at the pulse peaks and have the capability to penetrate easily into biological cells 
than the latter. The peak power is expressed as the ratio of the average power to the duty 
cycle, hence is twice higher than CW (Ando et al. 2011). Repetitive short pulses have also 
been reported to induce stress in membranes of cells leading to membrane disruption 
(Nguyen et al. 2015). The success of electroporation/ membrane disruption can be 
modulated by the following MW E field parameters i.e. pulse amplitude, duration, 
number, shape and the repetition frequency. For instance, increasing the pulse duration 
and pulse number could result in joule heating and result in irreversible electroporation 
(Pliquett et al. 2007). Near optimal conditions favouring electroporation/ membrane 
disruption would require an increase in the amplitude, pulse number and duration (Rols 
2006). The MW parameters required for the influx of small molecules such as fluorescent 
particles (3-2000 kDa) differs from that of larger molecules such as DNA (Batista 
Napotnik and Miklavcic 2018).  
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While the influx of small particles is easy, that of DNA is challenging and requires 
specialised conditions. This is because DNA molecules are negatively charged and are 
repelled by the cumulative negative charge on the membrane surface. While the influx of 
small molecules requires pulse duration between 10 to 100 µs, the influx of larger 
molecules require longer pulse durations lasting for a few milliseconds or a high voltage 
and short length pulses (Klenchin et al. 1991; Sukharev et al. 1992; Wolf et al. 1994; 
Satkauskas et al. 2002) 
 
Cellular factors usually include the membrane composition and cell walls. Significant cell 
wall difference exists in Gram-negative, Gram-positive, Mycobacteria and yeast cells and 
these have been discussed in section 1.20 The shape of the cell also affects the success of 
electroporation/ membrane disruption (Canatella et al. 2001; Maček-Lebar and Miklavčič 
2001; Pavlin et al. 2005). Cell membranes are composed of fatty acids (FA), cholesterol 
and membrane proteins (constituting about 50% of weight in cell membrane). These 
biomolecules contain ions that contribute to the transmembrane potential across the cell. 
The presence of the transmembrane potential does influence any external electric fields 
and could pose resistance to them. This interaction has the capacity to affect membrane 
fluidity and stability (Israelachvili and Mitchell 1975; Cullis and De Kruijff 1979; Smaby 
et al. 1994; Veatch and Keller 2005). The proportion of cells in suspension are also critical 
for electroporation/ membrane disruption. Dense cell suspensions tend to electrically 
shade other cells from E field radiation, thereby reducing the amount of E field exposures 
to such cells and reduce resealing process. In a low cell densities  where single cells are 
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dominant, the fraction of cells with the membrane disrupted is significant and the 
resealing process is not hindered (Pavlin et al. 2002; Pucihar et al. 2006).   
5.5 Challenges with MWs studies 
A critical review of the literature reveals that, there is no accepted mechanism to explain 
MW mediated nonthermal effect. There is also a significant challenge in comparing data 
across studies as there are inconsistencies in the MW parameters applied. For instance, 
the magnitude of the E and H fields and the MW power varies in many published studies. 
In some studies, a conventional MW oven is used which cannot generate a constant MW 
E field energy. To effectively investigate nonthermal MW bioeffect, parameters such as 
MW power, E and H field intensities and the sample volume need to be standardised. 
 
Controlling the temperature generated during MW exposure at a level that has no lethal 
effect on cells has been the common way to determine the existence of nonthermal MW 
effect. Major studies have focussed on the effect of 2.45 GHz MWs on mammalian cells, 
tissues and organs (Geddes et al. 2017) under nonthermal conditions, while those on 
bacterial and yeast cells are scarce. The most recent study shows the ability of 2.45 GHz 
MWs to alter cell membranes of E. coli (Rougier et al., 2014) under nonthermal 
conditions. In a similar study, membrane permeability was observed in a range of 
structurally diverse microorganisms but at a much higher frequency of 18 GHz (Shamis 
et al. 2011; Nguyen et al. 2015; Nguyen et al. 2016). Thus, there is a gap in knowledge 
with regards how MWs at 2.45 GHz interact with microorganisms under nonthermal 
conditions. Considering the significant difference in membrane composition that exist 
across microorganisms belonging to different taxa, there is the likelihood that they could 
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demonstrate varying responses following MW exposure. Also, 2.45 GHz is the designated 
bandwidth for the operation of common applicators such as computers, mobile phones 
and also in industrial and medical applications. Since mankind is frequently exposed to 
these devices, their possible effect on humans is an area of concern and continuous to 
attract research interest.  
 
5.6 Aim 
In light of the paucity of knowledge and the challenges in MW studies, the aim of this 
chapter was to investigate 
1. the biological effects of 2.45 GHz MWs on biological materials using a defined 
MW applicator that allows the control of MW power and delivers pulses into a 
fixed sample volume and minimising bulk sample heating.  
2. the ability of MWs to release nucleic acids from M. smegmatis as a model for M. 
abscessus.  
5.7 Specific objectives 
The specific objectives were to; 
1. characterise the E, E+H and H field intensities within the sample tube and MW 
cavity  
2. examine the effect of individual MW components (E, H and E+H) fields on the 
viability, morphology and membrane permeability of structurally diverse 
microorganisms to fluorescent dextran particles of various sizes (3, 10 and 70 kDa) 
following exposure to MW E. H and E+H fields. 
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3. determine if present, the half-life of MW mediated membrane disruption  
4. examine the ability of MW components to induce DNA release from M. smegmatis 
and to characterise their disruptive effect on nucleic acids. 
5.8 Materials 
5.8.1 Description of MW system  
As shown in the schematic diagram in Figure 5.2, the bench-top MW application system 
used in this study consists of the following elements: a MW signal generator (TEG-4000-
1, Telemakus), a MW switch (TES-7000-50, Telemakus), 20 dB directional couplers 1 
and 2 (ZABDC20-322H-S+, Mini-Circuits), MW power amplifier (ZHL-30W-252-S+), 
MW circulator (NG-3548, Racal-MESL), MW power sensor 1 (ZRP-Z51, Rhode & 
Schwarz), and power sensors 2 and 3 (TED-8000-40, Telemakus). Synchronized signal 
generation, switching on/off, and data acquisition from three power sensors are controlled 
by LabVIEW user interface. The combination of switch, attenuator and the directional 
coupler 1 produce microwave pulse with high on/off isolation (>50 dB) without turning 
on and off the MW signal generator. This also minimizes unwanted heating at the pulse 
OFF state due to leakage power. Power sensors 2 and 3 monitor the incident and the 
reflected power, respectively. Power sensor 1 also monitors the reflected power, which is 
technically redundant but was included as a safety measure in case the low-cost power 
sensors 2 and 3 fail. A cylindrical cavity resonator designed at 2.45 GHz when empty, 
reducing to about 2.45 GHz when sample-loaded (i.e. internal radius = 46 mm, internal 
height = 40 mm) is used as a MW applicator. This was made from Aluminium metal and 
operates in the TM010 mode. The cavity was critically coupled with a loop-terminated N-
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type connector, which couples to the MW H field around the cavity’s inner circumference. 
The maximum power delivered to the cavity was limited to 12 W (41 dBm). When excited 
in its TM010 mode, the cavity produces distinct E and H fields with the maximal E field 
obtained axially while maximal H field is obtained just inside the circumference, as shown 
in Figure 5.3. Each sample was contained in a 0.2 mL mini-micro tube (Alpha 
laboratories, UK) and was inserted into the cavity, one at a time, to allow samples to be 
exposed to the E field (position A), H field (position C) and E+H fields (position B), 
respectively. 
 
 
 
 
Figure 5.2. Schematic diagram of the bench-top microwave application system . 
Reproduced and modified with permission from (Williams et al. 2016) 
 
 
 
 
Signal generator
TEG-4000-1
Telemakus
Switch
TES-7000-50
Telemakus
Directional coupler 1
ZABDC20-322H-S+
Minicircuits
Power amplifier
ZHL-30W-252-S+
Minicircuits
Circulator
NG-3548
Racal-MESL
Directional coupler 2
ZABDC20-322H-S+
Minicircuits
Power sensor 2
TED-8000-40
Telemakus
Power sensor 3
TED-8000-40
Telemakus
Power sensor 1
NRP-Z51
Rhode & Schwarz
50Ω termination
Attenuators
30 dB 16 dB 16 dB
Pout
Laptop/
LabVIEW
Control and data acquisition
24 dB
Resonant cavity
138 
 
 
 
Figure 5.3. (Left) Modelling (COMSOL) of E and H field distribution inside the 
cavity. (Right) An illustration showing all sample tube positions (A, B, and C) inside the cavity 
aligned with E field maximum (A), mixed E+H field (B), and H-field maximum (C), respectively. 
In the experiment only one tube was inserted at a time. The distances between A-B and A-C are 
27 mm and 42 mm, respectively. This cavity was designed to study the separate effect of MW E, 
H and E+H fields.  
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Figure 5.4 Modelling (COMSOL) of the E field (A) and H field (B) distribution 
at the centre of the one-hole TM010 cavity. Maximum E and H fields were obtained at 
140 kV/m (1.4 kV/cm) and 0 A/m respectively. Picture reproduced with permission from 
(Williams et al. 2016). (B) A picture of the TM010 resonant cavity indicating sample location in 
the middle. This cavity was designed to study MW E field alone.  
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5.9 Methods 
5.9.1 Culture and preparation of bacterial and yeast cells 
The following microorganisms with differences in membrane structure were used in this 
study: Escherichia coli (NCTC 1093), Staphylococcus aureus (NCTC 13373), 
Mycobacterium smegmatis (NCTC 8159) and Candida albicans (NCPF 3179). E. coli, S. 
aureus, C. albicans and M. smegmatis were cultured as described earlier (section 2.3.2). 
Bacterial suspensions were also prepared to a concentration of 1 x108 CFU/mL as 
described in section 2.3.4. 
 
5.9.2 DNA extraction 
DNA was extracted from M. abscessus (ATCC 19977T) following the method discussed 
in section 3.8.3.  
5.10 MW irradiation 
Two separate MW excitation conditions were applied. To examine pulsed MW effects of 
biological cells, a 1% duty cycle for 60 seconds was applied to cells as this reduces global 
heating in sample solution. For the speedy release of DNA from bacterial cells to support 
the development of the detection assay, a higher duty cycle was investigated. The duty 
cycle refers to the ratio of pulse duration or pulse width to the total period of the waveform 
and is expressed in ratio or as a percentage.  
5.10.1 Effects of MW radiation on M. abscessus DNA  
To investigate the effect of MWs on purified M. abscessus DNA (3.5 ng/µL) where there 
is minimal global heating, 2.45 GHz MWs were applied at 1% duty cycle for 60 seconds. 
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The pulse period and the ON time were kept constant at 1000 ms and 10 ms, respectively. 
Post microwaved DNA were quantified for dsDNA and ssDNA to determine whether 
there is any decrease in the dsDNA and ssDNA concentrations. The concentrations were 
determined using the Qubit BR assay kit and Qubit 3.0 fluorometer. Untreated DNA was 
included as a control.  
 
5.10.2 Effect of 2.45 GHz MW on the cell density of M. smegmatis 
Cells of M. abscessus (170 µL; 1 x108 CFU/mL) were treated with MW E field alone at 
1% for 60 seconds, using the same pulse parameters as above (section 5.10.1). As a 
positive control, cells were treated with 1% Triton X-100 for 60 min at 37 °C. Triton X-
100 is a chemical known to disrupt bacterial cell wall. Untreated cells were included as a 
negative control.  
 
5.10.3 Determination of cell viability in MW treated samples 
The viability of cells (S. aureus, E. coli, C. albicans and M. smegmatis) was determined 
following exposure to E, H and E+H fields. MW power was pulsed at 1% duty cycle for 
60 sec. This time frame was used to minimise global heating while exposing samples to 
MW pulses. The pulse period was the same as above (section 5.10.1). Sample excitation 
was performed at room temperature and repeated 5 more times with a 2 min interval 
between each excitation cycle. Cell viability was determined immediately after MW 
exposure using the drop count method (Miles and Misra 1938). Cells were incubated 
overnight at 37 ºC and the dilution containing countable bacterial colonies (between 30 
and 300) were used to determine viability. M. smegmatis, E. coli and S. aureus were plated 
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on LB agar and C. albicans was plated on yeast extract agar. Cells without MW treatment 
were included as negative controls. 
 
5.10.4 Quantification of dsDNA released following MW treatment 
Using similar MW exposure conditions, sample volume and concentration, 170 µL 
aliquots of test microorganism (M. smegmatis) in a 0.2 mL mini-micro tube (Alpha 
laboratories, UK) were placed in the different radial positions of the TM010 mode resonant 
cavity to determine the effect of exposure to E, H and E+H fields on DNA release. Sample 
exposure was performed for 5 times. DNA concentration of the bacterial suspension was 
determined immediately following exposure to E, H and E+H fields using the Qubit 
dsDNA BR Assay Kit (Invitrogen) and Qubit 3.0 fluorometer (Invitrogen). Suspensions 
of MW treated cells (20 µL) were mixed with 180 µL of dsDNA BR Qubit assay reagent 
and vortexed. The concentration of dsDNA was then quantified using the Qubit 3.0 
fluorometer (Invitrogen). Untreated bacterial suspension was used as a negative control.  
 
5.10.5 MW induced membrane disruption 
To determine the effect of MW (E, H and E+H) field exposure on cell wall permeability 
the entry of fluorescently labelled dextran particles into micro-organisms of structural 
diversity was examined. Suspensions of the following size particles were prepared in 
water and tested; 3 kDa (Cat. No. D3308) and 70 kDa (Cat. No. D1818) both tetramethyl 
rhodamine (TMR) and 10 kDa Alexa 488 (Cat. No. D22910), all purchased from Fisher 
Scientific, UK. Cells were treated with MW power pulsed at 1% duty cycle for 60 sec. 
Sample excitation was repeated 5 more times with a 2 min interval between each 
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irradiation cycle to minimise sample heating. MW treated samples were centrifuged at 
10000 g for 5 min, washed twice with distilled water and then resuspended in 100 µL of 
distilled water. An aliquot (10 µL) of this suspension was spotted on a microscope slide, 
mounted with glass cover slip (diameter = 0.1-0.17 mm) (Fisher Scientific, UK) and 
observed with a fluorescent microscope (Leica DM IRB, Germany) using ×63 objective 
lens under oil immersion. TMR dextran particles (3 and 70 kDa) and 10 kDa Alexa 488 
were excited using the green (530-550 nm) and blue (460-490 nm) excitation filter blocks, 
respectively. Ten images from different fields of view were captured under phase contrast 
and fluorescent views, and subsequently analysed. The percentage of fluorescent cells 
after separate exposures to E, H and E+H fields were calculated as the ratio of the total 
number of cells under phase contrast to the number of fluorescent cells. Cell suspensions 
containing fluorescent dextran particles without MW treatment was used as controls. All 
experiments were performed in triplicate and the percentage of fluorescent and non-
fluorescent cells calculated as mean ± standard deviation (SD). To determine if MW 
exposure caused permanent damage to the cell wall, permeability to 10 kDa fluorescent 
dextran particles was assessed in M. smegmatis at 5, 10, 60, 120 and 300 seconds 
following MW E field exposure.  
5.11 Theoretical and experimental calculation of bulk sample heating 
To predict the rate of bulk heat generation following MW exposure of cell suspensions 
under the conditions used in this study, we employed a formula based on the definition of 
the specific heat capacity of the cell suspension, close to that of water Cw, of approximate 
value of 4.2 J/g/K. The initial rate of temperature rise in a sample during MW exposure 
is then defined as: dT/dt = P/(mCw), where m is the mass of the sample and P is the MW 
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rms power dissipated. The total sample volume is 170 µL (i.e. a mass of approximately 
0.17 g). Since the MW cavity is critically coupled and also, since the water sample 
provides the main load, the rms MW power dissipated is approximately the rms input 
power (Pin) generated by the MW circuitry, i.e. 12 W, which is reduced to an effective 
value of 0.12 W when taking into account the standard 1 % duty cycle. This yields an 
initial heating rate of approximately 0.17 0C/s over the standard 60 s exposure time, even 
if this initial heating rate were to be maintained the maximum possible temperature rise 
would be about 10 0C; in practice, heat transfer to the surroundings will limit this 
temperature rise to only a fraction of this maximum value, so we expect a temperature 
rise of a few 0C at most. To validate this calculation, the temperature of samples during 
MW excitation was measured using a Luxtron fibre optic temperature sensor (LumaSense 
Technologies, Santa Clara, CA, USA). Using this temperature sensor probe, the bulk 
temperature increases of the cell suspension placed at the E field position was measured 
to be 2.6 ± 0.4 ºC over 60 seconds exposure time at 1 % duty cycle with 12 W rms power 
input and this is entirely consistent with the calculation above.  
 
 
5.12 Theoretical calculation of MW power generated in one-hole and three-hole 
MW cavities  
The total power generated within the MW cavity was calculated using the formula 
below 
Pdiss = πε0ε2 f E12 V ……………. Eqn. 5.2 
where: 
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Pdiss = rms MW power dissipated into the cavity (around 12 W) 
𝜀0 = permittivity in vacuum, 8.85  10-12 F/m 
𝜀2 = dielectric loss factor of water, approximately 9.2 at 2.45 GHz 
f = microwave frequency, 2.45 GHz 
E1 = the spatially averaged electric field amplitude generated within the sample 
V = the sample volume placed in the MW cavity, 170 µL  
 
To determine the E field value, Eqn. 5.2 can be rearranged as; 
 
diss
1
2 0
P
E
f V

 
……  Eqn. 5.3 
 
Thus, the calculated E field value is estimated at 10.2 kV/m for the one-hole TM010 mode 
cavity. Using the 3-hole cavity designed for combined E, H and E+H fields excitation, the 
power dissipated in the cavity is readjusted to accommodate the two additional holes that 
have been created. The total power dissipated in the 3-hole cavity (fig 5.3, right) becomes;  
Pdiss = PA + PB + PC ……………. Eqn. 5.4 
where: 
PA = power dissipated at port A 
PB = power dissipated at port B, which is approximately half of that in PA (i.e. PB = ½ 
PA) 
PC = power dissipated in port C, which is approximately zero since there is almost zero 
E field at this position (rather, a maximum H field). 
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Thus, for the cavity displayed in Fig 5.3, with three samples at each of the ports A, B 
and C, Eqn. 5.3 now becomes  
 
diss
1
2 0
4
5
P
E
f V

 
 ……………. Eqn. 5.5 
Thus, the calculated E field amplitudes within the samples at for ports A, B and C is 9.2 
kV/m, 4.6 kV/m and 0 kV/m, respectively. To determine the magnitude of the H field at 
the perimeter of the cavity, the formula (below) was applied. 
 
 
H1 = E1  J1 (2.405)/𝜂0…………... Eqn. 5.6 
                                                    377 
 
where: 
J1(x) is a first order Bessel function of the first kind 
𝜂0 is the free space wave impedance, approximately 377 𝜂.  
Since J1 (2.405) = 0.519, the amplitude of the azimuthal magnetic field at port C is 
determined to be 12.6 A/m. 
 
5.13 Data Analysis 
Results were analysed with SPSS (v.23). Significant differences within groups were 
determined using one-way analysis of variance (ANOVA) followed by a multiple 
comparison analysis using Tukey and Bonferroni tests. Graphs were plotted in Microsoft 
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excel 2016. All simulations were performed using COMSOL Multiphysics software 
(version 5.3a). Schematic drawing of the bench-top microwave was performed using 3D 
SolidWorks.  
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5.14 Results 
5.14.1 Estimating the global heat generated in a microwaved sample using 
COMSOL  
The maximum E field and H field intensity at the central position of the one-hole TM010 
mode cavity (Fig 5.4) was calculated at 10.24 kV/m and 0 A/m respectively. Similarly, E 
and H field intensity at the central and circumferential sample positions within the three-
hole TM010 mode cavity (Fig. 5.3) were calculated to be approximately 9.16 kV/m and 
12.6 A/m (corresponding to a magnetic flux density of 15.80 µT), respectively. Based on 
the design of the cavity, the E field is halved at port B of the three-hole cavity and this 
was calculated to be 4.58 kV/m.  
 
By placing the sample tube into the three-hole TM010 mode cavity, the field intensity is 
perturbed. For this reason, the Q value (representing the amount power dissipated into the 
sample) at the three sample positions were measured by determining the Q value (power 
dissipated into sample) in each sample tube containing similar sample volumes of 170 µL. 
The Q values when cavity is loaded with sample and without sample at the E, E+H and H 
positions are presented in Table 5.1 below. 
Table 5.1 Mean Fₒ, Q and loss (dB) measured at E, E+H and H field positions with loaded 
sample (water)  
 E field E+H field H field 
Mean Fₒ (MHz) 2353.32 ± 2.92 
 
2392.3 ± 1.23 
 
2406.28 ± 0.05 
 
Mean QL 644 ± 10.98 1798.725 ± 143.20 
 
7459.05 ± 458.52 
 
Mean Loss (dB) -43.595 ± 0.13 
 
-34.4425 ± 0.63 
 
-23.1275 ± 0.38 
 
 
The Q value for the empty tube (QE) was measured at 7429 
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With the measured Q values, the power dissipated (Pdiss) and mean E field in the sample 
tube can be related by the formulae below; 
                                              Pdiss ∝ 𝛥 (
1
𝑄
)………………………. Eqn. 5.7 
          Pdiss  ∝ Ein 2  
Therefore;             Ein ∝ √𝛥 (
1
𝑄
) ……………………… Eqn. 5.8 
The inverse of the change in Q (∆Q) is determined using the formulae below; 
𝛥 (
1
𝑄
) =
1
𝑄𝐿
−
1
𝑄𝐸
 
Where QL represent the Q value when the cavity is loaded with water at E field position 
and QE is when the cavity is empty. Therefore,  
𝛥 (
1
𝑄
) =
1
644
−
1
7429
 
      = 0.001418 
Based on Eqn 5.8, mean E field at E field position is 0.03765 V/m. Similarly, inverse of 
∆Q and mean E field dissipated at position E+H are determined below; 
      
𝛥 (
1
𝑄
) =
1
𝑄𝐿
−
1
𝑄𝐸
 
Where QL represent the Q value when the cavity is loaded with water at E+H field 
position and QE is when the cavity is empty. 
     𝛥 (
1
𝑄
) =
1
1799
−
1
7429
 
       𝛥 (
1
𝑄
)  = 0.000421 
          Ein = 0. 02051 V/m 
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Finally, inverse of ∆Q and mean E field dissipated at the H field position is also 
determined below 
𝛥 (
1
𝑄
) =
1
𝑄𝐿
−
1
𝑄𝐸
 
Where QL represent the Q value when the cavity is loaded with water at H field position 
and QE is when the cavity is empty. 
𝛥 (
1
𝑄
) =
1
7459
−
1
7429
 
       𝛥 (
1
𝑄
)  ∝ 0 
              Therefore, Ein ∝ 0 V/m 
 
Based on the above formula, the fractional E field dissipated into the sample at the E, E+H 
and H field positions are 1, 0.544 and zero respectively. This further explains that there is 
E field reduction in the E+H positions. 
 
5.14.2 Effect of MW E field exposure on the cell morphology and viability of M. 
smegmatis 
The effect of MW energy (1% duty cycle for 60 seconds) on cellular morphology and cell 
viability of M. smegmatis was determined. Gross cellular morphology was not affected 
following MW treatment, as no significant difference in optical density was observed (p 
> 0.05). However, there was a significant decrease in cell density following chemical 
treatment (p < 0.001) (Fig 5.5).  
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Figure 5.5 Effect of MWs on the cell morphology of M. smegmatis . The optical 
density of cells of M. smegmatis were measured following MW treatment (1% duty cycle for 60 
seconds). Untreated and chemical (1% Triton X-100) treated cells were included as negative and 
positive controls respectively. M. smegmatis cells density were not affected following MW 
treatment (p > 0.05). Cells density was significantly reduced following chemical treatment (p < 
0.001). Data represent mean of triplicate experiment ± standard deviation.  
 
 
Cell membranes of microorganism act as a permeability barrier, protecting cells from the 
hostile environment and sustain viability. Any breach in membrane permeability will 
increase the influx and efflux of chemicals and may adversely affect viability. To 
determine the effect of MW exposure on the viability of M. smegmatis we counted the 
number of viable cells (CFU/mL) immediately following exposure to the E, H, and E+H 
fields. The effects of exposure to E field radiation can be seen in figure 5.6. At 1% MW 
pulsing, there was no significant loss (p > 0.05) of viability after 60 seconds. A higher 
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MW duty cycle (30%) was also tested to determine cells viability and when this was 
investigated, there was a significant loss of cells viability (p < 0.001) after 30 seconds. At 
this duty cycle, the temperature of cells suspension reached approximately 79°C. Thus, it 
possible that extreme heating could have resulted in the loss of cells viability (Fig 5.6).  
 
 
Figure 5.6 Effect of MW E field on M. smegmatis  viability. Suspension of M. 
smegmatis were treated with pulse MWs at 1% duty cycle for 60 secs and 30% duty cycles for 30 
seconds. Cells viability (expressed as percentage) was determined using the drop count method. 
Pulse MW treatment of cells at 30% duty cycle reduced the viability significantly (p < 0001). Data 
represent mean of 3 independent experiment ± standard deviation.  
 
 
The effect of the H field and the E+H fields combined at the same 1% duty cycle on the 
viability of M. smegmatis was investigated. As can be seen from fig 5.7, exposure had no 
significant effect (p>0.05) on viability.  
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Figure 5.7 The effect of E and E+H MW fields on the viability of M. smegmatis . 
Suspension of M. smegmatis were treated with E and E+H fields at 1% duty cycle for 1 min. MW 
treatment were repeated for 5 times. Cells viability was determined and expressed as a percentage. 
The E and E+H fields did not significantly affect cells viability (p > 0.05). Data represent mean 
of 3 independent experiment ± standard deviation.  
 
 
 
Since cells belonging to different taxa have different membrane compositions and cell 
wall structures, the effect of exposure of these cell types to the various MW fields were 
determined. The viability of E. coli, S. aureus and C. albicans under the same test 
condition (1% duty cycle for 60 seconds) and to eliminate global heating was investigated. 
Exposure to E, H and E+H fields at a 1% duty cycle for 60 seconds had no significant 
effect (p>0.05) on the viability of any of the test microorganisms (fig. 5.8).  
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Figure 5.8 The effects of E, H and E+H fields on cell viability . MW power was 
pulsed at 1% duty cycle for 60 seconds. Sample excitation was repeated 5 more times with a 2 
min interval between each excitation cycle. Cell viability after exposure to E, H and E+H fields 
was determined and expressed as percentage. Viability reduced (but not significantly) in cells 
treated with E fields alone (p>0.05), while cells treated with H and E+H fields remained 
unaffected as untreated. Data are mean ± SD of three independent experiments. 
 
 
 
 
5.14.3 Effect of MW E, H and E+H fields on membrane permeability 
Fluorescent dextran particles have been used to determine membrane integrity (Shamis et 
al. 2011). Infiltration of dextran particles into MW exposed cells would suggest some 
form of cell wall disruption. To determine if this was the case, cells E. coli, M. smegmatis, 
0
20
40
60
80
100
C. albicans (NCPF 3179) S. aureus (NCTC 13373) E. coli (NCTC 1093)
C
el
l v
ia
b
ili
ty
 (
%
)
Untreated E E+H H
155 
 
S. aureus and C. albicans were exposed to MW E, H and E+H fields at 1% duty cycle for 
60 seconds in the presence of 3 kDa fluorescent dextran particles. While exposure to the 
H field and a combination of E+H fields did not result in the internalisation of 3 kDa 
dextran particles (fig. 5.9), all microorganisms exposed to the E field alone exhibited a 
significant uptake of 3 kDa fluorescent dextran particles (p<0.05) (fig. 5.9 - 5.11).  
 
To determine if cell wall composition of a microorganism affected its ability to internalise 
dextran particles following exposure to E field radiation, the relative ability of the cells to 
internalise 3kDa dextran particles was compared (Fig 5.11). Cells of M. smegmatis (50.4 
± 2.5%) demonstrated a significantly higher (p < 0.05) level of particle uptake compared 
to the other isolates. The fluorescence of C. albicans (30.5 ± 2.1%) was significantly 
higher than those of E. coli (17.5 ± 1.9%) (p=0.01) but not in S. aureus (23.6 ± 4.6%) (p 
= 0.096).  
 
Variation in the degree of MW-mediated disruption in the test organisms was further 
assessed by comparing their ability to internalise 10 and 70 kDa fluorescent dextran 
particles. All micro-organisms except for S. aureus internalised 10 kDa dextran particles 
while none of the organisms appeared to internalise 70 kDa dextran particles (Fig 5.11). 
The low proportion of untreated fluorescent cells in each population are likely to represent 
dead or damaged cells which have non-specifically bound the fluorescent dextran particles 
(Shi et al. 2007; Peterson et al. 2012).  
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Figure 5.9 Quantification of fluorescent cells after separate exposure to MW E, H and E+H fields at 1% duty 
cycle for 60 seconds. Sample excitation was repeated 5 more times with a 2 min interval between each excitation cycle. Cells exposed 
to E+H-field (grey bars) and H-field (white bars) did not result in significant uptake of 3 kDa dextran particle in all cells tested as compared 
to the control group (orange bar) (p>0.05). Cells exposed to E field alone (dark bars) resulted in a significant uptake of 3 kDa fluorescent 
dextran particle (p<0.05). Values represent mean ± SD of three independent experiments.
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Figure 5.10 Uptake of varying sizes of fluorescent dextran particles into cells after MW E -field exposure at 1% 
duty cycle for 60 seconds. Sample excitation was repeated 5 more times with a 2 min interval between each excitation cycle. Images 
captured under phase contrast and fluorescent fields following 3 kDa, 10 kDa and 70 kDa dextran application to MW treated cell 
suspensions of M. smegmatis (NCTC 8159), E. coli (NCTC 1093), C. albicans (NCPF 3179) and S. aureus (NCTC 13373) with 
corresponding controls (MW untreated). Images in phase contrast are of the same field as fluorescent view. Mostly 3 kDa and 10 kDa 
dextran were internalised in M. smegmatis, E. coli, C. albicans but not 70 kDa. Only 3 kDa was internalised in S. aureus. Scale bars 
correspond to 20µm.  
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Figure 5.11 Quantification of fluorescent cells after MW E-field exposure at 1% duty cycle for 60 seconds . Sample 
excitation was repeated 5 more times with a 2 min interval between each excitation cycle. The percentage of fluorescent cells after MW 
treatment (grey bars) and the corresponding untreated cells (white bars) was determined for each dextran particle size. Percentage of 
fluorescent cells was calculated as a ratio of the number of cells in fluorescent view to the total number counted under phase contrast. The 
percentage of fluorescent cells with 3 kDa dextran uptake was significantly high in M. smegmatis than in all cells (p<0.05) and in C. 
albicans in comparison to E. coli (p=0.01). Fluorescent cells of M. smegmatis and S. aureus decreased significantly when dextran size was 
increased to 10 kDa (p<0.05). None of the cells internalised the 70 kDa dextran particle. The label (*) and (***) represents (p<0.05) and 
(p<0.0001) respectively between groups compared and are statistically significant. Values represent mean ± SD of three independent 
experiments. 
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Studies suggest that, different types of phospholipids and fatty acids interact differently 
with MWs and hence could contribute to their varying level of sensitivity to MWs 
(Nguyen et al., 2016). Owing to the observed difference in the uptake of dextran particles 
across the different types of microorganisms, we sought to determine whether differences 
in fatty acid and phospholipids did contribute to this. The percentage of fatty acids 
(saturated and unsaturated) and phospholipids present in all cells reported in previous 
studies were analysed and are presented in Table 5.2. Comparing Table 5.2 and Figure 
5.11, differences in fatty acids composition (saturated and unsaturated) does not explain 
why uptake of dextran particles across microorganisms differ, and thus other factors could 
be responsible.  
 
Table 5.2. Compositions of fatty acids (saturated and unsaturated) and phospholipids in cell 
membranes of S. aureus, E. coli, C. albicans and M. smegmatis.  
 
PG = Phosphatidyl glycerol 
LPG = Lysyl phosphatidyl glycerol 
PE = Phosphatidyl ethanolamine 
PC = Phosphatidyl choline 
PI = Phosphatidyl inositol 
CL = Cardiolipin 
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5.14.4 Duration of cell wall disruption  
To determine the time frame of cell wall disruption M. smegmatis cells were exposed to 
MW E fields 1% duty cycle for 60s and 10 kDa dextran particles were added at different 
time periods post exposure after which intracellular fluorescent was determined. The 
shortest time to be investigated was 5 seconds post exposure which resulted in a 75.6% 
reduction (p<0.05) compared to when cells are microwaved in the presence of dextran 
particles (positive control). There was no significant difference in dextran particle uptake 
at periods longer than 5 seconds suggesting that disruption is transient (Fig 5.12).  
 
 
 
Figure 5.12 Time taken to regain structural integrity following MW exposure 
at 1% duty cycle. Addition of dextran particle (10 kDa) to MW E field treated bacterial 
suspension was delayed for 5s, 10s, 60 and 300 seconds. The percentage of fluorescent bacteria 
was significantly high (p<0.05) in MW treated suspension containing dextran particle (positive 
control) than when the addition of dextran particle was delayed (5, 10, 60 and 300 seconds) and 
in untreated. Values represent mean ± SD of two independent experiments.  
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5.14.5 Effect of MW E field exposure on the release of DNA from M. smegmatis 
To determine if exposure to the level of MW radiation which disrupted membrane 
permeability did result in the release of intracellular material, the concentration of dsDNA 
in cultures of M. smegmatis before and after exposures to 1% pulse of E, H and E+H MW 
fields was determined. While there was no significant increase in the concentration of 
dsDNA following five sequential exposures to E+H and H field radiation, there was a 
significant increase (p<0.05) in dsDNA concentration following five E field exposures 
(fig. 5.13). A release of nucleic acids from the cells without significant loss of viability 
(Fig 5.8) was observed. This could be attributed to a myriad of factors. For instance, 
increased cells population could reduce the local E field distribution in sample suspension 
in comparison to low cell suspensions and subsequently decrease the transmembrane 
voltage on the cell membrane (Pucihar et al., 2007). In a high cell population other cells 
could be shielded from MW interaction. Thus, the amount of dsDNA released could not 
be released from the entire cell population. The orientation of cells in the suspension could 
also affect transmembrane potential as cells at the poles have maximal transmembrane 
potential than and are easily electroporated (Kanduser and Miklavcic, 2008).  
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Figure 5.13 Release of double stranded DNA (dsDNA) following MW exposure . 
A suspension of M. smegmatis was treated (5 times) with MW E, H and E+H fields. MW pulsing 
was kept at 1% duty cycle for 60 seconds. A 2 min interval was allowed between exposures to 
avoid sample heating. The concentration of dsDNA release was significantly higher (p<0.05) in 
suspensions treated with MW E field alone. Data are mean ± SD of three independent experiments.  
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5.14.6 Effect of MW E field exposure on purified DNA 
The effect of MW exposure on the structural integrity of genomic DNA isolated from M. 
smegmatis was determined to assess if the energy levels employed had a detrimental effect 
on DNA recovery. Nucleic acid concentration was measured immediately following MW 
exposure. The concentration of ssDNA and dsDNA following MW treatment at a 1% duty 
cycle for 60 seconds was significantly reduced (p < 0.001) (Fig 5.14). 30% duty cycle was 
applied to test its effect on DNA integrity as significant heating (79°C) is produced with 
higher MW pulses.   
 
 
Figure 5.14 Effect of MW exposure on the structural integrity of M. smegmatis 
genomic DNA. The concentration of dsDNA (blue bar) and ssDNA (red bar) were quantified 
using the Qubit assay reagent following MW treatment at 1% duty cycle for 60 seconds and 10 
minutes and at 30% duty cycle for 30 seconds. Untreated DNA was used as a control and the 
concentration of dsDNA and ssDNA were also quantified. MWs significantly reduced (p < 0.001) 
the concentration of dsDNA and ssDNA following MW treatment at 1% and 30% duty cycle for 
60 seconds and 30 seconds respectively. The concentration in nucleic acid concentration was not 
significant (ns) after multiple exposures (10 times) at 1% duty cycle for 60 seconds. Data represent 
mean of triplicate experiment ± standard deviation.  
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5.15 Discussion 
The biological effects of MWs are associated with thermal and non-thermal mechanisms. 
The former is attributed to temperature change while the latter is temperature independent 
and is thought to be due to the action of E and/ or H field effects (Challis 2005). The 
present study focused on characterising the effect of nonthermal MWs (E, H and E+H) on 
cell morphology, viability and the cell wall permeability of a range of structurally diverse 
microorganisms.  
 
To examine the existence of nonthermal MW effects, maintaining the temperature change 
at a level that is not detrimental to the cell is vital. To minimise the bulk temperature 
change during exposure to 1% duty cycle of MW energy was maintained at approximately 
2.6 °C. Under these conditions, exposure to E, H and E+H fields did not result in a 
significant change in cell morphology or in cell viability, however, when a higher duty 
cycle (30%) was applied to the cells the viability of the cells decreased significantly and 
this could be attributed to the heat generated by MWs. M. smegmatis was the most 
sensitive microorganism while S. aureus was the least. These results are likely to reflect 
differences in cell wall, polarity and membrane composition of lipids, fatty acids, 
cholesterol and phospholipids (Nguyen et al. 2015; Nguyen et al. 2016).  
 
The degree of MW induced cell wall disruption varied with the type and proportion of 
membrane phospholipids (Leontiadou et al. 2004 ; van Uitert et al. 2010a; Piggot et al. 
2011). Based on the percentages of phospholipids and fatty acids present in the cells 
studied, S. aureus membranes contain a significant proportion of unusual lipids 
(phosphatidyl glycerol (PG) and lysyl phosphatidyl glycerol (LPG)) which have been 
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predicted to enhance membrane disruption (Haest et al. 1972; Piggot et al. 2011). 
Experimentally, this was not the case in this study as there was lower dextran infiltration 
into S. aureus compared to the other microorganisms. A similar experimental observation 
has been reported by Nguyen and colleagues (Nguyen et al. 2015; Nguyen et al. 2016).  
 
Saturated fatty acids are known to reduce membrane fluidity and increase stability and as 
a consequence may increase resistance to an externally applied E field (Israelachvili and 
Mitchell 1975; Cullis and De Kruijff 1979; Smaby et al. 1994; Veatch and Keller 2005; 
van Uitert et al. 2010a; van Uitert et al. 2010b). The predominant fatty acids present in S. 
aureus are saturated, estimated to be more than 90% (Atilano et al. 2011; Brown et al. 
2013), hence they could have contributed to a reduction of infiltration by 10 kDa dextran.   
 
Phosphatidyl choline, phosphatidyl inositol and phosphatidyl ethanolamine are the major 
phospholipids in E. coli and C. albicans (Haest et al. 1969; Georgopapadakou et al. 1987), 
in addition to cardiolipin which is present in M. smegmatis (Crellin et al. 2013). 
Cardiolipin increases membrane fluidity and reduces mechanical stability (Unsay et al. 
2013b). The composition of saturated fatty acids in E. coli and C. albicans were below 
50% (Haest et al. 1969; Georgopapadakou et al. 1987) suggesting a less compact 
membrane. It is likely that the presence of these lipids and the high proportions of 
unsaturated fatty acids could have influenced infiltration of 3 and 10 kDa dextran 
particles. In the case of M. smegmatis, mycolic acid is the major fatty acids constituting 
about 30-60% and these are predominantly saturated (89%) (Taneja et al. 1979). The 
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expectation therefore is that, cell membranes in M. smegmatis will be compact and less 
permeable, but this was the most sensitive to MW and dextran infiltration.  
 
These results suggest that differences in fatty acids and phospholipids content cannot not 
provide a satisfactory explanation for the varying uptake of dextran particles and thus 
other membrane factors e.g. proteins, cytoskeleton and inherent physical factors (e.g. 
dielectric properties, microthermal heating) could be contributing factors.  
 
Cells in suspension are surrounded by water molecules normally referred to as bulk or 
free water. Water molecules can also be tightly coupled to cell membranes (i.e. bound 
water) and have different dielectric properties compared to bulk water (Robinson 1931). 
Electrical conductivity is higher in bound water than in bulk water (Robinson 1931; 
Kaatze 1990). Secondly, the intermolecular interaction between bound water and cell 
membrane surface is stronger than between bulk water molecules. Due to the strong 
molecular bonding, bound water molecules will have to surpass a higher potential barrier 
in order to align to an applied E field (Dawkins et al. 1979b), suggesting a higher MW 
absorption resulting in localised/microthermal heating effects. Measuring localised 
heating can be experimentally challenging if not impossible (Rougier et al. 2014). Thus, 
the effects observed may still reflect a combination of thermal and non-thermal effects as 
the bulk temperature measured (2.6°C) is unlikely to be a true reflection of the temperature 
at the cell membrane surface.  
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While no significant effect on cell viability and morphology was observed, there was a 
significant release of dsDNA from cells and the results suggest that once released this 
DNA may be subject to degradation but only following E field exposure. E field exposure 
realised a significant reduction in the concentration of ssDNA and dsDNA. This could 
possibly have occurred via DNA fragmentation and according to MW theory could not 
have been achieved via covalent bond disruption as MW energy are non-ionising and are 
not able to generate the required threshold energy (1 eV) to induce such bond disruption 
(Beavers 2001; Geddes et al. 2017). Reactive oxygen species (ROS) are generated in 
samples following MW treatment (Geddes et al. 2017). ROS generated are believed to 
launch a nucleophilic attack on phosphodiester bonds and this could have led to DNA 
fragmentation (Scholes et al. 1960; von sonntag 2007).  
 
The mechanism by which the E field interacts with biological cells remains unclear. High 
frequency vibration of cell membranes (mechanical cell stimulation), enhanced diffusion 
across membranes, abnormal gating of voltage channels, increased membrane 
conductance and pore formation have all been cited as possible mechanisms (Benz and 
Zimmermann 1980; Chernomordik et al. 1987; Dower et al. 1988; Hibino et al. 1993; 
Krassowska and Filev 2007; Bockmann et al. 2008; Marrink et al. 2009; Pall 2013, 2014, 
2015). Pore formation has been likened to the process of electroporation (Kinosita and 
Tsong 1977; Teissie and Tsong 1981; Tieleman 2004; van Uitert et al. 2010a; Shamis et 
al. 2011).  
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The result of this study confirmed the findings of Shamis and colleagues which reported 
that the observed biological effects are due to the  E field  (Shamis et al. 2011). Biological 
membranes act as electrical insulators. For influx/efflux mechanism to occur, their 
membrane must be destabilised, and this can be achieved via the application of an external 
E field higher than the membrane potential. The field causes membrane instability, 
transforming if from its stable impermeable state to one in which it is more permeable 
facilitating the efflux and influx of molecules.  
 
The effects of H and E+H fields on cell membranes at the power levels used in this study 
were non-existent. The reason being that, the port of the TM010 mode cavity for combined 
E and H field exposure has the E field intensity halved.  Since the observed effects are E 
field dependent, halving the magnitude is likely to diminish any biological effect as a 
critical E field value is usually required to induce electroporation.   
 
In a study by Kardos and colleagues, the application of static H fields at field strength of 
4 Tesla did cause pore formation in the skin of guinea pig (Kardos and Rabussay 2012). 
Also, the combined effect of E+H fields on yeast cells has been reported by Novickij and 
colleagues which  saw the permeabilization of yeast cells to exogenous particles (Novickij 
et al. 2016). Certainly, these results cannot be compared to the present study as the 
experimental design and the MW parameters are not the same. Static H field was used 
which is different from MW H field levels. Based on the result obtained, a critical H field 
value higher than what is reported in this study (H = 15.80 µ Tesla) if applied to cells 
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would have induced membrane disruption and enhanced permeabilization to dextran 
particles.  
 
In conclusion, this study has shown that MW generated E fields can temporarily disrupt 
cell wall permeability resulting in the uptake of dextran particles and the release of DNA. 
The study does not completely rule out thermal effects as the temperature measured is 
global and does not reflect localised heating. Further work is required to distinguish the 
contribution of these two forms of energy (i.e. thermal and electric). By optimising this 
approach, it may be possible to enhance the efficiency of influx and minimizing the 
detrimental target cell damage as mostly encountered in electroporation. Further studies 
are required to determine if this is indeed the case. The rapid release of DNA from cells 
following MW treatment is also an improvement on the current DNA extraction 
methodologies. The released DNA may be employed for downstream applications (e.g. 
PCR, DNA hybridisation) and to support the development of point-of-care applicators. 
The applicability of this is discussed in the next chapter.   
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Chapter 6 
Rapid method of detecting Mycobacterium abscessus and Mycobacterium smegmatis 
using microwave assisted Enzyme Linked oligonucleotide sandwiched 
hybridization assay (ELOSHA)  
 
 
 
 
 
 
 
 
 
171 
 
6.0 Introduction 
6.1 Technologies for diagnostics 
The increasing demand for technologies capable of rapidly detecting the presence of substances 
has received much attention in areas of clinical diagnosis, agriculture, defence and security and 
environmental monitoring (Luka et al. 2015; Vigneshvar et al. 2016). Examples of these 
technologies include; Gas chromatography - mass spectrometry (GC-MS), high pressure liquid 
chromatography (HPLC) and biosensors (Wang and Kricka 2018). The ability  of these tools to 
detect proteins, metabolites, whole cell bacteria and DNA has been demonstrated across numerous 
studies (Shi et al. 2007). DNA based diagnostic tools are the most specific in clinical (Choe et al. 
2015). Although they have proven to be sensitive and specific, current approaches  are time 
consuming due to the requirement for sample processing  i.e. DNA extraction and amplification 
step  making them unsuitable for near patients’ bedside use (Ng et al. 2015; Sajid et al. 2015). 
These limitations have driven the development of alternate detection technologies.  
 
Lateral flow assays (LFA) are a promising technology for the development of low-cost, rapid, 
easy to use diagnostic assays. They require minimal labour, generate results rapidly and can be 
read visually (Sajid et al. 2015). LFA are mostly built on the principle of ELISAs to detect proteins 
and DNA from clinical samples, the former being the most commonly detected (Hsieh et al. 2017). 
Detecting the latter is very sensitive and informative in disease diagnosis, as DNA is 
biochemically more stable than RNA, proteins and cells (Yang et al. 2017). Although LFA are 
promising, their sensitivity and signal intensity are affected by the concentration of DNA in the 
sample, especially when the test procedure does not include a DNA amplification step. To 
overcome this limitation, magnetic particles (MP’s) have been frequently used to enrich the 
recovery of target DNA from samples (Pankhurst et al. 2003; Chen et al. 2017b; Modh et al. 
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2018). The characteristic properties of MPs and their applications in diagnostic assays are 
discussed below.  
 
6.2 Magnetic particles (MPs) and applications in biosensing 
MPs (as shown in figure 6.1) are usually of the nano- and micrometre sizes, consisting of iron 
oxide (Fe2O3) embedded inside a non-magnetic matrix (Thielbeer et al. 2011; Giouroudi and 
Keplinger 2013).  MPs are usually smaller than the biological molecules the seek to detect  e.g. 
viruses (20-450 nm), proteins (5-50 nm), genes  (2 nm wide and 10-100 nm long),  (Giouroudi 
and Keplinger 2013). The applicability of MPs in biosensing is enhanced by their high density, 
hydrophilicity, uniform dispersion in suspension, colloidal stability and super-paramagnetism 
(Pankhurst et al. 2003). Super-paramagnetism is the property of magnetic materials which 
provides a super-fast response to an external magnetic field (Annink and Gill 2014). 
 
 
Fig 6.1. Photograph of streptavidin coated magnetite particle (MPs) . The particle 
presented are of 1 µm size (Adapted from: https://www.fishersci.ie/shop/products/sera-mag-
speedbeads-streptavidin-magnetic-beads-2/11869912) [Date accessed: 08.03.2018].  
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For MPs to interact with biological markers, their surfaces have to be modified with functional 
groups e.g. carboxylate (-COOH), amine (-NH2) or proteins e.g. streptavidin or neutravidin (Salata 
2004). In this study, streptavidin coated magnetic microparticles of commercial origin and with a 
size of about 1 µm were used to develop a hybridization assay for the detection of M. abscessus 
and M. smegmatis. Streptavidin MPs were opted to enable binding with the biotin functionalized 
probes designed in section 3.2. Biotin-streptavidin interaction is one of the strongest non-covalent 
interaction and demonstrates resistance to heat and extreme pH conditions (Chung et al. 2013; 
Annink and Gill 2014). Using this approach, DNA targets can be concentrated from diverse 
samples and hybridized to their complementary probes (Edelstein et al. 2000). The principle of 
the detection assay is discussed in the next section.  
 
6.3 Principle of Enzyme linked oligonucleotide sandwich hybridization assay  
Enzyme linked oligonucleotide sandwich hybridization assay (ELOSHA) is simple to perform 
and provides the best sensitivity compared to other DNA based methods (Bahadır and Sezgintürk 
2016; Mak et al. 2016). In principle, this assay involves the capture of a target gene, herein 
ssDNA, between two complementary probes (capture and detector) to form a 3-strand DNA 
complex. The capture probe has biotin attached at the 5’ end which anchors the ssDNA and the 
reporter probe to the surface of MP (fig 6.2). Preceding the anchor probe at the 5’ end is a sequence 
of five thymidine residues to allow probe flexibility when bound to the MP via biotin-streptavidin 
interaction. The robustness and reproducibility of ELOSHA assays depends on several factors 
such as the flexibility and length of the capture probe (Parham et al. 2007; Patel et al. 2011). Probe 
sequences greater than 20 base pairs provide stability for target-probe binding (Wang 2011). The 
presence of the target gene is determined indirectly via a signal generated from the detector probe 
upon reaction with substrates such as 3,3,5,5-tetramethylbenzidine (TMB) or alkaline phosphatase 
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(AP) (fig. 6.3) (Thieme et al. 2008). TMB reacts with horse radish peroxidase (HRP) to form a 
blue color with maximum absorbance at 370 and 652 nm. This enzyme substrate reaction is 
terminated by the addition of 0.1 M hydrochloric acid which gives a yellow color with absorption 
maxima at 450 nm (Eickhoff and Malik 2013).  
 
 
Figure 6.2 Principle of sandwich hybridization assay . The three-strand hybrid 
complex (anchor probe-target ssDNA-detector probe) are immobilized unto MPs. The three-
strand hybrid complex can be separated by the application of a magnetic field and the target gene 
is indirectly detected by the signal intensity generated by the detector (HRP) probe. The enzyme 
substrate reaction is then terminated by the addition of HCl (stopping solution).  
 
 
Any DNA based test capable of delivering speedy results will depend on the sample preparatory 
step i.e. DNA extraction. The current methods of DNA extraction, as discussed in section 1.20, 
are expensive and time consuming. The next section discusses the applications of MW technology 
to rapidly release nucleic acids to support the hybridization assay. 
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6.4 Microwave (MW) induced DNA release  
The applications of MWs in releasing nucleic acids from bacterial cells have been studied 
extensively. Joshi and colleagues have demonstrated the use of MW energy in disrupting 
vegetative and sporulating C. difficile to release ssDNA and facilitate the detection of C. difficle 
toxins using specific DNA probes (Joshi et al. 2014). A similar approach has also been used to 
recover DNA from Bacillus anthracis spores (Aslan et al. 2008) and Chlamydia trachomatis 
(Zhang et al. 2010). In chapter 5, it was observed that DNA release from cells was as a result of 
membrane disruption (Jankovic et al. 2014). In this chapter, the optimum MW condition for the 
release of ssDNA from M. abscessus and other microorganisms was investigated as it is key step 
in the development of a MP based detection assay.  
 
 
 
Figure 6.3 Flow chart of sample processing and detection of targeted bacteria .  
ssDNA released from MW treated bacterial suspensions will be applied to an ELISA assay using 
specific probes to determine the presence or absence of target gene.  
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6.5 Bacterial-macrophage infection model 
Preparation of target DNA can present several challenges depending on the composition and 
complexity of the sample. In diagnosing M. abscessus from cystic fibrosis (CF) patients, sputum 
is the sample of choice. Sputum is a complex mixture of pus, cell debris, dead tissues and could 
contain common bacterial pathogens e.g. Pseudomonas aeruginosa which is also frequently 
isolated from CF patients (Birmes et al. 2017). During infection, macrophages are produced, and 
these engulf and destroy invading pathogenic microorganisms. Paradoxically, some intracellular 
microorganisms have the preference to multiply within macrophages and escape killing (Price and 
Vance 2014). Thus, clinical sputum samples may include not only macrophages but M. abscessus 
trapped within macrophages. The ability of MW’s to interact with M. abscessus trapped within 
macrophages and to release bacterial nucleic acids is a key first step in the development of the 
detection assay described in section 6.3.  
 
In the absence of clinical samples, a bacteria-macrophage infection model was developed to 
mimic. bacterial cells trapped inside a macrophage. The ability of the MWs to disrupt both 
macrophage and bacterial membrane to release unfragmented target DNA, and to be detected in 
the hybridization assay will be investigated.  M. smegmatis instead of M. abscessus was used as a 
surrogate to infect macrophages as we were unable to obtain M. abscessus green fluorescent 
protein (GFP) expressing variant.  
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6.6 Aim 
The aim of this chapter is to develop a sandwich hybridization assay capable of detecting M. 
abscessus using specifically designed probes. The speed and sensitivity of the assay is enhanced 
by the application of MWs to liberate ssDNA from bacteria and from macrophages infected with 
bacteria which is subsequently captured by MPs. In future applications, this assay can be applied 
for the detection of M. tuberculosis.   
 
6.7 Objectives 
The objectives are; 
1. To determine the optimum MW conditions for the release of bacteria specific nucleic acid 
from bacteria and macrophages infected with bacteria 
2. To optimize the assay parameters for the specific detection of M. abscessus 
3. To determine the specificity and sensitivity of the assay in detecting M. abscessus  
4. To develop a bacterial infection model for the detection of M. smegmatis (surrogate for 
M. abscessus) 
5. To determine sensitivity of the assay in M. smegmatis-macrophage infected cultures 
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6.8 Materials 
6.8.1 Hybridization assay 
Magnetite particles (MPs) - Dynabeads MyOne streptavidin coated beads C1 were purchased from 
Invitrogen, Thermofisher. Tween 20, Triton X-100, Bovine Serum Albumin (BSA), 1M H2SO4 
(stopping solution) and 1-StepTM Ultra TMB-ELISA solution were all purchased from 
Thermofisher Scientific. A MagRack 6 for the separation of magnetic beads was purchased from 
(Sigma Aldrich).  
 
6.8.2 Developing macrophage-infection model 
Mouse BALB/c monocyte macrophage; J774A.1, were purchased from the European Collection 
of Authenticated Cell Cultures (ECACC 91051511) as it is a very effective phagocytic cell line  
(Anes et al. 2006; Jordao et al. 2008). Dubelco Minimum Essential Media (DMEM), L-Glutamine, 
Pen-Strep, Fetal bovine serum (FBS) and 1 X PBS (GibcoTM) were purchased from ThermoFisher 
Scientific, UK. Gentamicin sulphate was purchased from Sigma Aldrich.   
 
6.8.3 Fluorescent labelling and confocal microscopy 
Transferrin Alexa FluorTM 546, Mounting oil solution (Dako) and para-formaldehyde (PFA) were 
purchased from Thermofisher Scientific.  
 
6.9 Methodology 
6.9.1 Determining the optimum MW power for the release of nucleic acids 
To identify the optimum MW condition for the release of dsDNA and ssDNA from M. 
abscessus and from J774A.1 macrophage cells, 170 µL of each cell type; 
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M. abscessus suspension (3.4 x 107 CFU/mL) and J774A.1 (1 x 106 cells/mL) were 
irradiated separately with MWs pulsed at varying duty cycles (30%, 40% and 50%) for 
10 and 20 seconds. MW pulsing was kept at a width of 1000 ms while the ON period was 
varied at 300 ms, 400 ms and 500 ms corresponding to 30% and 40% and 50% duty cycles 
respectively. M. abscessus and macrophage cells without MW treatment were included as 
negative controls. MW treated samples were quantified for dsDNA and ssDNA using the 
Qubit BR assay kit and Qubit 3.0 fluorometer (Life Technologies). The integrity of the 
released DNA following MW treatment of bacterial cells were determined on a 1.5% 
agarose gel as described in section (3.8.5.1) 
 
6.9.2. Capture of biotin labelled probes by streptavidin coated MPs 
MPs (100 µL) were washed three times with 1 X PBS to remove the storage buffer which 
contained azide and can inhibit the hybridization assay. To immobilize biotin probes on to MPs, 
10 µL of 20 µM biotin modified probes were immobilized on 100 µL of MPs at room temperature 
for 1 hour in an orbital shaker (170 rpm). Unbound probes were removed from the MPs by the 
application of a magnet (MagRack 6, GE Healthcare) followed by washing with 1X PBS. To 
determine whether biotin probes had bound to the MPs, the concentration of probe before and 
after addition to MPs was determined. The difference in probe concentration before and after 
addition to beads was determined to estimate the amount of probe bound to bead. The Qubit 3.0 
fluorometer was used to determine probe concentration. The possibility of probes leeching from 
MPs after several washes was also determined by measuring the probe concentration in the wash 
buffers after three washing steps. 
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6.9.3 Blocking unbound and free sites on surfaces of MPs 
Reducing background signal generated by the non- specific binding of HRP labelled DNA probes 
was important in developing this assay. Three different blocking solutions were tested to 
determine their effectiveness at blocking non-specific binding to the surfaces of the MPs. MPs 
were incubated with 200 µL of one of the following blocking solutions: (i) 1% BSA + 1% Triton 
X-100+ 1% Tween 20, (ii) 2X casein and (iii) 1% BSA solution, at room temperature and shaking 
at 170 rpm for 1 hour. Following blocking, MPs were collected from the suspension using a 
magnet and washed three times with hybridization buffer (PBS-Tween 20 (0.05%)). To determine 
the success of the blocking process, MPs were incubated with probe modified with horse radish 
peroxidase (HRP) (5 µL, 10 µM) in 195 µL of hybridization buffer for 1 hour. MPs were then 
washed thrice with hybridization buffer and the presence of HRP, if any, was detected by the 
addition of TMB substrate followed by the addition of 0.1 M HCl.  
 
6.9.4 The detection of M. abscessus ssDNA using ELOSHA 
The presence of purified and crude (released from microwaved bacteria) ssDNA were determined 
using probes targeting either the rpoB or the erm-41gene. In a typical experiment, ssDNA obtained 
from M. abscessus cells i.e. purified = 10 ng/µL or microwaved = 20 ng/µL were incubated with 
biotin probe functionalized MPs (10 µL), HRP probe (5 µL, 10 µM) and 150 µL of hybridization 
buffer. The mixture contained in a microcentrifuge tube was incubated at 50°C in an orbital 
incubator shaker at 200 rpm for 1 hour. After 1 hour of hybridization, the hybrid complex was 
separated from the solution via the application of a magnet and the supernatant which includes 
unbound probes were removed. The MPs were washed thrice with hybridization buffer and the 
presence of target gene was indirectly detected by addition of 100 µL TMB substrate for 10 min 
which would generate a blue color for a positive test. The enzyme substrate reaction was then 
stopped by the addition of 100 µL of 0.1 M HCl yielding a yellow color. As a control, non-specific 
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bacteria (E. coli, S. aureus, C. albicans and Enterococcus faecalis) were included to determine 
the specificity of the assay. A no template control (NTC) was also included in the assay. 
 
 6.9.5 Determining the sensitivity and specificity of the detection assay  
The sensitivity of the ELOSHA was determined using the erm-41 probes with purified ssDNA as 
a template. Serial dilutions of the following purified ssDNA; 10 ng/ µL, 1 ng/µL, 100 pg/µL, 10 
pg/µL and 1 pg/µL were prepared and tested in the assay as described in section 6.9.4. The 
specificity of the assay was also determined using a cocktail of ssDNA obtained from non-M. 
abscessus isolates (C. albicans, E. coli, MRSA, M. smegmatis and E. faecalis). ssDNA from these 
bacterial cells with (positive DNA mix) or without (negative DNA mix) M. abscessus ssDNA 
were mixed to a final concentration of 10 ng/µL. Twenty microliters of these solutions were tested 
in the assay as described in section 6.9.4.  
 
6.9.6 Developing bacterial-macrophage infection model  
6.9.6.1 Cell Line culture and bacterial infection 
J774A.1 macrophage was cultured in Dubleco Modified Eagle media (DMEM) supplemented with 
10% FBS, 1% L-glutamine and 1% Pen-Strep (complete culture media). Macrophages were 
incubated at 37ºC in 5% CO2 to 80% confluency, harvested and seeded onto 16 mm diameter 
cover slips in an 8-well tissue culture plate to a concentration of 1.0 x 106 cells/mL and incubated 
overnight in a fresh culture media. Cells were then washed with warm culture media and replaced 
with culture media without 1% Pen-Strep (antibiotic-free medium) for bacterial infection. To 
allow optimum infection of macrophage cells, bacterial cells (GFP M. smegmatis) at varying 
concentrations of 1 x 106 CFU/mL, 5 x 106 CFU/mL and 1 x 107 CFU/mL were added to 
macrophage cells to achieve a multiplicity of infection (MOI) of 1, 5 and 10 respectively. 
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Macrophage infected with bacterial cells were incubated for 3 hours at 37 ºC in 5% CO2. The 
optimum bacterial concentration to infect bacterial cells identified by this method was used in 
subsequent assays.  
 
6.9.6.2 Estimating the percentage of viable intracellular bacteria 
Infected macrophage cells were incubated for 3 hours to allow phagocytosis. To estimate the 
percentage of viable intracellular GFP M. smegmatis, macrophage infected cells were treated with 
(Gen +) or without (Gen -) gentamicin 50 µg/mL and incubated at 37 °C for 1 hour to kill 
extracellular bacteria. Their previous incubation times after addition of bacterial cells were 2 hours 
followed by 1 hour with gentamicin. Cells were then washed three times with warm PBS and 
further lysed with 500 µL of distilled water at 37°C for 1 hour. Cell lysates were serially diluted, 
plated on LB agar and incubated at 37 °C overnight. Visible colonies were counted and calculated 
in log cfu/mL as described in chapter 2. The percentage of intracellular bacteria was estimated 
using the formula below.  
 
Viable intracellular bacteria = Bacterial concentration after gentamicin treatment (Gen +) x 100 
                                              Bacterial concentration without gentamicin treatment (Gen -) 
 
6.9.6.3 Fluorescent labelling and confocal microscopy 
Macrophages infected with GFP M. smegmatis were washed three times with ice cold 1X PBS 
(GibcoTM) to remove extracellular bacteria and stained with cold transferrin 546 (10 µg/mL) for 
15 min in the dark. After staining, cells were washed with 1X PBS and fixed with 3% para-
formaldehyde for 15 min in the dark. Fixed cells were then washed with warm 1X PBS, blotted 
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dry and mounted on a microscope slide and covered with 20 µL mounting oil immersion. Images 
were captured on a Leica SP5 confocal laser scanning microscope (Leica, Germany) under a X63 
objective lens. GFP and transferrin 546 were excited at 488 nm and 543 nm respectively and 
emissions were collected sequentially at 510 nm and 573 nm respectively. Z-stack images were 
generated with a z-step of 0.49 µm. Images were captured from 10 different fields and analysed 
using Fiji imaging software (Schindelin et al. 2012).  
 
6.9.6.4 Identification of M. smegmatis in macrophage cells  
Following the successful development of the macrophage-bacterial infection, cell suspension was 
treated with MWs at 40% duty cycle for 20 seconds to release ssDNA of M. smegmatis, which 
will include ssDNA of that of macrophage cells. Their concentration was determined with Qubit 
BR assay kit. The ssDNA released (20 ng/µL), quantified with the Qubit 3.0 fluorometer were 
tested in the detection assay (described in section 6.9.4) using M. smegmatis specific probes 
(designed in chapter 3).  
 
6.9.6.5 Sensitivity of assay in macrophage infected bacterial cells 
Macrophage infected bacterial cells were diluted 5, 25, 125 and 625 times in PBS. Sample 
dilutions were treated with MWs pulsed at 40% duty cycle for 20 seconds and the amount of 
ssDNA quantified using the Qubit BR assay kit. The ssDNA released (20 ng/µL) were then 
subjected to the detection assay as described in section 6.9.4.  
 
6.10 Statistical Analysis 
Analysis of data for the hybridisation assay were normalised against the E. coli control. In the 
absence of an E. coli control, the results were normalised against the negative control (No template 
control).  
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6.11 Results 
6.11.1 Determining optimum MW condition for the release of dsDNA and ssDNA 
The concentration of single stranded DNA (ssDNA) and double stranded DNA (dsDNA) released 
following MW treatment at varying duty cycles were quantified using the Qubit BR assay kit. 
After 20 seconds, maximum concentration of dsDNA was released at 30 % and 40% duty cycles 
in M. abscessus and at 50% duty cycle from 774A.1 macrophage (fig.6.4). There was no 
significant difference in dsDNA concentrations released from M. abscessus at 30 % and 40% duty 
cycles. Similarly, the maximum release of ssDNA was observed at 30% and 40% duty cycle from 
M. abscessus and at 30% from macrophage cells all after 20 seconds of MW treatment (fig.6.5). 
Again, there was no significant difference in ssDNA concentration at 30% and 40% duty cycles. 
The results in fig. 6.4 and fig. 6.5 indicates that increasing MW duty cycles to 50% decreases the 
concentration of ssDNA and dsDNA. It is likely that the decrease in dsDNA and ssDNA 
concentration be as a result of fragmentation induced by MWs. Temperature generation during 
MW excitation is inevitable. Thus, a combination of temperature and MW specific effect could 
be responsible for this decrease. Microwaved bacteria were electrophoresed in duplicate on 
agarose gel for all conditions tested. DNA released was observed at approximately 100 bp after 
20 seconds of microwave irradiation at 30%, 40% and 50% duty cycles. Except at 50% duty cycle, 
DNA was not visible after 10 seconds at 30% and 40% duty cycles. The reason for this observation 
could be attributed to the higher MW intensity and longer time duration, herein 20 seconds for 
which bacterial cells were exposed. On the contrary, low intensity MWs when applied for a short 
period of time (10 seconds) was not enough to cause DNA release (fig. 6.6). In comparison to the 
untreated cells, it is likely that DNA released following MW irradiation were predominantly 
ssDNA which were observed mainly at 100 bp. High molecular weight DNA (<3000 bp) and 
extracellular DNA attached to bacterial cells were observed trapped in the wells in the untreated 
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samples. The movement of these extracellular DNA could have been restricted owing to their 
overall size and attachment to bacterial cells (fig. 6.6).   
 
                                                                                                                                                                 
 
 
Figure 6.4. MW induced release of dsDNA from M. abscessus  and from J774A.1 
cells. M. abscesssus (3.4 x 107 CFU/mL) and J774A.1 macrophage (1.0 x 106 cells/mL) were 
treated with 12 W MW energy pulsed at 30%, 40% and 50% duty cycles for 10 (blue dots) and 20 
(red dots) seconds. The concentration of dsDNA released were determined using the Qubit 
dsDNA BR assay kit (Invitrogen) and Qubit 3.0 fluorometer. Data represent mean of triplicate 
experiment ± standard deviation.  
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Figure 6.5. MW induced release of ssDNA from M. abscessus  and J774A.1 cells . 
M. abscesssus (3.4 x 107 CFU/mL) and J774A.1 macrophage (1.0 x 106 cells/mL) were treated 
with 12 W MW energy pulsed at 30%, 40% and 50% duty cycles for 10 (blue dots) and 20 (red 
dots) seconds. The concentration of dsDNA released were determined using the Qubit dsDNA BR 
assay kit (Invitrogen) and Qubit 3.0 fluorometer. Data represent mean of triplicate experiment ± 
standard deviation. 
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Figure 6.6. Release of nucleic acids in post microwave irradiated M. abscessus cells.  Suspensions 
of M. abscessus (1x108 CFU/mL) were treated with microwave energy at 30%, 40% and 50% 
duty cycles for 10 and 20 seconds time intervals. Microwaved samples were loaded in duplicate 
for each microwave condition and compared with untreated samples. Lane L= molecular weight 
ladder
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6.11.2 Determining binding capacity of magnetite particles and the effect of 
blocking buffers to reduce background signals 
To confirm that biotin probes had bound to the MPs whose surface is modified with streptavidin, 
the two were mixed and incubated together. The concentration of biotin probe before and after 
addition of MPs was determined and the percentage of probe bound estimated. There was 
significant decrease (p < 0.001) in the concentration of biotin probe following the addition to MPs 
(orange bar), indicating that the probes were bound to MPs possibly via biotin-streptavidin 
interaction (fig 6.7). The binding capacity of the MPs was determined at 89.82% based on the 
ratio of bound and free biotin probe in the solution. Repeated washing of the biotin labelled probes 
did not result in the removal of the probes from the MP surface (fig. 6.8). When HRP labelled 
DNA probes lacking biotin modification was added to the MPs, there was no obvious decrease in 
their free concentration suggesting that minimal non-specific binding to surface of the MPs had 
occurred (fig 6.7). 
 
To determine if low level, non-specific DNA binding had occurred, HRP labelled DNA probes 
were mixed with MP, washed and then suspended in TMB solution. The results indicate that the 
HRP labelled probe does attach to the MPs resulting in a background signal (fig 6.9). To minimize 
the background signal, MPs immobilized with biotin probe were incubated with varying blocking 
solutions prior to incubation with the HRP probe. The background signal was effectively removed 
when MPs were blocked with a solution comprising 1% Tween 20, 1% Triton X-100 and 1% BSA 
(fig 6.10).  In contrast, casein (2x) and 1% BSA were not effective in preventing HRP from 
binding to the MP (fig. 6.10).  
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Figure 6.7 Characterization of the binding of biotin labelled probes to MPs. 
Biotin (10 µL, 20 µM) and HRP labelled probe (5 µL, 10 µM) were added separately to MPs (1.3 
x 108 particles/mL) and incubated at RT for 1 hour. The concentration of HRP and biotin probes 
in the supernatant after addition to MPs were quantified using the Qubit BR assay kit and Qubit 
3.0 fluorometer. Data represents the average of four separate experiments ± standard deviation. 
ns represent no significance. 
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Figure 6.8 Determining the ability of biotin probes to leech from MPs following 
repeated washing. Biotin probes bound to MPs (probe bound) were subjected to three washing 
steps and the supernatants were collected after the first (x1), second (X2) and third (X3) wash 
with hybridization buffer and the concentration of free probes, if any, in the washing buffers were 
quantified using the Qubit 3.0 fluorometer. Data represent mean of triplicate experiment ± 
standard deviation. 
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Figure 6.9 Signal generated by mixing MPs with HRP labelled DNA probe . MPs 
(1.3 x 108 particles/mL) incubated with HRP probes (5 µL, 10 µM) were washed thrice with 
hybridization buffer followed by the addition of TMB substrate for 10 min and stopping solution. 
A background signal was measured even after three washing step with hybridization buffer. Data 
represent mean of duplicate experiment ± standard deviation.  
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Figure 6.10 The ability of blocking buffers to reduce the background signal . The 
ability of different blocking solutions to reduce background signal were determined. HRP probe 
(5 µL, 10 µM) was added to blocked MPs (1.3 x 108 particles/mL) and incubated for 1 hour. The 
presence of HRP probe was determined by the addition of TMB. Background signal was 
effectively reduced below cut-off value when blocking solution comprising 1% Tween 20+1% 
Triton X-100+1% BSA was used. Data represent mean of triplicate experiment ± standard 
deviation. Data represent mean of duplicate experiment ± standard deviation.  
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6.11.3 Detection of purified M. abscessus DNA using ELOSHA  
The principle of the ELOSHA is based on the hybridization of target ssDNA to corresponding 
anchor and the detector probes, with the formation of a 3-strand DNA complex. This assay was 
developed to detect 50-nucleotide sequences within the rpoB and erm-41 genes of M. abscessus. 
The complex is anchored to streptavidin coated MPs via biotin interaction. The target ssDNA is 
indirectly detected by the signal generated from the detector probe (HRP) following the addition 
of TMB substrate (fig 6.2). We first looked at the ability of the erm-41 (fig. 6.11) and rpoB (fig. 
6.12) probes to distinguished M. abscessus from non-M. abscessus isolates (M. smegmatis, E. coli, 
MRSA, E. faecalis and C. albicans) using purified DNA to determine the specificity of the assay. 
Data were normalised against E. coli or against reaction mixture without DNA template i.e. no 
template controls (NTC).  Following normalisation of all data, the assay distinguished M. 
abscessus from non-M. abscessus isolates using the erm-41 (fig. 6.11) and the rpoB probe (fig. 
6.12). The rpoB probe was discontinued because it produced large variations between isolates.  
 
When the erm-41 was tested against impure ssDNA released from microwaved bacteria, it was 
able to distinguish M. abscessus isolates from non-M. abscessus isolates (fig. 6.13). Next, the 
ability of the assay to detect target M. abscessus DNA in the presence of DNA derived from a 
cocktail of non-M. abscessus isolates (C. albicans, E. coli, MRSA, M. smegmatis and E. faecalis) 
was determined. An aliquot of M. abscessus ssDNA was mixed with a cocktail of non-M. 
abscessus DNA (positive mix). The negative mix consisted of a cocktail of ssDNA isolated from 
non-M. abscessus isolates. All ssDNA was mixed at a concentration of 10 ng/µL.  As can be seen 
from figure 6.14, the assay was able to detect M. abscessus in the presence of unrelated bacterial 
DNA (fig. 6.14).  
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Figure 6.11 Colorimetric detection of purified M. abscessus  ssDNA using erm-
41 probe. ssDNA (10 ng/µL) obtained from 7 M. abscessus isolates and non-M. abscessus 
isolates were tested in the detection assay. M-9723 previously identified as M. smegmatis did not 
give any significant signal in comparison to the test isolates. A no template control (NTC) was 
also included. Data represent mean of triplicate experiment ± standard deviation. 
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Figure 6.12 Colorimetric detection of purified M. abscessus  DNA using rpoB 
probe. ssDNA (10 ng/µL) obtained from 7 M. abscessus isolates and non-M. abscessus isolates 
were tested in the detection assay. A no template control (NTC) was also included. Data represent 
mean of triplicate experiment ± standard deviation. 
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Figure 6.13 Colorimetric detection of microwaved M. abscessus  DNA using erm-
41 probe. ssDNA (20 ng/µL) obtained following MW treatment of bacterial suspensions (1x108 
CFU/mL) were subjected to the detection assay. M. abscessus ssDNA were detected from non. 
M. abscessus DNA. Positive control (ATCC 19977) and a NTC were also included. Data represent 
mean of triplicate experiment ± standard deviation. 
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Figure 6.14 Specificity of erm-41 gene assay for M. abscessus  in the presence of 
ssDNA cocktail derived from unrelated bacteria . The signal generated from pure M. 
abscessus ssDNA (ATCC 19977) and a positive mix (M. abscessus ssDNA was mixed with a 
cocktail of non-M. abscessus ssDNA) were significantly higher than that of the negative mix 
(cocktail of ssDNA isolated from non-M. abscessus isolates) and NTC (p < 0.05). The data 
represent mean of triplicate experiment ± standard deviation.  
 
 
6.11.4 Determining the limit of detection of the assay  
The sensitivity of the assay was determined using a range of concentrations of purified ssDNA: 
10 ng/µL, 1 ng/µL, 100 pg/µL and 10 pg/µL, 1 pg/µL, 0.1 pg/µL, 10 fg/µL and 1 fg/µL. As can 
be seen from fig 6.15 the limit of detection was 1 pg/µL.  
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Figure 6.15 Sensitivity of the assay using erm-41 probe. The limit of detection using 
purified ssDNA was 1 pg/µL. The difference in absorbance between 1 pg/µL and 0.1 pg/µL was 
significant (p < 0.05). Data are shown as mean of triplicate experiment ± standard deviation 
 
 
 
6.11.5 Development of macrophage-infection model 
The results above confirm the ability of the assay to detect M. abscessus when suspended in 
solution. While encouraging the next step would be to determine the ability of the approach to 
detect the presence of the pathogen in clinically relevant samples such as infected macrophages. 
Unfortunately, we lacked access to fully validated M. abscessus infected macrophage model. 
While the creation of such a model was feasible the amount of time required to optimize this 
approach was beyond the scope of this project. For this reason, we switched to an M. smegmatis 
infected macrophage model which had been developed as part of another project. This approached 
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offered the additional advantage that we could employ a GFP expressing M. smegmatis and thus 
visualize the location of the bacteria within the infected cells.  
 
To optimize the uptake of GFP M. smegmatis into macrophage cells, varying concentrations of 
the bacteria were incubated with macrophages to achieve an MOI of 1, 5 and 10 bacteria per 
macrophage. To determine the number of viable intracellular bacteria, cells sticking to the external 
surfaces of the macrophages (extracellular bacteria) were killed by exposure to gentamicin after 
which the cells were lysed in water. Gentamicin does not penetrate macrophage cell membranes 
hence does not interfere with the viability of intracellular bacteria. To determine the appropriate 
level of gentamicin to use in this assay a time-kill experiment using 50 and 100 µg/mL of 
gentamicin was performed. As can be seen from figure 6.16, treatment with 50 µg/mL resulted in 
bacterial killing after 60 min of treatment of macrophage exposed cells and was the level used in 
subsequent studies.  
 
The optimum MOI by exposing the macrophages to a range of bacterial concentrations was 
determined. Using an MOI of 1, uptake of bacteria was sparse, leaving most of the macrophages 
empty without bacilli. At MOI of 10, macrophages had high numbers of both intracellular and 
extracellular bacilli. When macrophages were infected with bacterial cells at MOI of 5, the number 
of bacilli in macrophages were almost even, resulting in an average of 2-3 bacilli per macrophage 
(fig 6.18). Overall the concentration of viable intracellular bacteria was estimated at 2.8 x105 
CFU/mL (fig 6.16) representing about 86.81±8.47% of the total bacteria being phagocytosed. For 
this reason, subsequent macrophage infection was carried out at a MOI of 5.  
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In addition to measuring the recovery of viable bacteria from infected macrophages, the ability of 
this bacterium to express GFP meant that it was possible to visualize the location within infected 
macrophages using a fluorescent microscope (fig 6.17).  While a useful tool to determine bacterial 
uptake, it is unable to distinguish between live and dead cells as dead cells retain the ability to 
fluoresce. 
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Figure 6.16 Time-kill kinetics of gentamicin against GFP-M. smegmatis . GFP M. 
smegmatis (1 x 106 CFU/mL) was treated with varying concentration of gentamicin (10, 50 and 
100 µg/mL) and incubated at 37 °C for 30 min and 60 min. Cells without gentamicin treatment 
were set as controls and the concentration of viable cells determined using the Miles and Misra 
method. The results are expressed as log CFU/mL. After 60 min, cells viability was completely 
lost after gentamicin treatment at 50 and 100 µg/mL. Data represent mean of triplicate experiment 
± standard deviation.  
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Figure 6.17 Estimating the concentration of viable intracellular bacteria . 
J774A.1 macrophage was infected with GFP M. smegmatis at MOI = 5 for 3 hours including 1 
hour gentamicin treatment. Post infected cells were treated with (+) or without (-) gentamicin (50 
µg/mL) for 1 hour to kill extracellular bacteria. Macrophage cells were washed thrice with warm 
PBS and lysed with distilled water for 1 hour at 37 °C. Bacterial concentration in cell lysate was 
determined using the Miles and Misra method. The concentration of bacterial cells used to infect 
macrophages were also quantified (initial inoculum). The percentage of viable internalized 
bacteria was estimated at 86.81±8.47%. Data represent mean of triplicate experiment. (***) 
represent p < 0.001.  
 
 
0
1
2
3
4
5
6
7
8
Initial inoculum Gen (-) Gen (+)
Lo
g 
C
FU
/m
L
***
***
203 
 
 
Figure 6.18 Determining the optimum bacterial concentration for macrophage infection . J774A.1 macrophage (1.0 x 
106 cells/mL) were infected with varying concentrations of GFP-M. smegmatis (1 x 106 CFU/mL, 5 x 106 CFU/mL and 1 x 107 CFU/mL) 
resulting in a MOI of 1 (A), 5 (B) and 10 (C) respectively. Infected macrophages were incubated for 3 hours and the macrophage membrane 
stained with Transferrin Alexa 546 (red). Stained cells were observed on a confocal microscope under x63 objective lens. Internalized 
GFP-M. smegmatis was confirmed by capturing Z-stack images and analysed with Image J. Captured images are presented in orthogonal 
views (XZ and YZ) to confirm phagocytic activity. Scale bar in each image correspond to 10 µm.   
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6.11.6 Detection of M. smegmatis in macrophage cells  
Following the successful development of the macrophage-M. smegmatis infection model, the next 
step was to determine the ability of the assay to detect the presence of M. smegmatis engulfed by 
macrophage cells. Infected macrophages were treated with MWs at 40% duty cycle for 20 seconds 
and the released ssDNA was detected using the hybridization assay developed in this study. Using 
the rpoB probe (designed in chapter 3) specific for M. smegmatis, the specificity of the assay was 
determined using purified M. smegmatis ssDNA, macrophages infected with M. smegmatis, lysed 
non-infected macrophages, lysed macrophages spiked with 10 ng/µL of E. coli DNA (control 
DNA) and a no template control (NTC). With the cut-off value determined at 0.314, a positive 
signal was obtained from purified M. smegmatis ssDNA and from M. smegmatis infected 
macrophages but not in non-infected macrophages or from lysed non-infected macrophages 
spiked with E. coli DNA (control DNA) or from the NTC (fig. 6.18). For this particular assay, the 
rpoB probe was used rather than the erm-41 since the erm-41 gene was specific to M. abscessus 
only. The M. smegmatis specific rpoB probe that was designed in section 3.10.3 was able to 
distinguish M. smegmatis from M. abscessus. For this reason, the same probe sequences (anchor 
and detector) were modified with biotin and HRP respectively and synthesized to be used in this 
detection assay.   
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Figure 6.19 Detection of M. smegmatis  DNA in macrophage infected cells. Purified 
ssDNA was obtained from M. smegmatis, microwaved M. smegmatis infected macrophages (20 
ng/uL), lysed non-infected macrophages spiked with E. coli DNA (20 ng/uL), lysed non-infected 
macrophages (20 ng/uL) and a NTC were tested in the detection assay using the rpoB gene. The 
presence of target gene was determined by measuring the signal generated by HRP. Data represent 
mean of triplicate experiment ± standard deviation. 
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6.11.7 Determining the limit of detection of assay in macrophage-bacterial 
suspensions 
In section 6.10.5, the concentration of viable intracellular M. smegmatis released upon 
macrophage lysis was estimated at 2.85 x 105 CFU/mL. The following range of dilutions, 5, 25, 
625 and 3125-fold of this lysate were prepared to determine the limit of detection of the ELOSHA. 
The concentration of ssDNA in sample dilutions before and after MW treatment were quantified 
using the Qubit 3.0 fluorometer. Sample dilutions were treated with MW at 40% duty cycle for 
20 seconds. The concentration of ssDNA (from macrophages and M. smegmatis) was significantly 
increased after MW treatment in samples diluted to a factor of 5, 25, 125 and 625, but not in the 
sample diluted by a factor of 3125 (fig 6.20). The initial ssDNA concentration measured before 
MW exposure is likely to be extracellular nucleic acids present in the cell suspension (fig. 6.19). 
Cells treated with MWs saw a gradual reduction in the concentration of ssDNA (fig 6.20). The 
number of viable bacteria present in each sample dilution was determined using the Miles and 
Misra method and the results displayed in figure 6. 21. As can be seen, there was about a one log 
reduction (from the first to the last dilution) in the concentration of viable bacterial with increasing 
sample dilutions. On the basis of the results presented in figure 6.22 the minimum number of 
intracellular M. smegmatis that could be detected using the assay in its current configuration was 
approximately 7.8 x 104 CFU/mL. 
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Figure 6.20 Quantification of ssDNA in sample dilutions following MW 
treatment . Macrophage infected with bacterial cells at MOI of 5(section 6.10.5) were diluted in 
water to yield the following dilution range 5, 25, 125, 625 and 3125. Diluted cells were treated 
with MWs at 40% duty cycle for 20 seconds and the concentration of ssDNA released after MW 
excitation was quantified using the Qubit 3.0 fluorometer. Blue and orange bars indicate samples 
before and after microwave treatment respectively. The concentration of ssDNA decreases 
gradually in samples from dilution factor of 5 to 625 but was not detected at a dilution of 3125. 
Data represent mean of triplicate experiment ± standard deviation.  
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Figure 6.21 Concentration of viable bacteria in lysed macrophage infected cells . 
Macrophage cells (1.0 x 106 cells/mL) were infected with GFP M. smegmatis (5.0 x 106 cfu/mL) 
representing a MOI of 5 and incubated for 2 hours and treated with gentamicin for additional 1 
hour to kill extracellular bacteria. Post infected macrophages are lysed in water to release 
intracellular bacteria and diluted to the factors of 5, 25, 125, 625 and 3125. The concentration of 
viable bacteria in each of the dilutions were enumerated and the concentration calculated as log 
CFU/mL. Data represent mean of triplicate experiment ± standard deviation.  
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Figure 6.22 Detection of M. smegmatis  in sample dilutions using ELOSHA . 
Sample dilutions diluted were treated with MWs at 40% duty cycle for 20 seconds. ssDNA 
released from sample dilutions were analysed in the detection assay targeting the rpoB gene of M. 
abscessus. The limit of detection was obtained at a dilution factor of 25, corresponding to 4.89 
log CFU/mL. NTC was included in the assay. Data represent mean of triplicate experiment ± 
standard deviation.  
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6.12 Discussion 
Diseases associated with M. abscessus e.g. cystic fibrosis are of public health importance and 
requires attention. More worrying is their possibility of being transmitted from one person to 
another via aerosol generation (Birmes et al. 2017). The current DNA based diagnostic tests for 
M. abscessus e.g. Cobas Amplicor, INNO-LiPA, GenoType NTM-DR kit are sensitive and 
specific but are costly, have long turnaround time and are not easily integrated into the medical 
workflow. They are also only as good as the quality and quantity of DNA they must work with.  
The above challenge necessitates the need to develop simple and low-cost technologies for DNA 
extraction which can be integrated into POC assays. The release of DNA from bacteria such as 
members of the mycobacteria family is particularly challenging due to the rigidity of the 
mycobacterial cell wall. Commercial DNA extraction tools struggle with speed and are costly, 
hence cannot be easily integrated into current diagnostic approaches (Kaser et al. 2009; Käser et 
al. 2010). 
 
In this proof-of-concept study, an assay capable to detect the presence of M. abscessus has been 
developed. This prototype assay employs MW technology to release ssDNA from microorganisms 
in under 20 seconds, followed by detection of these targets using a colorimetric sandwich 
hybridization assay using target specific DNA probes. To enhance the development of the assay, 
MPs modified with probes were used to enrich targets via their complementary sequence. The 
target was then identified indirectly by the signal generated from the HRP modified detector probe 
following a catalytic oxidation with TMB substrate solution. Using this principle, the assay was 
able to distinguish M. abscessus from non-M. abscessus using the erm-41 probe. Based on the 
inconsistency of the rpoB probe, i.e. generating variability in signal intensity in two of the isolates 
(8899 and 10006) and having a higher cut-off value than the erm-41 probe, further application of 
the probe was discontinued. This observation further establishes the need for experimental testing 
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of probes designed using bioinformatic tools and brings to light the limitation in using 
bioinformatic approaches which mostly employ heuristic approaches. Additionally, the genome 
sequences obtained from NCBI only represent a fraction of the diversity that exist in the real 
world, hence the possibility of detecting non-specific bacteria. The assay demonstrated specificity 
in detecting M. abscessus in the presence of other non-M. abscessus ssDNA and in complex 
mixture of macrophages and M. smegmatis, pointing to the robustness of the prototype assay. The 
sensitivity of the assay with regards to the detection of purified M. abscessus DNA was 1.0 pg/µL 
and in the presence of macrophages a positive signal was generated with as few as 7.8 x 104 
CFU/mL of M. smegmatis. 
 
Diagnostic assays (displayed in appendix 4) currently employed for M. abscessus detection 
requires between 4-6 hours to generate results (Peter-Getzlaff et al. 2008; Ngan et al. 2011; Qvist 
et al. 2015; Shenai et al. 2016; Rocchetti et al. 2017). The prototype assay cannot yet be compared 
to these assays as it requires optimization (outlined in section 7.3) and is yet to be evaluated using 
clinical samples. The relative rapidity of the assay is due to the application of MWs to release 
DNA for detection. The ability of microwaves to mediate the rapid release of DNA from bacteria 
has previously been reported (Vaid and Bishop 1998; Joshi et al. 2014). The mechanism by which 
MWs release nucleic acids from cells is unclear. Membrane disruption via thermal or athermal 
means has been frequently reported (Copty et al. 2006). When higher MW power is used, this 
could induce dsDNA and ssDNA fragmentation (Vaid and Bishop 1998) and this could 
compromise the sensitivity of the assay.  For this reason, the optimum MW conditions i.e. MW 
power, MW pulse rate and duration of exposure needed to be determined. In our study MW power 
(12W) pulsed at 40% duty cycle was optimal for the release of unfragmented ssDNA targets. A 
major advantage in MW mediated DNA isolation is that it is rapid and does not require the use of 
expensive or toxic reagents. In addition, the MW technology can be incorporated into microfluidic 
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devices (Breadmore et al. 2003) facilitating the development of POC devices. To improve on the 
sensitivity of the assay, the MW conditions required to liberate ssDNA from low concentrations 
of bacterial cells need to be identified. Also, the concentration of probes displayed on the surface 
of MPs, the concentration of MPs themselves and DNA probes design needs further optimization.  
 
In conclusion, a simple ELOSHA for the detection of M. abscessus and of M. smegmatis ssDNA 
in macrophage cells have been developed. The assay has the potential to be developed into a rapid 
POC which could be used to screen patients upon admission to hospital to enable appropriate 
treatment regimens and clinical management decisions to be made.  In the future, the assay can 
be developed to detect other common pathogens of public health importance, particularly M. 
tuberculosis.  
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Chapter 7 
General Discussion 
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7.1 General Discussion 
The aim of this project was to develop a rapid and simple assay capable of detecting M. 
abscessus and which could ultimately be adapted to detect M. tb. Chapter 3 describes the 
development of a novel chemical-based DNA extraction method for the recovery of high 
yield, pure DNA from rigid M. abscessus cells. Lysis buffer A proved to be the most 
effective, when compared to commercial systems, at recovering DNA from cells of M. 
abscessus. Using this method, sufficient DNA template was isolated to support VNTR 
and PCR based characterisation of the collection of suspected clinical isolates of M. 
abscessus. In combination with clarithromycin sensitivity testing, 7 of the 8 bacterial 
isolates were identified as M. abscessus and one as M. smegmatis. 
 
In chapter 4, a bioinformatic approach was employed to design probes and primers which 
recognised the erm-41 and rpoB genes of M. abscessus and M. smegmatis. The specificity 
and sensitivity of these probes was determined against the panel of 7 M. abscessus clinical 
isolates and a collection of non-M. abscessus isolates using PCR assay. The probes which 
performed the best in terms of specificity and sensitivity test were then used to form the 
basis of the detection assay.  
 
In Chapter 5 the interaction of pulsed nonthermal 2.45 GHz MWs with cell viability and 
membrane integrity of structurally diverse microorganisms was explored. The results 
showed that exposure to sub-lethal MW power levels disrupted cell membrane integrity 
and resulted in the uptake of dextran particles and the release of nucleic acids. The effect 
appeared to be due to the actions of the E field as the H field alone did not cause any 
membrane disruption. The results also showed that a critical E field intensity is required 
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to cause membrane disruption as halving the E field intensity diminished this effect. 
Although the effects seen occurred within approximately 2°C change in bulk temperature, 
there could be some microthermal influence. Thus, cells membrane disruption may be a 
combination of both thermal and MW specific effects.  
 
The development of the detection assay is discussed in chapter 6. The main accelerating 
component of the hybridisation assay is the use of MWs to release nucleic acids from 
microorganisms within 20 seconds. Nucleic acids are mainly locked within the cell’s 
nucleus which is then surrounded by layers of cell membranes and a cell wall (Tortoli 
2014). Using the erm-41 probe designed in chapter 4 and magnetite particles, a detection 
assay capable of distinguishing M. abscessus from non-M. abscessus was developed. The 
assay recorded a sensitivity to the level of 1 pg/uL in detecting purified M. abscessus 
ssDNA and 7.8 x104 CFU/mL in macrophage infected M. smegmatis cells.  
 
In our recent publication, we report the development of a novel split ring MW resonator 
capable of releasing single stranded DNA from C. difficile spores. The split ring resonator 
MW applicator was designed so that so that it could be incorporated into a portable 
handheld diagnostic device. With this approach, different strains of C. difficle were 
distinguished using specific probes (Hayder et al., 2019). Based on our published data, 
the current detection assay has the potential of being built into a handheld lateral flow 
assay for the detection of M. abscessus and other pathogens of public health importance.  
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7.2 Final conclusions 
Overall, this study has successfully achieved the principal aim of developing a rapid assay 
which can detect M. abscessus. The study further proves it is robust and can detect M. 
abscessus in the presence of non-M. abscessus ssDNA and in detecting M. smegmatis in 
the presence of macrophage cells. The speed of the current assay was enhanced using 
MWs to disrupt bacterial cells and release ssDNA within 20 seconds. The mechanism by 
which nucleic acids were released from cells was dependent on the MW E fields plus 
possible thermal temperature effect.  
 
7.3 Future work  
1. Develop a macrophage infection model using M. abscessus 
2. Optimising assay parameters such as probe design, magnetic particle 
concentrations and the concentration of biotin probes loaded on the magnetite 
particles surface to increase sensitivity and reduce the time required to generate a 
result 
3. Optimise the various components of the hybridisation buffer as this contributes to 
hybridisation efficiency and could also reduce the assay time 
4. Testing the robustness of the current prototype assay using clinical samples 
5. Adapt the technology to detect M. tuberculosis 
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